GO:1904851 BP positive regulation of establishment of protein localization to telomere
|
10
|
4.17e-06
|
8.40e-01
|
1.68e-04
|
GO:0048026 BP positive regulation of mRNA splicing, via spliceosome
|
19
|
4.70e-10
|
8.25e-01
|
5.78e-08
|
GO:1904874 BP positive regulation of telomerase RNA localization to Cajal body
|
15
|
3.30e-08
|
8.24e-01
|
2.61e-06
|
GO:0000470 BP maturation of LSU-rRNA
|
12
|
2.49e-06
|
7.85e-01
|
1.17e-04
|
GO:2000767 BP positive regulation of cytoplasmic translation
|
13
|
2.62e-06
|
7.52e-01
|
1.18e-04
|
GO:0000463 BP maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
15
|
8.22e-07
|
7.35e-01
|
5.05e-05
|
GO:0015986 BP proton motive force-driven ATP synthesis
|
20
|
1.40e-08
|
7.33e-01
|
1.27e-06
|
GO:0000387 BP spliceosomal snRNP assembly
|
28
|
2.39e-11
|
7.29e-01
|
3.77e-09
|
GO:0030490 BP maturation of SSU-rRNA
|
20
|
1.87e-08
|
7.26e-01
|
1.59e-06
|
GO:0000447 BP endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
10
|
7.63e-05
|
7.22e-01
|
1.92e-03
|
GO:0000462 BP maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)
|
24
|
9.74e-10
|
7.21e-01
|
1.13e-07
|
GO:0050850 BP positive regulation of calcium-mediated signaling
|
11
|
3.84e-05
|
-7.17e-01
|
1.13e-03
|
GO:0042274 BP ribosomal small subunit biogenesis
|
71
|
1.06e-23
|
6.88e-01
|
3.89e-21
|
GO:0000727 BP double-strand break repair via break-induced replication
|
12
|
3.95e-05
|
6.85e-01
|
1.15e-03
|
GO:1903241 BP U2-type prespliceosome assembly
|
25
|
3.86e-09
|
6.80e-01
|
3.89e-07
|
GO:0045040 BP protein insertion into mitochondrial outer membrane
|
14
|
1.42e-05
|
6.70e-01
|
4.68e-04
|
GO:0009303 BP rRNA transcription
|
13
|
2.95e-05
|
6.69e-01
|
9.07e-04
|
GO:0006270 BP DNA replication initiation
|
25
|
7.59e-09
|
6.67e-01
|
7.30e-07
|
GO:1904871 BP positive regulation of protein localization to Cajal body
|
11
|
1.61e-04
|
6.57e-01
|
3.52e-03
|
GO:0032543 BP mitochondrial translation
|
94
|
2.06e-27
|
6.47e-01
|
1.14e-24
|
GO:0042273 BP ribosomal large subunit biogenesis
|
35
|
3.87e-11
|
6.45e-01
|
5.35e-09
|
GO:0098761 BP cellular response to interleukin-7
|
11
|
2.49e-04
|
6.38e-01
|
4.97e-03
|
GO:0030150 BP protein import into mitochondrial matrix
|
18
|
4.33e-06
|
6.25e-01
|
1.71e-04
|
GO:0002181 BP cytoplasmic translation
|
89
|
1.93e-24
|
6.25e-01
|
8.56e-22
|
GO:0006122 BP mitochondrial electron transport, ubiquinol to cytochrome c
|
12
|
2.07e-04
|
6.19e-01
|
4.33e-03
|
GO:0090267 BP positive regulation of mitotic cell cycle spindle assembly checkpoint
|
12
|
2.07e-04
|
6.18e-01
|
4.33e-03
|
GO:0048025 BP negative regulation of mRNA splicing, via spliceosome
|
21
|
1.07e-06
|
6.15e-01
|
6.05e-05
|
GO:0045039 BP protein insertion into mitochondrial inner membrane
|
13
|
1.24e-04
|
6.15e-01
|
2.94e-03
|
GO:0042776 BP proton motive force-driven mitochondrial ATP synthesis
|
54
|
7.01e-15
|
6.12e-01
|
1.72e-12
|
GO:0030174 BP regulation of DNA-templated DNA replication initiation
|
13
|
1.35e-04
|
6.11e-01
|
3.14e-03
|
GO:0055119 BP relaxation of cardiac muscle
|
12
|
2.46e-04
|
-6.11e-01
|
4.97e-03
|
GO:0001682 BP tRNA 5’-leader removal
|
13
|
1.41e-04
|
6.10e-01
|
3.22e-03
|
GO:0043116 BP negative regulation of vascular permeability
|
11
|
5.04e-04
|
-6.06e-01
|
8.85e-03
|
GO:0000460 BP maturation of 5.8S rRNA
|
13
|
1.56e-04
|
6.06e-01
|
3.46e-03
|
GO:2000234 BP positive regulation of rRNA processing
|
10
|
9.35e-04
|
6.04e-01
|
1.40e-02
|
GO:0006364 BP rRNA processing
|
113
|
1.33e-28
|
6.04e-01
|
1.37e-25
|
GO:0006353 BP DNA-templated transcription termination
|
11
|
5.42e-04
|
6.02e-01
|
9.26e-03
|
GO:0006123 BP mitochondrial electron transport, cytochrome c to oxygen
|
15
|
5.74e-05
|
6.00e-01
|
1.55e-03
|
GO:0042254 BP ribosome biogenesis
|
28
|
8.47e-08
|
5.85e-01
|
6.46e-06
|
GO:0000027 BP ribosomal large subunit assembly
|
18
|
2.00e-05
|
5.81e-01
|
6.52e-04
|
GO:0043691 BP reverse cholesterol transport
|
10
|
1.80e-03
|
-5.70e-01
|
2.17e-02
|
GO:0044571 BP [2Fe-2S] cluster assembly
|
11
|
1.15e-03
|
5.66e-01
|
1.57e-02
|
GO:0002183 BP cytoplasmic translational initiation
|
11
|
1.21e-03
|
5.63e-01
|
1.63e-02
|
GO:0035235 BP ionotropic glutamate receptor signaling pathway
|
10
|
2.07e-03
|
-5.63e-01
|
2.39e-02
|
GO:0006405 BP RNA export from nucleus
|
17
|
6.22e-05
|
5.61e-01
|
1.62e-03
|
GO:0034501 BP protein localization to kinetochore
|
11
|
1.35e-03
|
5.58e-01
|
1.75e-02
|
GO:0034427 BP nuclear-transcribed mRNA catabolic process, exonucleolytic, 3’-5’
|
10
|
2.25e-03
|
5.58e-01
|
2.57e-02
|
GO:0017158 BP regulation of calcium ion-dependent exocytosis
|
15
|
1.91e-04
|
-5.56e-01
|
4.09e-03
|
GO:0000028 BP ribosomal small subunit assembly
|
14
|
3.46e-04
|
5.52e-01
|
6.38e-03
|
GO:0000245 BP spliceosomal complex assembly
|
28
|
4.44e-07
|
5.51e-01
|
2.98e-05
|
GO:0000338 BP protein deneddylation
|
11
|
1.55e-03
|
5.51e-01
|
1.95e-02
|
GO:0006268 BP DNA unwinding involved in DNA replication
|
21
|
1.37e-05
|
5.48e-01
|
4.66e-04
|
GO:2000779 BP regulation of double-strand break repair
|
26
|
1.43e-06
|
5.46e-01
|
7.35e-05
|
GO:0006784 BP heme A biosynthetic process
|
10
|
2.92e-03
|
5.44e-01
|
3.13e-02
|
GO:0000380 BP alternative mRNA splicing, via spliceosome
|
22
|
1.07e-05
|
5.42e-01
|
3.88e-04
|
GO:0006164 BP purine nucleotide biosynthetic process
|
12
|
1.17e-03
|
5.41e-01
|
1.59e-02
|
GO:0000375 BP RNA splicing, via transesterification reactions
|
25
|
3.99e-06
|
5.33e-01
|
1.65e-04
|
GO:0006626 BP protein targeting to mitochondrion
|
28
|
1.18e-06
|
5.30e-01
|
6.51e-05
|
GO:0000492 BP box C/D snoRNP assembly
|
10
|
3.69e-03
|
5.30e-01
|
3.66e-02
|
GO:1901838 BP positive regulation of transcription of nucleolar large rRNA by RNA polymerase I
|
10
|
3.70e-03
|
5.30e-01
|
3.66e-02
|
GO:0046685 BP response to arsenic-containing substance
|
11
|
2.56e-03
|
5.25e-01
|
2.83e-02
|
GO:0032981 BP mitochondrial respiratory chain complex I assembly
|
55
|
1.74e-11
|
5.24e-01
|
2.96e-09
|
GO:0070328 BP triglyceride homeostasis
|
13
|
1.14e-03
|
-5.21e-01
|
1.57e-02
|
GO:0042407 BP cristae formation
|
15
|
4.77e-04
|
5.21e-01
|
8.44e-03
|
GO:2000736 BP regulation of stem cell differentiation
|
20
|
5.81e-05
|
5.19e-01
|
1.55e-03
|
GO:0006401 BP RNA catabolic process
|
28
|
2.19e-06
|
5.17e-01
|
1.10e-04
|
GO:0031145 BP anaphase-promoting complex-dependent catabolic process
|
20
|
6.49e-05
|
5.16e-01
|
1.67e-03
|
GO:0006613 BP cotranslational protein targeting to membrane
|
10
|
4.91e-03
|
5.14e-01
|
4.54e-02
|
GO:0010460 BP positive regulation of heart rate
|
11
|
3.72e-03
|
-5.05e-01
|
3.66e-02
|
GO:0000244 BP spliceosomal tri-snRNP complex assembly
|
15
|
7.58e-04
|
5.02e-01
|
1.20e-02
|
GO:0031589 BP cell-substrate adhesion
|
16
|
5.43e-04
|
-4.99e-01
|
9.26e-03
|
GO:0006120 BP mitochondrial electron transport, NADH to ubiquinone
|
38
|
1.02e-07
|
4.99e-01
|
7.49e-06
|
GO:0006783 BP heme biosynthetic process
|
23
|
3.70e-05
|
4.97e-01
|
1.11e-03
|
GO:0006412 BP translation
|
168
|
1.85e-28
|
4.94e-01
|
1.37e-25
|
GO:0075522 BP IRES-dependent viral translational initiation
|
11
|
4.77e-03
|
4.91e-01
|
4.43e-02
|
GO:0006337 BP nucleosome disassembly
|
16
|
6.87e-04
|
4.90e-01
|
1.10e-02
|
GO:0006368 BP transcription elongation by RNA polymerase II
|
34
|
8.93e-07
|
4.87e-01
|
5.34e-05
|
GO:0000398 BP mRNA splicing, via spliceosome
|
182
|
1.15e-29
|
4.86e-01
|
2.54e-26
|
GO:0038096 BP Fc-gamma receptor signaling pathway involved in phagocytosis
|
15
|
1.15e-03
|
-4.85e-01
|
1.57e-02
|
GO:0034551 BP mitochondrial respiratory chain complex III assembly
|
12
|
3.92e-03
|
4.81e-01
|
3.77e-02
|
GO:0051131 BP chaperone-mediated protein complex assembly
|
18
|
4.31e-04
|
4.79e-01
|
7.76e-03
|
GO:1901800 BP positive regulation of proteasomal protein catabolic process
|
15
|
1.32e-03
|
4.79e-01
|
1.73e-02
|
GO:0023019 BP signal transduction involved in regulation of gene expression
|
15
|
1.33e-03
|
-4.79e-01
|
1.73e-02
|
GO:0010633 BP negative regulation of epithelial cell migration
|
10
|
9.04e-03
|
4.77e-01
|
6.83e-02
|
GO:1904754 BP positive regulation of vascular associated smooth muscle cell migration
|
12
|
4.36e-03
|
-4.75e-01
|
4.16e-02
|
GO:0007017 BP microtubule-based process
|
14
|
2.26e-03
|
4.71e-01
|
2.57e-02
|
GO:0086002 BP cardiac muscle cell action potential involved in contraction
|
11
|
6.88e-03
|
-4.71e-01
|
5.65e-02
|
GO:1904294 BP positive regulation of ERAD pathway
|
17
|
7.83e-04
|
4.70e-01
|
1.21e-02
|
GO:0001732 BP formation of cytoplasmic translation initiation complex
|
15
|
1.61e-03
|
4.70e-01
|
2.00e-02
|
GO:0006479 BP protein methylation
|
13
|
3.37e-03
|
4.70e-01
|
3.43e-02
|
GO:0045842 BP positive regulation of mitotic metaphase/anaphase transition
|
12
|
4.97e-03
|
4.68e-01
|
4.54e-02
|
GO:0098703 BP calcium ion import across plasma membrane
|
12
|
5.10e-03
|
-4.67e-01
|
4.61e-02
|
GO:0097428 BP protein maturation by iron-sulfur cluster transfer
|
10
|
1.10e-02
|
4.64e-01
|
7.84e-02
|
GO:0050684 BP regulation of mRNA processing
|
18
|
6.51e-04
|
4.64e-01
|
1.06e-02
|
GO:0006400 BP tRNA modification
|
24
|
8.42e-05
|
4.64e-01
|
2.07e-03
|
GO:0006360 BP transcription by RNA polymerase I
|
15
|
1.91e-03
|
4.63e-01
|
2.26e-02
|
GO:0006418 BP tRNA aminoacylation for protein translation
|
18
|
6.75e-04
|
4.63e-01
|
1.09e-02
|
GO:0010569 BP regulation of double-strand break repair via homologous recombination
|
16
|
1.36e-03
|
4.63e-01
|
1.75e-02
|
GO:0019934 BP cGMP-mediated signaling
|
11
|
7.94e-03
|
-4.62e-01
|
6.15e-02
|
GO:0019886 BP antigen processing and presentation of exogenous peptide antigen via MHC class II
|
15
|
2.01e-03
|
-4.61e-01
|
2.34e-02
|
GO:0033627 BP cell adhesion mediated by integrin
|
31
|
9.67e-06
|
-4.59e-01
|
3.57e-04
|
GO:0007263 BP nitric oxide mediated signal transduction
|
11
|
8.61e-03
|
-4.57e-01
|
6.59e-02
|
GO:0007004 BP telomere maintenance via telomerase
|
21
|
2.88e-04
|
4.57e-01
|
5.59e-03
|
GO:0009395 BP phospholipid catabolic process
|
10
|
1.25e-02
|
-4.56e-01
|
8.57e-02
|
GO:0030520 BP intracellular estrogen receptor signaling pathway
|
16
|
1.61e-03
|
4.55e-01
|
2.00e-02
|
GO:0033365 BP protein localization to organelle
|
12
|
6.31e-03
|
-4.55e-01
|
5.33e-02
|
GO:0006334 BP nucleosome assembly
|
68
|
8.78e-11
|
4.55e-01
|
1.14e-08
|
GO:0009060 BP aerobic respiration
|
60
|
1.26e-09
|
4.53e-01
|
1.37e-07
|
GO:0060382 BP regulation of DNA strand elongation
|
16
|
1.71e-03
|
4.53e-01
|
2.09e-02
|
GO:0045820 BP negative regulation of glycolytic process
|
12
|
6.91e-03
|
-4.50e-01
|
5.65e-02
|
GO:0006390 BP mitochondrial transcription
|
11
|
9.75e-03
|
4.50e-01
|
7.10e-02
|
GO:0071353 BP cellular response to interleukin-4
|
19
|
7.23e-04
|
4.48e-01
|
1.15e-02
|
GO:0006388 BP tRNA splicing, via endonucleolytic cleavage and ligation
|
12
|
7.27e-03
|
4.48e-01
|
5.81e-02
|
GO:1904507 BP positive regulation of telomere maintenance in response to DNA damage
|
15
|
2.70e-03
|
4.47e-01
|
2.94e-02
|
GO:0045824 BP negative regulation of innate immune response
|
22
|
2.94e-04
|
4.46e-01
|
5.65e-03
|
GO:0022408 BP negative regulation of cell-cell adhesion
|
12
|
7.61e-03
|
-4.45e-01
|
5.99e-02
|
GO:0007007 BP inner mitochondrial membrane organization
|
19
|
7.88e-04
|
4.45e-01
|
1.21e-02
|
GO:0008033 BP tRNA processing
|
20
|
5.85e-04
|
4.44e-01
|
9.80e-03
|
GO:0031124 BP mRNA 3’-end processing
|
22
|
3.13e-04
|
4.44e-01
|
5.83e-03
|
GO:0038202 BP TORC1 signaling
|
12
|
7.90e-03
|
4.43e-01
|
6.13e-02
|
GO:0051932 BP synaptic transmission, GABAergic
|
15
|
3.07e-03
|
-4.41e-01
|
3.24e-02
|
GO:0070935 BP 3’-UTR-mediated mRNA stabilization
|
13
|
5.87e-03
|
4.41e-01
|
5.09e-02
|
GO:0042659 BP regulation of cell fate specification
|
13
|
5.92e-03
|
4.41e-01
|
5.11e-02
|
GO:0046596 BP regulation of viral entry into host cell
|
10
|
1.58e-02
|
-4.41e-01
|
1.03e-01
|
GO:0048024 BP regulation of mRNA splicing, via spliceosome
|
18
|
1.22e-03
|
4.40e-01
|
1.63e-02
|
GO:1903861 BP positive regulation of dendrite extension
|
15
|
3.18e-03
|
-4.40e-01
|
3.32e-02
|
GO:0042797 BP tRNA transcription by RNA polymerase III
|
12
|
8.82e-03
|
4.37e-01
|
6.71e-02
|
GO:0000413 BP protein peptidyl-prolyl isomerization
|
17
|
1.83e-03
|
4.37e-01
|
2.18e-02
|
GO:0006913 BP nucleocytoplasmic transport
|
44
|
5.44e-07
|
4.37e-01
|
3.44e-05
|
GO:1900273 BP positive regulation of long-term synaptic potentiation
|
15
|
3.52e-03
|
-4.35e-01
|
3.55e-02
|
GO:0006983 BP ER overload response
|
11
|
1.25e-02
|
4.35e-01
|
8.57e-02
|
GO:0045109 BP intermediate filament organization
|
20
|
7.74e-04
|
-4.34e-01
|
1.21e-02
|
GO:0048681 BP negative regulation of axon regeneration
|
10
|
1.75e-02
|
-4.34e-01
|
1.10e-01
|
GO:0002026 BP regulation of the force of heart contraction
|
10
|
1.77e-02
|
-4.33e-01
|
1.11e-01
|
GO:0007140 BP male meiotic nuclear division
|
15
|
3.76e-03
|
-4.32e-01
|
3.67e-02
|
GO:0070979 BP protein K11-linked ubiquitination
|
30
|
4.20e-05
|
4.32e-01
|
1.18e-03
|
GO:0045332 BP phospholipid translocation
|
19
|
1.15e-03
|
-4.31e-01
|
1.57e-02
|
GO:0045116 BP protein neddylation
|
21
|
6.36e-04
|
4.31e-01
|
1.04e-02
|
GO:0070131 BP positive regulation of mitochondrial translation
|
16
|
2.91e-03
|
4.30e-01
|
3.13e-02
|
GO:0046655 BP folic acid metabolic process
|
13
|
7.41e-03
|
4.29e-01
|
5.90e-02
|
GO:0048546 BP digestive tract morphogenesis
|
10
|
1.95e-02
|
-4.27e-01
|
1.17e-01
|
GO:0006376 BP mRNA splice site recognition
|
16
|
3.34e-03
|
4.24e-01
|
3.42e-02
|
GO:0006406 BP mRNA export from nucleus
|
51
|
1.75e-07
|
4.23e-01
|
1.25e-05
|
GO:0019079 BP viral genome replication
|
10
|
2.10e-02
|
4.22e-01
|
1.23e-01
|
GO:0086091 BP regulation of heart rate by cardiac conduction
|
21
|
8.46e-04
|
-4.21e-01
|
1.27e-02
|
GO:0000076 BP DNA replication checkpoint signaling
|
13
|
8.69e-03
|
4.20e-01
|
6.63e-02
|
GO:0070934 BP CRD-mediated mRNA stabilization
|
11
|
1.63e-02
|
4.18e-01
|
1.06e-01
|
GO:0006536 BP glutamate metabolic process
|
13
|
9.44e-03
|
4.16e-01
|
7.04e-02
|
GO:1902236 BP negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway
|
17
|
3.00e-03
|
4.16e-01
|
3.19e-02
|
GO:0010745 BP negative regulation of macrophage derived foam cell differentiation
|
10
|
2.28e-02
|
-4.16e-01
|
1.27e-01
|
GO:0008016 BP regulation of heart contraction
|
11
|
1.71e-02
|
-4.15e-01
|
1.09e-01
|
GO:0033314 BP mitotic DNA replication checkpoint signaling
|
10
|
2.32e-02
|
4.15e-01
|
1.28e-01
|
GO:0006310 BP DNA recombination
|
46
|
1.21e-06
|
4.14e-01
|
6.51e-05
|
GO:0045453 BP bone resorption
|
17
|
3.18e-03
|
-4.13e-01
|
3.32e-02
|
GO:0008380 BP RNA splicing
|
164
|
7.04e-20
|
4.13e-01
|
2.22e-17
|
GO:0048535 BP lymph node development
|
11
|
1.79e-02
|
-4.12e-01
|
1.11e-01
|
GO:0021762 BP substantia nigra development
|
35
|
2.46e-05
|
4.12e-01
|
7.67e-04
|
GO:0006260 BP DNA replication
|
87
|
3.10e-11
|
4.12e-01
|
4.57e-09
|
GO:0016973 BP poly(A)+ mRNA export from nucleus
|
18
|
2.52e-03
|
4.11e-01
|
2.81e-02
|
GO:0046323 BP glucose import
|
12
|
1.42e-02
|
-4.09e-01
|
9.55e-02
|
GO:0006397 BP mRNA processing
|
161
|
4.23e-19
|
4.08e-01
|
1.17e-16
|
GO:0045333 BP cellular respiration
|
33
|
5.02e-05
|
4.08e-01
|
1.37e-03
|
GO:0008654 BP phospholipid biosynthetic process
|
20
|
1.64e-03
|
-4.07e-01
|
2.03e-02
|
GO:0045943 BP positive regulation of transcription by RNA polymerase I
|
22
|
9.83e-04
|
4.06e-01
|
1.45e-02
|
GO:0030007 BP intracellular potassium ion homeostasis
|
10
|
2.64e-02
|
-4.06e-01
|
1.39e-01
|
GO:0006396 BP RNA processing
|
75
|
1.30e-09
|
4.05e-01
|
1.37e-07
|
GO:0032006 BP regulation of TOR signaling
|
16
|
5.19e-03
|
4.04e-01
|
4.65e-02
|
GO:0034080 BP CENP-A containing chromatin assembly
|
10
|
2.72e-02
|
4.03e-01
|
1.42e-01
|
GO:0071280 BP cellular response to copper ion
|
14
|
9.20e-03
|
4.02e-01
|
6.92e-02
|
GO:0051292 BP nuclear pore complex assembly
|
11
|
2.12e-02
|
4.01e-01
|
1.23e-01
|
GO:0045446 BP endothelial cell differentiation
|
10
|
2.80e-02
|
-4.01e-01
|
1.44e-01
|
GO:0006620 BP post-translational protein targeting to endoplasmic reticulum membrane
|
10
|
2.82e-02
|
4.01e-01
|
1.44e-01
|
GO:0051445 BP regulation of meiotic cell cycle
|
19
|
2.50e-03
|
4.01e-01
|
2.79e-02
|
GO:0071318 BP cellular response to ATP
|
14
|
9.69e-03
|
-3.99e-01
|
7.10e-02
|
GO:0051085 BP chaperone cofactor-dependent protein refolding
|
30
|
1.55e-04
|
3.99e-01
|
3.46e-03
|
GO:0007094 BP mitotic spindle assembly checkpoint signaling
|
28
|
2.57e-04
|
3.99e-01
|
5.08e-03
|
GO:0006413 BP translational initiation
|
53
|
5.35e-07
|
3.98e-01
|
3.44e-05
|
GO:0030539 BP male genitalia development
|
12
|
1.70e-02
|
-3.98e-01
|
1.09e-01
|
GO:0000070 BP mitotic sister chromatid segregation
|
31
|
1.33e-04
|
3.96e-01
|
3.14e-03
|
GO:0003382 BP epithelial cell morphogenesis
|
11
|
2.31e-02
|
-3.96e-01
|
1.28e-01
|
GO:0045494 BP photoreceptor cell maintenance
|
23
|
1.05e-03
|
-3.95e-01
|
1.52e-02
|
GO:0071397 BP cellular response to cholesterol
|
15
|
8.34e-03
|
-3.93e-01
|
6.43e-02
|
GO:0043928 BP exonucleolytic catabolism of deadenylated mRNA
|
13
|
1.41e-02
|
3.93e-01
|
9.53e-02
|
GO:0022617 BP extracellular matrix disassembly
|
26
|
5.47e-04
|
-3.92e-01
|
9.26e-03
|
GO:1905168 BP positive regulation of double-strand break repair via homologous recombination
|
34
|
7.83e-05
|
3.91e-01
|
1.95e-03
|
GO:0061077 BP chaperone-mediated protein folding
|
38
|
3.11e-05
|
3.90e-01
|
9.43e-04
|
GO:0036297 BP interstrand cross-link repair
|
37
|
4.17e-05
|
3.89e-01
|
1.18e-03
|
GO:0030510 BP regulation of BMP signaling pathway
|
11
|
2.56e-02
|
-3.89e-01
|
1.36e-01
|
GO:2000463 BP positive regulation of excitatory postsynaptic potential
|
20
|
2.63e-03
|
-3.89e-01
|
2.89e-02
|
GO:0070316 BP regulation of G0 to G1 transition
|
22
|
1.65e-03
|
3.88e-01
|
2.03e-02
|
GO:0043393 BP regulation of protein binding
|
10
|
3.39e-02
|
3.87e-01
|
1.64e-01
|
GO:0045671 BP negative regulation of osteoclast differentiation
|
19
|
3.48e-03
|
-3.87e-01
|
3.51e-02
|
GO:0006939 BP smooth muscle contraction
|
18
|
4.50e-03
|
-3.87e-01
|
4.25e-02
|
GO:0045454 BP cell redox homeostasis
|
35
|
7.50e-05
|
3.87e-01
|
1.91e-03
|
GO:0006352 BP DNA-templated transcription initiation
|
17
|
5.96e-03
|
3.85e-01
|
5.11e-02
|
GO:0160049 BP negative regulation of cGAS/STING signaling pathway
|
11
|
2.71e-02
|
3.85e-01
|
1.42e-01
|
GO:0050807 BP regulation of synapse organization
|
12
|
2.10e-02
|
3.85e-01
|
1.23e-01
|
GO:0008015 BP blood circulation
|
15
|
9.94e-03
|
-3.84e-01
|
7.19e-02
|
GO:0006491 BP N-glycan processing
|
10
|
3.56e-02
|
-3.84e-01
|
1.69e-01
|
GO:0046475 BP glycerophospholipid catabolic process
|
11
|
2.76e-02
|
-3.84e-01
|
1.43e-01
|
GO:0043589 BP skin morphogenesis
|
11
|
2.77e-02
|
-3.83e-01
|
1.43e-01
|
GO:0016446 BP somatic hypermutation of immunoglobulin genes
|
12
|
2.20e-02
|
3.82e-01
|
1.26e-01
|
GO:0085020 BP protein K6-linked ubiquitination
|
14
|
1.37e-02
|
3.81e-01
|
9.27e-02
|
GO:1902036 BP regulation of hematopoietic stem cell differentiation
|
10
|
3.73e-02
|
3.80e-01
|
1.75e-01
|
GO:0016226 BP iron-sulfur cluster assembly
|
29
|
3.94e-04
|
3.80e-01
|
7.21e-03
|
GO:0044030 BP regulation of DNA methylation
|
11
|
2.92e-02
|
3.80e-01
|
1.48e-01
|
GO:0033044 BP regulation of chromosome organization
|
17
|
6.72e-03
|
3.80e-01
|
5.61e-02
|
GO:0008156 BP negative regulation of DNA replication
|
13
|
1.82e-02
|
3.78e-01
|
1.13e-01
|
GO:0014059 BP regulation of dopamine secretion
|
15
|
1.12e-02
|
-3.78e-01
|
7.95e-02
|
GO:2000819 BP regulation of nucleotide-excision repair
|
25
|
1.08e-03
|
3.78e-01
|
1.53e-02
|
GO:0070542 BP response to fatty acid
|
12
|
2.39e-02
|
-3.77e-01
|
1.30e-01
|
GO:0002028 BP regulation of sodium ion transport
|
13
|
1.92e-02
|
-3.75e-01
|
1.15e-01
|
GO:0031053 BP primary miRNA processing
|
13
|
1.97e-02
|
3.74e-01
|
1.17e-01
|
GO:0036159 BP inner dynein arm assembly
|
11
|
3.26e-02
|
3.72e-01
|
1.60e-01
|
GO:0042554 BP superoxide anion generation
|
12
|
2.57e-02
|
-3.72e-01
|
1.36e-01
|
GO:1904862 BP inhibitory synapse assembly
|
10
|
4.18e-02
|
-3.72e-01
|
1.88e-01
|
GO:0035234 BP ectopic germ cell programmed cell death
|
12
|
2.58e-02
|
3.72e-01
|
1.37e-01
|
GO:0071404 BP cellular response to low-density lipoprotein particle stimulus
|
13
|
2.11e-02
|
-3.70e-01
|
1.23e-01
|
GO:0019722 BP calcium-mediated signaling
|
52
|
4.04e-06
|
-3.70e-01
|
1.65e-04
|
GO:0048843 BP negative regulation of axon extension involved in axon guidance
|
19
|
5.30e-03
|
-3.69e-01
|
4.69e-02
|
GO:0030071 BP regulation of mitotic metaphase/anaphase transition
|
32
|
3.02e-04
|
3.69e-01
|
5.68e-03
|
GO:0032094 BP response to food
|
14
|
1.75e-02
|
3.67e-01
|
1.10e-01
|
GO:0007080 BP mitotic metaphase chromosome alignment
|
42
|
4.00e-05
|
3.66e-01
|
1.15e-03
|
GO:0006465 BP signal peptide processing
|
13
|
2.23e-02
|
3.66e-01
|
1.26e-01
|
GO:0001892 BP embryonic placenta development
|
18
|
7.19e-03
|
-3.66e-01
|
5.77e-02
|
GO:0033344 BP cholesterol efflux
|
19
|
5.84e-03
|
-3.65e-01
|
5.09e-02
|
GO:2000311 BP regulation of AMPA receptor activity
|
10
|
4.55e-02
|
-3.65e-01
|
1.99e-01
|
GO:0031638 BP zymogen activation
|
13
|
2.27e-02
|
-3.65e-01
|
1.27e-01
|
GO:0050885 BP neuromuscular process controlling balance
|
31
|
4.40e-04
|
-3.65e-01
|
7.85e-03
|
GO:0018146 BP keratan sulfate biosynthetic process
|
14
|
1.83e-02
|
-3.64e-01
|
1.13e-01
|
GO:0055091 BP phospholipid homeostasis
|
12
|
2.92e-02
|
-3.64e-01
|
1.48e-01
|
GO:0061795 BP Golgi lumen acidification
|
10
|
4.66e-02
|
3.63e-01
|
2.01e-01
|
GO:0048557 BP embryonic digestive tract morphogenesis
|
10
|
4.68e-02
|
-3.63e-01
|
2.01e-01
|
GO:0051290 BP protein heterotetramerization
|
13
|
2.35e-02
|
3.63e-01
|
1.29e-01
|
GO:0051968 BP positive regulation of synaptic transmission, glutamatergic
|
19
|
6.19e-03
|
-3.63e-01
|
5.25e-02
|
GO:0051179 BP localization
|
20
|
4.99e-03
|
3.63e-01
|
4.54e-02
|
GO:0032790 BP ribosome disassembly
|
13
|
2.36e-02
|
3.63e-01
|
1.29e-01
|
GO:0006796 BP phosphate-containing compound metabolic process
|
13
|
2.36e-02
|
-3.63e-01
|
1.29e-01
|
GO:0006298 BP mismatch repair
|
27
|
1.13e-03
|
3.62e-01
|
1.57e-02
|
GO:0043401 BP steroid hormone mediated signaling pathway
|
14
|
1.91e-02
|
-3.62e-01
|
1.15e-01
|
GO:2001235 BP positive regulation of apoptotic signaling pathway
|
29
|
7.99e-04
|
-3.60e-01
|
1.22e-02
|
GO:0002098 BP tRNA wobble uridine modification
|
13
|
2.51e-02
|
3.59e-01
|
1.34e-01
|
GO:0106074 BP aminoacyl-tRNA metabolism involved in translational fidelity
|
13
|
2.53e-02
|
3.58e-01
|
1.35e-01
|
GO:1990573 BP potassium ion import across plasma membrane
|
23
|
2.94e-03
|
-3.58e-01
|
3.15e-02
|
GO:0040029 BP epigenetic regulation of gene expression
|
21
|
4.56e-03
|
3.58e-01
|
4.29e-02
|
GO:0006261 BP DNA-templated DNA replication
|
27
|
1.32e-03
|
3.57e-01
|
1.73e-02
|
GO:0051044 BP positive regulation of membrane protein ectodomain proteolysis
|
12
|
3.23e-02
|
-3.57e-01
|
1.59e-01
|
GO:0006282 BP regulation of DNA repair
|
59
|
2.26e-06
|
3.56e-01
|
1.11e-04
|
GO:0000956 BP nuclear-transcribed mRNA catabolic process
|
17
|
1.13e-02
|
3.55e-01
|
7.98e-02
|
GO:0010763 BP positive regulation of fibroblast migration
|
11
|
4.18e-02
|
-3.54e-01
|
1.88e-01
|
GO:0051028 BP mRNA transport
|
59
|
2.57e-06
|
3.54e-01
|
1.18e-04
|
GO:0032786 BP positive regulation of DNA-templated transcription, elongation
|
14
|
2.20e-02
|
3.53e-01
|
1.26e-01
|
GO:0060047 BP heart contraction
|
12
|
3.41e-02
|
3.53e-01
|
1.64e-01
|
GO:0006623 BP protein targeting to vacuole
|
13
|
2.82e-02
|
-3.52e-01
|
1.44e-01
|
GO:0045776 BP negative regulation of blood pressure
|
14
|
2.28e-02
|
-3.51e-01
|
1.27e-01
|
GO:0006998 BP nuclear envelope organization
|
15
|
1.87e-02
|
3.51e-01
|
1.14e-01
|
GO:0051973 BP positive regulation of telomerase activity
|
31
|
7.79e-04
|
3.49e-01
|
1.21e-02
|
GO:0006644 BP phospholipid metabolic process
|
27
|
1.75e-03
|
-3.48e-01
|
2.13e-02
|
GO:0030488 BP tRNA methylation
|
27
|
1.78e-03
|
3.48e-01
|
2.15e-02
|
GO:0080009 BP mRNA methylation
|
17
|
1.33e-02
|
3.47e-01
|
9.02e-02
|
GO:0006457 BP protein folding
|
131
|
7.44e-12
|
3.47e-01
|
1.37e-09
|
GO:0045292 BP mRNA cis splicing, via spliceosome
|
14
|
2.51e-02
|
3.46e-01
|
1.34e-01
|
GO:0006367 BP transcription initiation at RNA polymerase II promoter
|
40
|
1.55e-04
|
3.46e-01
|
3.46e-03
|
GO:0045907 BP positive regulation of vasoconstriction
|
16
|
1.67e-02
|
-3.46e-01
|
1.08e-01
|
GO:0048477 BP oogenesis
|
20
|
7.55e-03
|
-3.45e-01
|
5.97e-02
|
GO:0071285 BP cellular response to lithium ion
|
10
|
5.91e-02
|
-3.45e-01
|
2.31e-01
|
GO:1905820 BP positive regulation of chromosome separation
|
10
|
5.92e-02
|
3.45e-01
|
2.31e-01
|
GO:0010744 BP positive regulation of macrophage derived foam cell differentiation
|
10
|
5.93e-02
|
-3.44e-01
|
2.31e-01
|
GO:0046835 BP carbohydrate phosphorylation
|
20
|
7.73e-03
|
-3.44e-01
|
6.02e-02
|
GO:0021954 BP central nervous system neuron development
|
13
|
3.18e-02
|
-3.44e-01
|
1.57e-01
|
GO:0006119 BP oxidative phosphorylation
|
12
|
3.97e-02
|
3.43e-01
|
1.82e-01
|
GO:0070886 BP positive regulation of calcineurin-NFAT signaling cascade
|
15
|
2.19e-02
|
3.42e-01
|
1.25e-01
|
GO:0019985 BP translesion synthesis
|
13
|
3.29e-02
|
3.42e-01
|
1.60e-01
|
GO:0035641 BP locomotory exploration behavior
|
11
|
5.01e-02
|
-3.41e-01
|
2.09e-01
|
GO:0006488 BP dolichol-linked oligosaccharide biosynthetic process
|
16
|
1.86e-02
|
3.40e-01
|
1.14e-01
|
GO:0002218 BP activation of innate immune response
|
25
|
3.28e-03
|
3.40e-01
|
3.38e-02
|
GO:0060261 BP positive regulation of transcription initiation by RNA polymerase II
|
58
|
7.74e-06
|
3.40e-01
|
3.01e-04
|
GO:0018108 BP peptidyl-tyrosine phosphorylation
|
31
|
1.08e-03
|
-3.39e-01
|
1.53e-02
|
GO:0031110 BP regulation of microtubule polymerization or depolymerization
|
11
|
5.17e-02
|
3.39e-01
|
2.13e-01
|
GO:0046425 BP regulation of receptor signaling pathway via JAK-STAT
|
11
|
5.19e-02
|
-3.39e-01
|
2.14e-01
|
GO:0061158 BP 3’-UTR-mediated mRNA destabilization
|
16
|
1.91e-02
|
3.38e-01
|
1.15e-01
|
GO:0016082 BP synaptic vesicle priming
|
10
|
6.60e-02
|
-3.36e-01
|
2.46e-01
|
GO:0045050 BP protein insertion into ER membrane by stop-transfer membrane-anchor sequence
|
11
|
5.39e-02
|
3.36e-01
|
2.18e-01
|
GO:0007492 BP endoderm development
|
15
|
2.45e-02
|
-3.35e-01
|
1.32e-01
|
GO:0006813 BP potassium ion transport
|
32
|
1.06e-03
|
-3.34e-01
|
1.52e-02
|
GO:0061844 BP antimicrobial humoral immune response mediated by antimicrobial peptide
|
22
|
6.89e-03
|
3.33e-01
|
5.65e-02
|
GO:0007274 BP neuromuscular synaptic transmission
|
17
|
1.77e-02
|
-3.32e-01
|
1.11e-01
|
GO:0060294 BP cilium movement involved in cell motility
|
13
|
3.83e-02
|
-3.32e-01
|
1.78e-01
|
GO:0045815 BP transcription initiation-coupled chromatin remodeling
|
34
|
8.17e-04
|
3.32e-01
|
1.24e-02
|
GO:0019228 BP neuronal action potential
|
11
|
5.68e-02
|
-3.32e-01
|
2.25e-01
|
GO:1902004 BP positive regulation of amyloid-beta formation
|
16
|
2.17e-02
|
-3.31e-01
|
1.25e-01
|
GO:0033619 BP membrane protein proteolysis
|
10
|
6.97e-02
|
3.31e-01
|
2.52e-01
|
GO:0061001 BP regulation of dendritic spine morphogenesis
|
15
|
2.65e-02
|
-3.31e-01
|
1.40e-01
|
GO:0007084 BP mitotic nuclear membrane reassembly
|
10
|
7.03e-02
|
3.31e-01
|
2.54e-01
|
GO:0010906 BP regulation of glucose metabolic process
|
20
|
1.05e-02
|
-3.30e-01
|
7.53e-02
|
GO:0035720 BP intraciliary anterograde transport
|
18
|
1.53e-02
|
3.30e-01
|
1.01e-01
|
GO:0007076 BP mitotic chromosome condensation
|
17
|
1.87e-02
|
3.29e-01
|
1.14e-01
|
GO:0031503 BP protein-containing complex localization
|
14
|
3.29e-02
|
3.29e-01
|
1.60e-01
|
GO:0042176 BP regulation of protein catabolic process
|
16
|
2.26e-02
|
3.29e-01
|
1.27e-01
|
GO:0050873 BP brown fat cell differentiation
|
24
|
5.24e-03
|
-3.29e-01
|
4.66e-02
|
GO:0009968 BP negative regulation of signal transduction
|
30
|
1.82e-03
|
-3.29e-01
|
2.17e-02
|
GO:0045945 BP positive regulation of transcription by RNA polymerase III
|
18
|
1.57e-02
|
3.29e-01
|
1.03e-01
|
GO:0030502 BP negative regulation of bone mineralization
|
10
|
7.29e-02
|
-3.28e-01
|
2.58e-01
|
GO:0050765 BP negative regulation of phagocytosis
|
12
|
4.95e-02
|
3.27e-01
|
2.08e-01
|
GO:0036092 BP phosphatidylinositol-3-phosphate biosynthetic process
|
20
|
1.13e-02
|
-3.27e-01
|
7.96e-02
|
GO:1902275 BP regulation of chromatin organization
|
10
|
7.35e-02
|
3.27e-01
|
2.59e-01
|
GO:0045739 BP positive regulation of DNA repair
|
44
|
1.78e-04
|
3.27e-01
|
3.85e-03
|
GO:0043277 BP apoptotic cell clearance
|
14
|
3.45e-02
|
-3.26e-01
|
1.65e-01
|
GO:0042167 BP heme catabolic process
|
11
|
6.20e-02
|
3.25e-01
|
2.37e-01
|
GO:0071310 BP cellular response to organic substance
|
10
|
7.52e-02
|
-3.25e-01
|
2.64e-01
|
GO:0050921 BP positive regulation of chemotaxis
|
12
|
5.25e-02
|
-3.23e-01
|
2.15e-01
|
GO:0006383 BP transcription by RNA polymerase III
|
24
|
6.17e-03
|
3.23e-01
|
5.25e-02
|
GO:0009062 BP fatty acid catabolic process
|
10
|
7.72e-02
|
-3.23e-01
|
2.67e-01
|
GO:0045047 BP protein targeting to ER
|
14
|
3.66e-02
|
3.23e-01
|
1.73e-01
|
GO:0032367 BP intracellular cholesterol transport
|
11
|
6.40e-02
|
-3.23e-01
|
2.42e-01
|
GO:0010996 BP response to auditory stimulus
|
11
|
6.43e-02
|
-3.22e-01
|
2.43e-01
|
GO:0034454 BP microtubule anchoring at centrosome
|
11
|
6.43e-02
|
-3.22e-01
|
2.43e-01
|
GO:0016322 BP neuron remodeling
|
12
|
5.34e-02
|
-3.22e-01
|
2.16e-01
|
GO:0010591 BP regulation of lamellipodium assembly
|
10
|
7.84e-02
|
3.21e-01
|
2.69e-01
|
GO:0009880 BP embryonic pattern specification
|
15
|
3.15e-02
|
-3.21e-01
|
1.57e-01
|
GO:0031018 BP endocrine pancreas development
|
13
|
4.54e-02
|
-3.21e-01
|
1.99e-01
|
GO:0006275 BP regulation of DNA replication
|
44
|
2.44e-04
|
3.20e-01
|
4.97e-03
|
GO:0034975 BP protein folding in endoplasmic reticulum
|
11
|
6.73e-02
|
3.19e-01
|
2.47e-01
|
GO:0051276 BP chromosome organization
|
22
|
9.72e-03
|
3.18e-01
|
7.10e-02
|
GO:0048599 BP oocyte development
|
13
|
4.70e-02
|
-3.18e-01
|
2.01e-01
|
GO:0042730 BP fibrinolysis
|
12
|
5.64e-02
|
-3.18e-01
|
2.25e-01
|
GO:2001222 BP regulation of neuron migration
|
11
|
6.79e-02
|
-3.18e-01
|
2.49e-01
|
GO:0051123 BP RNA polymerase II preinitiation complex assembly
|
46
|
1.93e-04
|
3.18e-01
|
4.11e-03
|
GO:0071786 BP endoplasmic reticulum tubular network organization
|
11
|
6.84e-02
|
3.17e-01
|
2.50e-01
|
GO:0007088 BP regulation of mitotic nuclear division
|
21
|
1.18e-02
|
3.17e-01
|
8.20e-02
|
GO:0007346 BP regulation of mitotic cell cycle
|
63
|
1.40e-05
|
3.16e-01
|
4.68e-04
|
GO:1902808 BP positive regulation of cell cycle G1/S phase transition
|
11
|
6.96e-02
|
3.16e-01
|
2.52e-01
|
GO:0032434 BP regulation of proteasomal ubiquitin-dependent protein catabolic process
|
13
|
4.92e-02
|
3.15e-01
|
2.08e-01
|
GO:0051168 BP nuclear export
|
12
|
6.00e-02
|
3.14e-01
|
2.33e-01
|
GO:0045190 BP isotype switching
|
16
|
3.01e-02
|
3.13e-01
|
1.51e-01
|
GO:0043068 BP positive regulation of programmed cell death
|
11
|
7.26e-02
|
-3.13e-01
|
2.58e-01
|
GO:0043129 BP surfactant homeostasis
|
12
|
6.10e-02
|
-3.12e-01
|
2.33e-01
|
GO:0050919 BP negative chemotaxis
|
25
|
6.94e-03
|
-3.12e-01
|
5.65e-02
|
GO:0043303 BP mast cell degranulation
|
12
|
6.14e-02
|
-3.12e-01
|
2.35e-01
|
GO:0071805 BP potassium ion transmembrane transport
|
66
|
1.18e-05
|
-3.12e-01
|
4.09e-04
|
GO:0045176 BP apical protein localization
|
10
|
8.81e-02
|
3.12e-01
|
2.91e-01
|
GO:1900087 BP positive regulation of G1/S transition of mitotic cell cycle
|
33
|
1.97e-03
|
3.11e-01
|
2.30e-02
|
GO:0045987 BP positive regulation of smooth muscle contraction
|
10
|
8.84e-02
|
-3.11e-01
|
2.91e-01
|
GO:0006821 BP chloride transport
|
22
|
1.17e-02
|
-3.10e-01
|
8.20e-02
|
GO:0002476 BP antigen processing and presentation of endogenous peptide antigen via MHC class Ib
|
14
|
4.48e-02
|
-3.10e-01
|
1.98e-01
|
GO:0002486 BP antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent
|
14
|
4.48e-02
|
-3.10e-01
|
1.98e-01
|
GO:0006754 BP ATP biosynthetic process
|
14
|
4.48e-02
|
3.10e-01
|
1.98e-01
|
GO:0006139 BP nucleobase-containing compound metabolic process
|
29
|
3.90e-03
|
3.10e-01
|
3.77e-02
|
GO:0008210 BP estrogen metabolic process
|
17
|
2.78e-02
|
3.08e-01
|
1.43e-01
|
GO:0035725 BP sodium ion transmembrane transport
|
54
|
1.02e-04
|
-3.06e-01
|
2.45e-03
|
GO:0050848 BP regulation of calcium-mediated signaling
|
10
|
9.43e-02
|
3.06e-01
|
3.01e-01
|
GO:0042326 BP negative regulation of phosphorylation
|
13
|
5.67e-02
|
-3.05e-01
|
2.25e-01
|
GO:0008608 BP attachment of spindle microtubules to kinetochore
|
16
|
3.46e-02
|
3.05e-01
|
1.65e-01
|
GO:1902600 BP proton transmembrane transport
|
98
|
1.82e-07
|
3.05e-01
|
1.26e-05
|
GO:0070509 BP calcium ion import
|
11
|
7.99e-02
|
-3.05e-01
|
2.74e-01
|
GO:0015918 BP sterol transport
|
13
|
5.81e-02
|
-3.04e-01
|
2.29e-01
|
GO:0000278 BP mitotic cell cycle
|
117
|
1.43e-08
|
3.04e-01
|
1.27e-06
|
GO:0051984 BP positive regulation of chromosome segregation
|
13
|
5.84e-02
|
3.03e-01
|
2.30e-01
|
GO:0007193 BP adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway
|
26
|
7.68e-03
|
-3.02e-01
|
6.00e-02
|
GO:0034727 BP piecemeal microautophagy of the nucleus
|
17
|
3.11e-02
|
-3.02e-01
|
1.56e-01
|
GO:0003094 BP glomerular filtration
|
11
|
8.32e-02
|
-3.02e-01
|
2.80e-01
|
GO:0045948 BP positive regulation of translational initiation
|
15
|
4.32e-02
|
3.01e-01
|
1.93e-01
|
GO:0031424 BP keratinization
|
17
|
3.17e-02
|
-3.01e-01
|
1.57e-01
|
GO:0046488 BP phosphatidylinositol metabolic process
|
13
|
6.02e-02
|
-3.01e-01
|
2.33e-01
|
GO:0006839 BP mitochondrial transport
|
14
|
5.27e-02
|
2.99e-01
|
2.15e-01
|
GO:0035313 BP wound healing, spreading of epidermal cells
|
11
|
8.73e-02
|
-2.98e-01
|
2.89e-01
|
GO:0006895 BP Golgi to endosome transport
|
15
|
4.64e-02
|
-2.97e-01
|
2.01e-01
|
GO:0046902 BP regulation of mitochondrial membrane permeability
|
11
|
8.81e-02
|
2.97e-01
|
2.91e-01
|
GO:0033198 BP response to ATP
|
11
|
8.90e-02
|
-2.96e-01
|
2.92e-01
|
GO:0040037 BP negative regulation of fibroblast growth factor receptor signaling pathway
|
13
|
6.48e-02
|
2.96e-01
|
2.43e-01
|
GO:0034389 BP lipid droplet organization
|
13
|
6.48e-02
|
2.96e-01
|
2.43e-01
|
GO:0019432 BP triglyceride biosynthetic process
|
17
|
3.49e-02
|
-2.96e-01
|
1.66e-01
|
GO:0051775 BP response to redox state
|
10
|
1.06e-01
|
2.95e-01
|
3.25e-01
|
GO:0046928 BP regulation of neurotransmitter secretion
|
13
|
6.59e-02
|
-2.95e-01
|
2.46e-01
|
GO:0030970 BP retrograde protein transport, ER to cytosol
|
16
|
4.16e-02
|
2.94e-01
|
1.88e-01
|
GO:0072384 BP organelle transport along microtubule
|
13
|
6.65e-02
|
2.94e-01
|
2.46e-01
|
GO:0099560 BP synaptic membrane adhesion
|
13
|
6.66e-02
|
-2.94e-01
|
2.46e-01
|
GO:0034063 BP stress granule assembly
|
26
|
9.52e-03
|
2.94e-01
|
7.05e-02
|
GO:0061351 BP neural precursor cell proliferation
|
19
|
2.68e-02
|
2.94e-01
|
1.41e-01
|
GO:0007200 BP phospholipase C-activating G protein-coupled receptor signaling pathway
|
26
|
9.64e-03
|
-2.93e-01
|
7.09e-02
|
GO:0006892 BP post-Golgi vesicle-mediated transport
|
15
|
4.92e-02
|
2.93e-01
|
2.08e-01
|
GO:1902455 BP negative regulation of stem cell population maintenance
|
20
|
2.33e-02
|
2.93e-01
|
1.28e-01
|
GO:1904036 BP negative regulation of epithelial cell apoptotic process
|
11
|
9.32e-02
|
-2.92e-01
|
2.99e-01
|
GO:0043484 BP regulation of RNA splicing
|
63
|
6.17e-05
|
2.92e-01
|
1.62e-03
|
GO:1903672 BP positive regulation of sprouting angiogenesis
|
14
|
5.87e-02
|
2.92e-01
|
2.30e-01
|
GO:0006417 BP regulation of translation
|
71
|
2.20e-05
|
2.91e-01
|
7.04e-04
|
GO:0072344 BP rescue of stalled ribosome
|
29
|
6.63e-03
|
2.91e-01
|
5.57e-02
|
GO:0043923 BP positive regulation by host of viral transcription
|
15
|
5.11e-02
|
2.91e-01
|
2.12e-01
|
GO:0045048 BP protein insertion into ER membrane
|
10
|
1.11e-01
|
2.91e-01
|
3.36e-01
|
GO:0032924 BP activin receptor signaling pathway
|
13
|
6.97e-02
|
-2.91e-01
|
2.52e-01
|
GO:0045651 BP positive regulation of macrophage differentiation
|
12
|
8.17e-02
|
2.90e-01
|
2.77e-01
|
GO:0033690 BP positive regulation of osteoblast proliferation
|
10
|
1.12e-01
|
-2.90e-01
|
3.37e-01
|
GO:0071902 BP positive regulation of protein serine/threonine kinase activity
|
22
|
1.85e-02
|
2.90e-01
|
1.14e-01
|
GO:0006900 BP vesicle budding from membrane
|
13
|
7.08e-02
|
2.89e-01
|
2.54e-01
|
GO:0001774 BP microglial cell activation
|
16
|
4.53e-02
|
-2.89e-01
|
1.99e-01
|
GO:0051988 BP regulation of attachment of spindle microtubules to kinetochore
|
10
|
1.14e-01
|
2.89e-01
|
3.39e-01
|
GO:0031069 BP hair follicle morphogenesis
|
19
|
2.94e-02
|
-2.89e-01
|
1.48e-01
|
GO:0001708 BP cell fate specification
|
18
|
3.43e-02
|
-2.88e-01
|
1.64e-01
|
GO:0048468 BP cell development
|
10
|
1.15e-01
|
-2.88e-01
|
3.41e-01
|
GO:0007059 BP chromosome segregation
|
89
|
2.82e-06
|
2.87e-01
|
1.23e-04
|
GO:0010811 BP positive regulation of cell-substrate adhesion
|
23
|
1.72e-02
|
-2.87e-01
|
1.09e-01
|
GO:0035729 BP cellular response to hepatocyte growth factor stimulus
|
11
|
1.00e-01
|
2.86e-01
|
3.15e-01
|
GO:0032968 BP positive regulation of transcription elongation by RNA polymerase II
|
48
|
6.02e-04
|
2.86e-01
|
1.00e-02
|
GO:0030166 BP proteoglycan biosynthetic process
|
14
|
6.39e-02
|
-2.86e-01
|
2.42e-01
|
GO:0051315 BP attachment of mitotic spindle microtubules to kinetochore
|
15
|
5.54e-02
|
2.86e-01
|
2.22e-01
|
GO:0030195 BP negative regulation of blood coagulation
|
10
|
1.18e-01
|
-2.85e-01
|
3.44e-01
|
GO:0045821 BP positive regulation of glycolytic process
|
13
|
7.55e-02
|
-2.85e-01
|
2.64e-01
|
GO:0007042 BP lysosomal lumen acidification
|
24
|
1.58e-02
|
2.85e-01
|
1.03e-01
|
GO:0032508 BP DNA duplex unwinding
|
54
|
3.02e-04
|
2.84e-01
|
5.68e-03
|
GO:0140042 BP lipid droplet formation
|
11
|
1.03e-01
|
-2.84e-01
|
3.19e-01
|
GO:0009083 BP branched-chain amino acid catabolic process
|
13
|
7.66e-02
|
2.84e-01
|
2.66e-01
|
GO:0002682 BP regulation of immune system process
|
23
|
1.88e-02
|
-2.83e-01
|
1.14e-01
|
GO:0070166 BP enamel mineralization
|
10
|
1.22e-01
|
-2.82e-01
|
3.48e-01
|
GO:0051452 BP intracellular pH reduction
|
13
|
7.81e-02
|
2.82e-01
|
2.69e-01
|
GO:0042026 BP protein refolding
|
21
|
2.55e-02
|
2.82e-01
|
1.36e-01
|
GO:0017148 BP negative regulation of translation
|
76
|
2.23e-05
|
2.81e-01
|
7.04e-04
|
GO:0032516 BP positive regulation of phosphoprotein phosphatase activity
|
12
|
9.24e-02
|
2.81e-01
|
2.98e-01
|
GO:0007097 BP nuclear migration
|
16
|
5.22e-02
|
2.80e-01
|
2.14e-01
|
GO:0140052 BP cellular response to oxidised low-density lipoprotein particle stimulus
|
11
|
1.09e-01
|
-2.79e-01
|
3.32e-01
|
GO:0001755 BP neural crest cell migration
|
28
|
1.07e-02
|
-2.79e-01
|
7.62e-02
|
GO:0044319 BP wound healing, spreading of cells
|
14
|
7.12e-02
|
2.78e-01
|
2.55e-01
|
GO:0034138 BP toll-like receptor 3 signaling pathway
|
11
|
1.10e-01
|
-2.78e-01
|
3.34e-01
|
GO:0008637 BP apoptotic mitochondrial changes
|
16
|
5.41e-02
|
2.78e-01
|
2.18e-01
|
GO:0051602 BP response to electrical stimulus
|
17
|
4.72e-02
|
-2.78e-01
|
2.02e-01
|
GO:0002281 BP macrophage activation involved in immune response
|
10
|
1.28e-01
|
-2.78e-01
|
3.60e-01
|
GO:0009725 BP response to hormone
|
27
|
1.27e-02
|
2.77e-01
|
8.65e-02
|
GO:0071625 BP vocalization behavior
|
10
|
1.31e-01
|
-2.76e-01
|
3.62e-01
|
GO:0045930 BP negative regulation of mitotic cell cycle
|
17
|
4.98e-02
|
-2.75e-01
|
2.09e-01
|
GO:0045742 BP positive regulation of epidermal growth factor receptor signaling pathway
|
23
|
2.26e-02
|
-2.75e-01
|
1.27e-01
|
GO:0060546 BP negative regulation of necroptotic process
|
16
|
5.78e-02
|
2.74e-01
|
2.29e-01
|
GO:0070848 BP response to growth factor
|
12
|
1.00e-01
|
2.74e-01
|
3.16e-01
|
GO:0050900 BP leukocyte migration
|
19
|
3.89e-02
|
-2.74e-01
|
1.80e-01
|
GO:0010634 BP positive regulation of epithelial cell migration
|
28
|
1.22e-02
|
-2.74e-01
|
8.46e-02
|
GO:0061157 BP mRNA destabilization
|
19
|
3.92e-02
|
2.73e-01
|
1.81e-01
|
GO:0045954 BP positive regulation of natural killer cell mediated cytotoxicity
|
13
|
8.82e-02
|
-2.73e-01
|
2.91e-01
|
GO:0001655 BP urogenital system development
|
13
|
8.83e-02
|
2.73e-01
|
2.91e-01
|
GO:0018279 BP protein N-linked glycosylation via asparagine
|
23
|
2.35e-02
|
2.73e-01
|
1.29e-01
|
GO:0007268 BP chemical synaptic transmission
|
99
|
2.83e-06
|
-2.72e-01
|
1.23e-04
|
GO:0071233 BP cellular response to leucine
|
11
|
1.19e-01
|
-2.72e-01
|
3.44e-01
|
GO:0071816 BP tail-anchored membrane protein insertion into ER membrane
|
17
|
5.23e-02
|
2.72e-01
|
2.15e-01
|
GO:0048008 BP platelet-derived growth factor receptor signaling pathway
|
30
|
1.01e-02
|
-2.72e-01
|
7.25e-02
|
GO:2000352 BP negative regulation of endothelial cell apoptotic process
|
21
|
3.19e-02
|
-2.70e-01
|
1.57e-01
|
GO:0006414 BP translational elongation
|
18
|
4.73e-02
|
2.70e-01
|
2.02e-01
|
GO:0010842 BP retina layer formation
|
13
|
9.20e-02
|
-2.70e-01
|
2.97e-01
|
GO:0060048 BP cardiac muscle contraction
|
24
|
2.21e-02
|
-2.70e-01
|
1.26e-01
|
GO:2001244 BP positive regulation of intrinsic apoptotic signaling pathway
|
24
|
2.21e-02
|
2.70e-01
|
1.26e-01
|
GO:0030042 BP actin filament depolymerization
|
11
|
1.22e-01
|
2.69e-01
|
3.48e-01
|
GO:0006281 BP DNA repair
|
238
|
9.66e-13
|
2.69e-01
|
1.94e-10
|
GO:2000434 BP regulation of protein neddylation
|
15
|
7.17e-02
|
2.69e-01
|
2.56e-01
|
GO:0090201 BP negative regulation of release of cytochrome c from mitochondria
|
18
|
4.87e-02
|
2.68e-01
|
2.07e-01
|
GO:0003215 BP cardiac right ventricle morphogenesis
|
12
|
1.08e-01
|
-2.68e-01
|
3.31e-01
|
GO:2000036 BP regulation of stem cell population maintenance
|
10
|
1.42e-01
|
2.68e-01
|
3.77e-01
|
GO:0060291 BP long-term synaptic potentiation
|
34
|
6.99e-03
|
-2.67e-01
|
5.66e-02
|
GO:0003184 BP pulmonary valve morphogenesis
|
12
|
1.09e-01
|
-2.67e-01
|
3.32e-01
|
GO:1902430 BP negative regulation of amyloid-beta formation
|
15
|
7.33e-02
|
-2.67e-01
|
2.59e-01
|
GO:0043473 BP pigmentation
|
14
|
8.43e-02
|
-2.66e-01
|
2.82e-01
|
GO:0001958 BP endochondral ossification
|
23
|
2.72e-02
|
-2.66e-01
|
1.42e-01
|
GO:0015701 BP bicarbonate transport
|
20
|
3.98e-02
|
-2.66e-01
|
1.82e-01
|
GO:0033617 BP mitochondrial cytochrome c oxidase assembly
|
25
|
2.17e-02
|
2.65e-01
|
1.25e-01
|
GO:0038095 BP Fc-epsilon receptor signaling pathway
|
17
|
5.85e-02
|
-2.65e-01
|
2.30e-01
|
GO:0001913 BP T cell mediated cytotoxicity
|
12
|
1.12e-01
|
2.65e-01
|
3.37e-01
|
GO:0030521 BP androgen receptor signaling pathway
|
20
|
4.03e-02
|
2.65e-01
|
1.84e-01
|
GO:0042755 BP eating behavior
|
10
|
1.47e-01
|
-2.65e-01
|
3.85e-01
|
GO:2000772 BP regulation of cellular senescence
|
11
|
1.28e-01
|
2.65e-01
|
3.60e-01
|
GO:0006284 BP base-excision repair
|
28
|
1.54e-02
|
2.65e-01
|
1.02e-01
|
GO:1900745 BP positive regulation of p38MAPK cascade
|
22
|
3.18e-02
|
-2.64e-01
|
1.57e-01
|
GO:0090280 BP positive regulation of calcium ion import
|
12
|
1.13e-01
|
-2.64e-01
|
3.38e-01
|
GO:0034333 BP adherens junction assembly
|
11
|
1.29e-01
|
2.64e-01
|
3.60e-01
|
GO:0060020 BP Bergmann glial cell differentiation
|
10
|
1.50e-01
|
-2.63e-01
|
3.90e-01
|
GO:0007173 BP epidermal growth factor receptor signaling pathway
|
41
|
3.62e-03
|
-2.63e-01
|
3.60e-02
|
GO:0030325 BP adrenal gland development
|
21
|
3.73e-02
|
-2.62e-01
|
1.75e-01
|
GO:0060644 BP mammary gland epithelial cell differentiation
|
10
|
1.52e-01
|
2.62e-01
|
3.93e-01
|
GO:0030224 BP monocyte differentiation
|
14
|
9.04e-02
|
2.61e-01
|
2.94e-01
|
GO:0019933 BP cAMP-mediated signaling
|
34
|
8.51e-03
|
-2.61e-01
|
6.54e-02
|
GO:0043403 BP skeletal muscle tissue regeneration
|
14
|
9.13e-02
|
2.61e-01
|
2.96e-01
|
GO:0051259 BP protein complex oligomerization
|
18
|
5.56e-02
|
2.61e-01
|
2.22e-01
|
GO:0010458 BP exit from mitosis
|
14
|
9.18e-02
|
2.60e-01
|
2.97e-01
|
GO:0055075 BP potassium ion homeostasis
|
12
|
1.20e-01
|
-2.59e-01
|
3.46e-01
|
GO:0045582 BP positive regulation of T cell differentiation
|
27
|
1.99e-02
|
2.59e-01
|
1.17e-01
|
GO:0090307 BP mitotic spindle assembly
|
45
|
2.68e-03
|
2.59e-01
|
2.94e-02
|
GO:0071679 BP commissural neuron axon guidance
|
11
|
1.38e-01
|
2.59e-01
|
3.72e-01
|
GO:0051056 BP regulation of small GTPase mediated signal transduction
|
97
|
1.14e-05
|
-2.58e-01
|
4.08e-04
|
GO:0042391 BP regulation of membrane potential
|
38
|
5.94e-03
|
-2.58e-01
|
5.11e-02
|
GO:0032200 BP telomere organization
|
12
|
1.22e-01
|
2.58e-01
|
3.48e-01
|
GO:0017015 BP regulation of transforming growth factor beta receptor signaling pathway
|
20
|
4.64e-02
|
-2.57e-01
|
2.01e-01
|
GO:0061744 BP motor behavior
|
17
|
6.64e-02
|
2.57e-01
|
2.46e-01
|
GO:0002639 BP positive regulation of immunoglobulin production
|
16
|
7.52e-02
|
2.57e-01
|
2.64e-01
|
GO:0046827 BP positive regulation of protein export from nucleus
|
19
|
5.30e-02
|
2.56e-01
|
2.15e-01
|
GO:0045995 BP regulation of embryonic development
|
44
|
3.26e-03
|
2.56e-01
|
3.38e-02
|
GO:0030574 BP collagen catabolic process
|
23
|
3.33e-02
|
-2.56e-01
|
1.61e-01
|
GO:0001568 BP blood vessel development
|
28
|
1.96e-02
|
-2.55e-01
|
1.17e-01
|
GO:0000723 BP telomere maintenance
|
54
|
1.20e-03
|
2.55e-01
|
1.62e-02
|
GO:0051036 BP regulation of endosome size
|
11
|
1.43e-01
|
2.55e-01
|
3.80e-01
|
GO:0008045 BP motor neuron axon guidance
|
16
|
7.77e-02
|
2.55e-01
|
2.68e-01
|
GO:0032511 BP late endosome to vacuole transport via multivesicular body sorting pathway
|
11
|
1.44e-01
|
2.55e-01
|
3.80e-01
|
GO:0006739 BP NADP metabolic process
|
10
|
1.63e-01
|
2.54e-01
|
4.14e-01
|
GO:0007159 BP leukocyte cell-cell adhesion
|
19
|
5.60e-02
|
-2.53e-01
|
2.24e-01
|
GO:1905606 BP regulation of presynapse assembly
|
15
|
8.97e-02
|
-2.53e-01
|
2.93e-01
|
GO:0035307 BP positive regulation of protein dephosphorylation
|
23
|
3.58e-02
|
2.53e-01
|
1.70e-01
|
GO:0008217 BP regulation of blood pressure
|
43
|
4.13e-03
|
-2.53e-01
|
3.95e-02
|
GO:0006611 BP protein export from nucleus
|
30
|
1.67e-02
|
2.52e-01
|
1.08e-01
|
GO:0032515 BP negative regulation of phosphoprotein phosphatase activity
|
11
|
1.48e-01
|
2.52e-01
|
3.88e-01
|
GO:0033962 BP P-body assembly
|
14
|
1.04e-01
|
2.51e-01
|
3.21e-01
|
GO:1903830 BP magnesium ion transmembrane transport
|
15
|
9.22e-02
|
-2.51e-01
|
2.97e-01
|
GO:0007269 BP neurotransmitter secretion
|
17
|
7.32e-02
|
-2.51e-01
|
2.59e-01
|
GO:0007596 BP blood coagulation
|
55
|
1.30e-03
|
-2.51e-01
|
1.73e-02
|
GO:0031643 BP positive regulation of myelination
|
11
|
1.50e-01
|
-2.51e-01
|
3.90e-01
|
GO:0010717 BP regulation of epithelial to mesenchymal transition
|
14
|
1.05e-01
|
2.50e-01
|
3.24e-01
|
GO:0042267 BP natural killer cell mediated cytotoxicity
|
20
|
5.28e-02
|
-2.50e-01
|
2.15e-01
|
GO:0071168 BP protein localization to chromatin
|
19
|
5.92e-02
|
2.50e-01
|
2.31e-01
|
GO:2000781 BP positive regulation of double-strand break repair
|
38
|
7.67e-03
|
2.50e-01
|
6.00e-02
|
GO:0072711 BP cellular response to hydroxyurea
|
10
|
1.71e-01
|
2.50e-01
|
4.25e-01
|
GO:0006094 BP gluconeogenesis
|
36
|
9.53e-03
|
2.50e-01
|
7.05e-02
|
GO:0046839 BP phospholipid dephosphorylation
|
11
|
1.52e-01
|
-2.50e-01
|
3.93e-01
|
GO:0051279 BP regulation of release of sequestered calcium ion into cytosol
|
13
|
1.20e-01
|
-2.49e-01
|
3.45e-01
|
GO:0032926 BP negative regulation of activin receptor signaling pathway
|
11
|
1.53e-01
|
-2.49e-01
|
3.94e-01
|
GO:0014009 BP glial cell proliferation
|
13
|
1.20e-01
|
-2.49e-01
|
3.46e-01
|
GO:0090043 BP regulation of tubulin deacetylation
|
13
|
1.20e-01
|
2.49e-01
|
3.46e-01
|
GO:0090336 BP positive regulation of brown fat cell differentiation
|
12
|
1.37e-01
|
2.48e-01
|
3.71e-01
|
GO:0048545 BP response to steroid hormone
|
13
|
1.22e-01
|
-2.48e-01
|
3.48e-01
|
GO:0010043 BP response to zinc ion
|
16
|
8.64e-02
|
-2.48e-01
|
2.87e-01
|
GO:0048469 BP cell maturation
|
17
|
7.72e-02
|
2.48e-01
|
2.67e-01
|
GO:0031076 BP embryonic camera-type eye development
|
10
|
1.75e-01
|
-2.48e-01
|
4.30e-01
|
GO:1904659 BP glucose transmembrane transport
|
13
|
1.23e-01
|
-2.47e-01
|
3.49e-01
|
GO:0000086 BP G2/M transition of mitotic cell cycle
|
46
|
3.74e-03
|
2.47e-01
|
3.67e-02
|
GO:0036120 BP cellular response to platelet-derived growth factor stimulus
|
19
|
6.32e-02
|
-2.46e-01
|
2.41e-01
|
GO:0017156 BP calcium-ion regulated exocytosis
|
18
|
7.07e-02
|
-2.46e-01
|
2.54e-01
|
GO:1902459 BP positive regulation of stem cell population maintenance
|
43
|
5.24e-03
|
2.46e-01
|
4.66e-02
|
GO:0002687 BP positive regulation of leukocyte migration
|
10
|
1.78e-01
|
-2.46e-01
|
4.34e-01
|
GO:0007064 BP mitotic sister chromatid cohesion
|
15
|
9.96e-02
|
2.46e-01
|
3.15e-01
|
GO:0043087 BP regulation of GTPase activity
|
49
|
3.01e-03
|
-2.45e-01
|
3.19e-02
|
GO:0048388 BP endosomal lumen acidification
|
13
|
1.26e-01
|
2.45e-01
|
3.56e-01
|
GO:0046785 BP microtubule polymerization
|
16
|
9.04e-02
|
2.45e-01
|
2.94e-01
|
GO:0070588 BP calcium ion transmembrane transport
|
74
|
2.88e-04
|
-2.44e-01
|
5.59e-03
|
GO:0007369 BP gastrulation
|
17
|
8.21e-02
|
2.44e-01
|
2.78e-01
|
GO:0036302 BP atrioventricular canal development
|
10
|
1.83e-01
|
-2.43e-01
|
4.39e-01
|
GO:0070286 BP axonemal dynein complex assembly
|
11
|
1.63e-01
|
2.43e-01
|
4.13e-01
|
GO:0031274 BP positive regulation of pseudopodium assembly
|
10
|
1.84e-01
|
2.42e-01
|
4.41e-01
|
GO:1990166 BP protein localization to site of double-strand break
|
11
|
1.64e-01
|
2.42e-01
|
4.14e-01
|
GO:0000266 BP mitochondrial fission
|
16
|
9.38e-02
|
2.42e-01
|
3.01e-01
|
GO:0051764 BP actin crosslink formation
|
10
|
1.86e-01
|
2.42e-01
|
4.44e-01
|
GO:0019076 BP viral release from host cell
|
18
|
7.61e-02
|
2.42e-01
|
2.65e-01
|
GO:0045785 BP positive regulation of cell adhesion
|
42
|
6.81e-03
|
-2.41e-01
|
5.65e-02
|
GO:0000289 BP nuclear-transcribed mRNA poly(A) tail shortening
|
19
|
6.86e-02
|
2.41e-01
|
2.51e-01
|
GO:0070585 BP protein localization to mitochondrion
|
10
|
1.87e-01
|
2.41e-01
|
4.46e-01
|
GO:0014911 BP positive regulation of smooth muscle cell migration
|
19
|
6.91e-02
|
-2.41e-01
|
2.52e-01
|
GO:0061640 BP cytoskeleton-dependent cytokinesis
|
18
|
7.69e-02
|
2.41e-01
|
2.67e-01
|
GO:0048143 BP astrocyte activation
|
13
|
1.34e-01
|
-2.40e-01
|
3.68e-01
|
GO:0050709 BP negative regulation of protein secretion
|
13
|
1.34e-01
|
-2.40e-01
|
3.68e-01
|
GO:0019827 BP stem cell population maintenance
|
31
|
2.08e-02
|
2.40e-01
|
1.23e-01
|
GO:0010824 BP regulation of centrosome duplication
|
19
|
7.16e-02
|
2.39e-01
|
2.56e-01
|
GO:0003014 BP renal system process
|
11
|
1.73e-01
|
-2.38e-01
|
4.27e-01
|
GO:0043408 BP regulation of MAPK cascade
|
28
|
2.97e-02
|
-2.37e-01
|
1.49e-01
|
GO:0098655 BP monoatomic cation transmembrane transport
|
21
|
5.99e-02
|
-2.37e-01
|
2.33e-01
|
GO:0045840 BP positive regulation of mitotic nuclear division
|
20
|
6.66e-02
|
-2.37e-01
|
2.46e-01
|
GO:0006901 BP vesicle coating
|
11
|
1.74e-01
|
2.37e-01
|
4.28e-01
|
GO:0033280 BP response to vitamin D
|
10
|
1.95e-01
|
-2.37e-01
|
4.53e-01
|
GO:0040015 BP negative regulation of multicellular organism growth
|
10
|
1.95e-01
|
-2.37e-01
|
4.54e-01
|
GO:0043523 BP regulation of neuron apoptotic process
|
15
|
1.13e-01
|
2.37e-01
|
3.38e-01
|
GO:0002042 BP cell migration involved in sprouting angiogenesis
|
16
|
1.02e-01
|
2.36e-01
|
3.18e-01
|
GO:0050714 BP positive regulation of protein secretion
|
38
|
1.18e-02
|
-2.36e-01
|
8.20e-02
|
GO:0006308 BP DNA catabolic process
|
11
|
1.75e-01
|
2.36e-01
|
4.30e-01
|
GO:2000045 BP regulation of G1/S transition of mitotic cell cycle
|
46
|
5.67e-03
|
2.36e-01
|
4.96e-02
|
GO:1901796 BP regulation of signal transduction by p53 class mediator
|
41
|
9.03e-03
|
2.36e-01
|
6.83e-02
|
GO:0001952 BP regulation of cell-matrix adhesion
|
11
|
1.76e-01
|
-2.36e-01
|
4.31e-01
|
GO:0085029 BP extracellular matrix assembly
|
10
|
1.97e-01
|
-2.35e-01
|
4.56e-01
|
GO:0060236 BP regulation of mitotic spindle organization
|
19
|
7.58e-02
|
2.35e-01
|
2.65e-01
|
GO:0034644 BP cellular response to UV
|
54
|
2.79e-03
|
2.35e-01
|
3.03e-02
|
GO:0051301 BP cell division
|
335
|
1.56e-13
|
2.35e-01
|
3.45e-11
|
GO:0048711 BP positive regulation of astrocyte differentiation
|
10
|
1.99e-01
|
2.35e-01
|
4.57e-01
|
GO:0006801 BP superoxide metabolic process
|
14
|
1.29e-01
|
-2.34e-01
|
3.60e-01
|
GO:0006997 BP nucleus organization
|
24
|
4.69e-02
|
2.34e-01
|
2.01e-01
|
GO:0045780 BP positive regulation of bone resorption
|
14
|
1.29e-01
|
-2.34e-01
|
3.60e-01
|
GO:0048286 BP lung alveolus development
|
31
|
2.41e-02
|
-2.34e-01
|
1.31e-01
|
GO:0010586 BP miRNA metabolic process
|
10
|
2.00e-01
|
-2.34e-01
|
4.60e-01
|
GO:2000042 BP negative regulation of double-strand break repair via homologous recombination
|
23
|
5.22e-02
|
2.34e-01
|
2.14e-01
|
GO:0043517 BP positive regulation of DNA damage response, signal transduction by p53 class mediator
|
11
|
1.79e-01
|
-2.34e-01
|
4.35e-01
|
GO:1902176 BP negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway
|
14
|
1.31e-01
|
2.33e-01
|
3.62e-01
|
GO:0043249 BP erythrocyte maturation
|
13
|
1.46e-01
|
2.33e-01
|
3.83e-01
|
GO:0070830 BP bicellular tight junction assembly
|
28
|
3.31e-02
|
-2.33e-01
|
1.61e-01
|
GO:0031297 BP replication fork processing
|
35
|
1.73e-02
|
2.33e-01
|
1.09e-01
|
GO:0007275 BP multicellular organism development
|
45
|
7.01e-03
|
-2.32e-01
|
5.66e-02
|
GO:0003180 BP aortic valve morphogenesis
|
27
|
3.71e-02
|
-2.32e-01
|
1.75e-01
|
GO:0030279 BP negative regulation of ossification
|
14
|
1.34e-01
|
-2.32e-01
|
3.68e-01
|
GO:0006744 BP ubiquinone biosynthetic process
|
15
|
1.21e-01
|
2.31e-01
|
3.47e-01
|
GO:0001782 BP B cell homeostasis
|
19
|
8.08e-02
|
-2.31e-01
|
2.76e-01
|
GO:0045089 BP positive regulation of innate immune response
|
21
|
6.69e-02
|
2.31e-01
|
2.46e-01
|
GO:0097421 BP liver regeneration
|
25
|
4.59e-02
|
2.31e-01
|
2.00e-01
|
GO:0048935 BP peripheral nervous system neuron development
|
10
|
2.07e-01
|
-2.31e-01
|
4.72e-01
|
GO:0033120 BP positive regulation of RNA splicing
|
14
|
1.35e-01
|
2.31e-01
|
3.69e-01
|
GO:0001833 BP inner cell mass cell proliferation
|
14
|
1.36e-01
|
2.30e-01
|
3.70e-01
|
GO:0050775 BP positive regulation of dendrite morphogenesis
|
19
|
8.27e-02
|
-2.30e-01
|
2.79e-01
|
GO:0032465 BP regulation of cytokinesis
|
38
|
1.42e-02
|
2.30e-01
|
9.55e-02
|
GO:0071385 BP cellular response to glucocorticoid stimulus
|
15
|
1.23e-01
|
2.30e-01
|
3.50e-01
|
GO:0034220 BP monoatomic ion transmembrane transport
|
68
|
1.06e-03
|
-2.30e-01
|
1.52e-02
|
GO:0048489 BP synaptic vesicle transport
|
13
|
1.52e-01
|
-2.30e-01
|
3.93e-01
|
GO:0016242 BP negative regulation of macroautophagy
|
14
|
1.37e-01
|
-2.30e-01
|
3.71e-01
|
GO:0032781 BP positive regulation of ATP-dependent activity
|
17
|
1.02e-01
|
2.29e-01
|
3.17e-01
|
GO:0032480 BP negative regulation of type I interferon production
|
19
|
8.44e-02
|
2.29e-01
|
2.82e-01
|
GO:0045662 BP negative regulation of myoblast differentiation
|
16
|
1.14e-01
|
-2.28e-01
|
3.39e-01
|
GO:0071514 BP genomic imprinting
|
12
|
1.71e-01
|
-2.28e-01
|
4.25e-01
|
GO:0010971 BP positive regulation of G2/M transition of mitotic cell cycle
|
27
|
4.03e-02
|
2.28e-01
|
1.84e-01
|
GO:0043069 BP negative regulation of programmed cell death
|
19
|
8.62e-02
|
2.27e-01
|
2.87e-01
|
GO:0060444 BP branching involved in mammary gland duct morphogenesis
|
10
|
2.13e-01
|
-2.27e-01
|
4.81e-01
|
GO:0051321 BP meiotic cell cycle
|
43
|
9.93e-03
|
2.27e-01
|
7.19e-02
|
GO:0007160 BP cell-matrix adhesion
|
76
|
6.20e-04
|
-2.27e-01
|
1.02e-02
|
GO:0071480 BP cellular response to gamma radiation
|
26
|
4.50e-02
|
2.27e-01
|
1.98e-01
|
GO:0090181 BP regulation of cholesterol metabolic process
|
10
|
2.14e-01
|
-2.27e-01
|
4.82e-01
|
GO:0051549 BP positive regulation of keratinocyte migration
|
10
|
2.15e-01
|
-2.26e-01
|
4.83e-01
|
GO:0048675 BP axon extension
|
25
|
5.02e-02
|
-2.26e-01
|
2.09e-01
|
GO:0051561 BP positive regulation of mitochondrial calcium ion concentration
|
11
|
1.94e-01
|
2.26e-01
|
4.53e-01
|
GO:0031571 BP mitotic G1 DNA damage checkpoint signaling
|
12
|
1.75e-01
|
2.26e-01
|
4.30e-01
|
GO:0071108 BP protein K48-linked deubiquitination
|
23
|
6.07e-02
|
-2.26e-01
|
2.33e-01
|
GO:0061029 BP eyelid development in camera-type eye
|
12
|
1.76e-01
|
2.25e-01
|
4.31e-01
|
GO:0030517 BP negative regulation of axon extension
|
14
|
1.44e-01
|
-2.25e-01
|
3.80e-01
|
GO:0097435 BP supramolecular fiber organization
|
10
|
2.17e-01
|
2.25e-01
|
4.85e-01
|
GO:0032757 BP positive regulation of interleukin-8 production
|
38
|
1.62e-02
|
2.25e-01
|
1.06e-01
|
GO:0006607 BP NLS-bearing protein import into nucleus
|
17
|
1.08e-01
|
2.25e-01
|
3.31e-01
|
GO:0098609 BP cell-cell adhesion
|
131
|
8.80e-06
|
-2.25e-01
|
3.30e-04
|
GO:0033554 BP cellular response to stress
|
11
|
1.96e-01
|
-2.25e-01
|
4.55e-01
|
GO:1990403 BP embryonic brain development
|
16
|
1.21e-01
|
2.24e-01
|
3.47e-01
|
GO:1903428 BP positive regulation of reactive oxygen species biosynthetic process
|
11
|
1.98e-01
|
-2.24e-01
|
4.57e-01
|
GO:0000381 BP regulation of alternative mRNA splicing, via spliceosome
|
45
|
9.44e-03
|
2.24e-01
|
7.04e-02
|
GO:0010761 BP fibroblast migration
|
17
|
1.10e-01
|
2.24e-01
|
3.35e-01
|
GO:0032230 BP positive regulation of synaptic transmission, GABAergic
|
10
|
2.21e-01
|
-2.24e-01
|
4.89e-01
|
GO:0071360 BP cellular response to exogenous dsRNA
|
16
|
1.22e-01
|
2.23e-01
|
3.48e-01
|
GO:0006486 BP protein glycosylation
|
58
|
3.29e-03
|
-2.23e-01
|
3.38e-02
|
GO:0001578 BP microtubule bundle formation
|
28
|
4.10e-02
|
2.23e-01
|
1.86e-01
|
GO:0006402 BP mRNA catabolic process
|
26
|
4.91e-02
|
2.23e-01
|
2.08e-01
|
GO:1904706 BP negative regulation of vascular associated smooth muscle cell proliferation
|
18
|
1.02e-01
|
-2.23e-01
|
3.18e-01
|
GO:0046598 BP positive regulation of viral entry into host cell
|
10
|
2.23e-01
|
2.23e-01
|
4.89e-01
|
GO:0048255 BP mRNA stabilization
|
27
|
4.55e-02
|
2.22e-01
|
1.99e-01
|
GO:1900034 BP regulation of cellular response to heat
|
15
|
1.36e-01
|
2.22e-01
|
3.70e-01
|
GO:0046856 BP phosphatidylinositol dephosphorylation
|
29
|
3.89e-02
|
-2.22e-01
|
1.80e-01
|
GO:0007626 BP locomotory behavior
|
42
|
1.30e-02
|
-2.22e-01
|
8.85e-02
|
GO:0050829 BP defense response to Gram-negative bacterium
|
28
|
4.31e-02
|
-2.21e-01
|
1.93e-01
|
GO:0071493 BP cellular response to UV-B
|
10
|
2.27e-01
|
-2.21e-01
|
4.94e-01
|
GO:0030511 BP positive regulation of transforming growth factor beta receptor signaling pathway
|
25
|
5.65e-02
|
2.20e-01
|
2.25e-01
|
GO:0071276 BP cellular response to cadmium ion
|
21
|
8.10e-02
|
2.20e-01
|
2.76e-01
|
GO:0046686 BP response to cadmium ion
|
16
|
1.28e-01
|
2.20e-01
|
3.60e-01
|
GO:0097009 BP energy homeostasis
|
37
|
2.10e-02
|
-2.19e-01
|
1.23e-01
|
GO:1902902 BP negative regulation of autophagosome assembly
|
12
|
1.89e-01
|
-2.19e-01
|
4.49e-01
|
GO:0071470 BP cellular response to osmotic stress
|
13
|
1.72e-01
|
2.19e-01
|
4.26e-01
|
GO:0034605 BP cellular response to heat
|
41
|
1.54e-02
|
2.19e-01
|
1.02e-01
|
GO:0030101 BP natural killer cell activation
|
10
|
2.31e-01
|
-2.19e-01
|
4.99e-01
|
GO:0060749 BP mammary gland alveolus development
|
12
|
1.90e-01
|
-2.19e-01
|
4.51e-01
|
GO:0007188 BP adenylate cyclase-modulating G protein-coupled receptor signaling pathway
|
19
|
9.92e-02
|
-2.18e-01
|
3.15e-01
|
GO:0046628 BP positive regulation of insulin receptor signaling pathway
|
17
|
1.19e-01
|
-2.18e-01
|
3.45e-01
|
GO:0030198 BP extracellular matrix organization
|
84
|
5.48e-04
|
-2.18e-01
|
9.26e-03
|
GO:0042832 BP defense response to protozoan
|
13
|
1.73e-01
|
2.18e-01
|
4.28e-01
|
GO:0006606 BP protein import into nucleus
|
92
|
3.03e-04
|
2.18e-01
|
5.68e-03
|
GO:0010033 BP response to organic substance
|
24
|
6.49e-02
|
2.18e-01
|
2.43e-01
|
GO:0045638 BP negative regulation of myeloid cell differentiation
|
15
|
1.45e-01
|
2.17e-01
|
3.82e-01
|
GO:0009408 BP response to heat
|
27
|
5.08e-02
|
2.17e-01
|
2.11e-01
|
GO:0010765 BP positive regulation of sodium ion transport
|
10
|
2.34e-01
|
-2.17e-01
|
5.04e-01
|
GO:0031529 BP ruffle organization
|
12
|
1.93e-01
|
-2.17e-01
|
4.51e-01
|
GO:0010801 BP negative regulation of peptidyl-threonine phosphorylation
|
15
|
1.46e-01
|
2.17e-01
|
3.83e-01
|
GO:0010288 BP response to lead ion
|
13
|
1.76e-01
|
2.17e-01
|
4.30e-01
|
GO:1904385 BP cellular response to angiotensin
|
14
|
1.60e-01
|
2.17e-01
|
4.08e-01
|
GO:0030901 BP midbrain development
|
18
|
1.12e-01
|
2.16e-01
|
3.37e-01
|
GO:0006826 BP iron ion transport
|
15
|
1.48e-01
|
2.16e-01
|
3.87e-01
|
GO:0032793 BP positive regulation of CREB transcription factor activity
|
10
|
2.39e-01
|
-2.15e-01
|
5.07e-01
|
GO:0048146 BP positive regulation of fibroblast proliferation
|
41
|
1.71e-02
|
2.15e-01
|
1.09e-01
|
GO:0042632 BP cholesterol homeostasis
|
57
|
4.98e-03
|
-2.15e-01
|
4.54e-02
|
GO:0003203 BP endocardial cushion morphogenesis
|
15
|
1.49e-01
|
-2.15e-01
|
3.89e-01
|
GO:0009311 BP oligosaccharide metabolic process
|
11
|
2.17e-01
|
-2.15e-01
|
4.85e-01
|
GO:0070306 BP lens fiber cell differentiation
|
10
|
2.40e-01
|
-2.15e-01
|
5.08e-01
|
GO:0015693 BP magnesium ion transport
|
13
|
1.80e-01
|
-2.15e-01
|
4.36e-01
|
GO:0001829 BP trophectodermal cell differentiation
|
12
|
1.98e-01
|
2.15e-01
|
4.56e-01
|
GO:0036465 BP synaptic vesicle recycling
|
12
|
1.98e-01
|
-2.15e-01
|
4.56e-01
|
GO:0060070 BP canonical Wnt signaling pathway
|
78
|
1.07e-03
|
-2.14e-01
|
1.52e-02
|
GO:0003009 BP skeletal muscle contraction
|
14
|
1.65e-01
|
-2.14e-01
|
4.15e-01
|
GO:0006959 BP humoral immune response
|
22
|
8.22e-02
|
2.14e-01
|
2.78e-01
|
GO:0038066 BP p38MAPK cascade
|
14
|
1.66e-01
|
2.14e-01
|
4.16e-01
|
GO:0097401 BP synaptic vesicle lumen acidification
|
15
|
1.52e-01
|
2.14e-01
|
3.93e-01
|
GO:0035988 BP chondrocyte proliferation
|
11
|
2.20e-01
|
-2.14e-01
|
4.87e-01
|
GO:0006883 BP intracellular sodium ion homeostasis
|
13
|
1.83e-01
|
-2.13e-01
|
4.39e-01
|
GO:0008053 BP mitochondrial fusion
|
22
|
8.34e-02
|
2.13e-01
|
2.80e-01
|
GO:0042744 BP hydrogen peroxide catabolic process
|
11
|
2.22e-01
|
2.13e-01
|
4.89e-01
|
GO:0002250 BP adaptive immune response
|
75
|
1.49e-03
|
-2.12e-01
|
1.90e-02
|
GO:0040008 BP regulation of growth
|
11
|
2.24e-01
|
-2.12e-01
|
4.91e-01
|
GO:0031507 BP heterochromatin formation
|
29
|
4.89e-02
|
2.11e-01
|
2.08e-01
|
GO:1903543 BP positive regulation of exosomal secretion
|
14
|
1.71e-01
|
2.11e-01
|
4.25e-01
|
GO:0071425 BP hematopoietic stem cell proliferation
|
20
|
1.03e-01
|
2.11e-01
|
3.20e-01
|
GO:0010457 BP centriole-centriole cohesion
|
13
|
1.89e-01
|
-2.10e-01
|
4.50e-01
|
GO:0010608 BP post-transcriptional regulation of gene expression
|
23
|
8.12e-02
|
2.10e-01
|
2.76e-01
|
GO:0001825 BP blastocyst formation
|
18
|
1.24e-01
|
2.10e-01
|
3.51e-01
|
GO:0019233 BP sensory perception of pain
|
19
|
1.14e-01
|
-2.09e-01
|
3.39e-01
|
GO:0070372 BP regulation of ERK1 and ERK2 cascade
|
27
|
6.04e-02
|
2.09e-01
|
2.33e-01
|
GO:0007130 BP synaptonemal complex assembly
|
13
|
1.93e-01
|
-2.09e-01
|
4.51e-01
|
GO:0043086 BP negative regulation of catalytic activity
|
11
|
2.31e-01
|
2.09e-01
|
4.99e-01
|
GO:0060997 BP dendritic spine morphogenesis
|
14
|
1.77e-01
|
-2.08e-01
|
4.32e-01
|
GO:0042130 BP negative regulation of T cell proliferation
|
19
|
1.16e-01
|
-2.08e-01
|
3.43e-01
|
GO:0061136 BP regulation of proteasomal protein catabolic process
|
18
|
1.26e-01
|
2.08e-01
|
3.56e-01
|
GO:0035162 BP embryonic hemopoiesis
|
12
|
2.12e-01
|
2.08e-01
|
4.80e-01
|
GO:0043488 BP regulation of mRNA stability
|
35
|
3.32e-02
|
2.08e-01
|
1.61e-01
|
GO:0007204 BP positive regulation of cytosolic calcium ion concentration
|
61
|
4.98e-03
|
-2.08e-01
|
4.54e-02
|
GO:0048661 BP positive regulation of smooth muscle cell proliferation
|
43
|
1.84e-02
|
-2.08e-01
|
1.13e-01
|
GO:0045862 BP positive regulation of proteolysis
|
19
|
1.17e-01
|
2.08e-01
|
3.44e-01
|
GO:0046940 BP nucleoside monophosphate phosphorylation
|
10
|
2.57e-01
|
2.07e-01
|
5.27e-01
|
GO:0007214 BP gamma-aminobutyric acid signaling pathway
|
12
|
2.14e-01
|
-2.07e-01
|
4.82e-01
|
GO:0014032 BP neural crest cell development
|
17
|
1.40e-01
|
2.07e-01
|
3.75e-01
|
GO:0007623 BP circadian rhythm
|
44
|
1.78e-02
|
2.07e-01
|
1.11e-01
|
GO:0050821 BP protein stabilization
|
189
|
1.02e-06
|
2.06e-01
|
5.95e-05
|
GO:0042059 BP negative regulation of epidermal growth factor receptor signaling pathway
|
15
|
1.67e-01
|
-2.06e-01
|
4.19e-01
|
GO:0050808 BP synapse organization
|
33
|
4.09e-02
|
-2.06e-01
|
1.86e-01
|
GO:0071218 BP cellular response to misfolded protein
|
11
|
2.38e-01
|
2.06e-01
|
5.07e-01
|
GO:0007162 BP negative regulation of cell adhesion
|
34
|
3.80e-02
|
-2.06e-01
|
1.78e-01
|
GO:0021670 BP lateral ventricle development
|
11
|
2.39e-01
|
2.05e-01
|
5.07e-01
|
GO:0090303 BP positive regulation of wound healing
|
19
|
1.23e-01
|
-2.05e-01
|
3.49e-01
|
GO:0007528 BP neuromuscular junction development
|
26
|
7.13e-02
|
-2.04e-01
|
2.55e-01
|
GO:0035810 BP positive regulation of urine volume
|
10
|
2.64e-01
|
-2.04e-01
|
5.35e-01
|
GO:0045859 BP regulation of protein kinase activity
|
11
|
2.42e-01
|
2.04e-01
|
5.08e-01
|
GO:0008631 BP intrinsic apoptotic signaling pathway in response to oxidative stress
|
16
|
1.58e-01
|
2.04e-01
|
4.05e-01
|
GO:0009650 BP UV protection
|
12
|
2.22e-01
|
2.04e-01
|
4.89e-01
|
GO:0001824 BP blastocyst development
|
20
|
1.15e-01
|
2.04e-01
|
3.41e-01
|
GO:0035335 BP peptidyl-tyrosine dephosphorylation
|
24
|
8.43e-02
|
-2.04e-01
|
2.82e-01
|
GO:0032870 BP cellular response to hormone stimulus
|
16
|
1.59e-01
|
-2.04e-01
|
4.05e-01
|
GO:1903779 BP regulation of cardiac conduction
|
12
|
2.22e-01
|
-2.03e-01
|
4.89e-01
|
GO:0070828 BP heterochromatin organization
|
22
|
9.96e-02
|
2.03e-01
|
3.15e-01
|
GO:0061723 BP glycophagy
|
12
|
2.24e-01
|
-2.03e-01
|
4.91e-01
|
GO:0045653 BP negative regulation of megakaryocyte differentiation
|
11
|
2.45e-01
|
2.02e-01
|
5.12e-01
|
GO:0051262 BP protein tetramerization
|
17
|
1.49e-01
|
2.02e-01
|
3.89e-01
|
GO:0043547 BP positive regulation of GTPase activity
|
102
|
4.24e-04
|
-2.02e-01
|
7.69e-03
|
GO:0043651 BP linoleic acid metabolic process
|
12
|
2.26e-01
|
-2.02e-01
|
4.93e-01
|
GO:0034243 BP regulation of transcription elongation by RNA polymerase II
|
21
|
1.10e-01
|
2.02e-01
|
3.33e-01
|
GO:0031647 BP regulation of protein stability
|
76
|
2.37e-03
|
2.02e-01
|
2.68e-02
|
GO:0048568 BP embryonic organ development
|
29
|
6.02e-02
|
2.02e-01
|
2.33e-01
|
GO:0006513 BP protein monoubiquitination
|
39
|
2.95e-02
|
2.02e-01
|
1.48e-01
|
GO:0043279 BP response to alkaloid
|
10
|
2.70e-01
|
2.01e-01
|
5.41e-01
|
GO:0010667 BP negative regulation of cardiac muscle cell apoptotic process
|
20
|
1.19e-01
|
-2.01e-01
|
3.45e-01
|
GO:0046034 BP ATP metabolic process
|
24
|
8.89e-02
|
2.01e-01
|
2.92e-01
|
GO:0019538 BP protein metabolic process
|
11
|
2.49e-01
|
-2.01e-01
|
5.18e-01
|
GO:0001516 BP prostaglandin biosynthetic process
|
12
|
2.29e-01
|
-2.00e-01
|
4.97e-01
|
GO:0030155 BP regulation of cell adhesion
|
38
|
3.28e-02
|
-2.00e-01
|
1.60e-01
|
GO:0048812 BP neuron projection morphogenesis
|
43
|
2.32e-02
|
-2.00e-01
|
1.28e-01
|
GO:0043507 BP positive regulation of JUN kinase activity
|
24
|
8.99e-02
|
-2.00e-01
|
2.94e-01
|
GO:0007009 BP plasma membrane organization
|
13
|
2.12e-01
|
-2.00e-01
|
4.80e-01
|
GO:0034113 BP heterotypic cell-cell adhesion
|
22
|
1.05e-01
|
-2.00e-01
|
3.24e-01
|
GO:1990845 BP adaptive thermogenesis
|
10
|
2.76e-01
|
1.99e-01
|
5.47e-01
|
GO:0036151 BP phosphatidylcholine acyl-chain remodeling
|
13
|
2.16e-01
|
-1.98e-01
|
4.84e-01
|
GO:0072657 BP protein localization to membrane
|
21
|
1.16e-01
|
1.98e-01
|
3.43e-01
|
GO:2001046 BP positive regulation of integrin-mediated signaling pathway
|
10
|
2.79e-01
|
-1.98e-01
|
5.47e-01
|
GO:0000132 BP establishment of mitotic spindle orientation
|
30
|
6.09e-02
|
1.98e-01
|
2.33e-01
|
GO:0048144 BP fibroblast proliferation
|
34
|
4.60e-02
|
1.98e-01
|
2.00e-01
|
GO:0021772 BP olfactory bulb development
|
16
|
1.71e-01
|
-1.98e-01
|
4.25e-01
|
GO:0090136 BP epithelial cell-cell adhesion
|
10
|
2.80e-01
|
-1.97e-01
|
5.47e-01
|
GO:0032691 BP negative regulation of interleukin-1 beta production
|
13
|
2.18e-01
|
1.97e-01
|
4.85e-01
|
GO:0055013 BP cardiac muscle cell development
|
21
|
1.18e-01
|
1.97e-01
|
3.44e-01
|
GO:0042771 BP intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
|
29
|
6.65e-02
|
-1.97e-01
|
2.46e-01
|
GO:1902476 BP chloride transmembrane transport
|
51
|
1.50e-02
|
-1.97e-01
|
1.00e-01
|
GO:0042149 BP cellular response to glucose starvation
|
44
|
2.39e-02
|
1.97e-01
|
1.30e-01
|
GO:0034332 BP adherens junction organization
|
17
|
1.61e-01
|
1.96e-01
|
4.11e-01
|
GO:0010917 BP negative regulation of mitochondrial membrane potential
|
10
|
2.83e-01
|
1.96e-01
|
5.50e-01
|
GO:0002088 BP lens development in camera-type eye
|
19
|
1.39e-01
|
-1.96e-01
|
3.73e-01
|
GO:0090023 BP positive regulation of neutrophil chemotaxis
|
19
|
1.39e-01
|
-1.96e-01
|
3.73e-01
|
GO:0048208 BP COPII vesicle coating
|
24
|
9.69e-02
|
1.96e-01
|
3.08e-01
|
GO:0042246 BP tissue regeneration
|
13
|
2.22e-01
|
-1.96e-01
|
4.89e-01
|
GO:0140861 BP DNA repair-dependent chromatin remodeling
|
22
|
1.12e-01
|
1.96e-01
|
3.37e-01
|
GO:2000379 BP positive regulation of reactive oxygen species metabolic process
|
28
|
7.33e-02
|
1.96e-01
|
2.59e-01
|
GO:0042551 BP neuron maturation
|
11
|
2.61e-01
|
-1.96e-01
|
5.32e-01
|
GO:0045830 BP positive regulation of isotype switching
|
13
|
2.22e-01
|
1.96e-01
|
4.89e-01
|
GO:0097049 BP motor neuron apoptotic process
|
12
|
2.41e-01
|
-1.95e-01
|
5.08e-01
|
GO:0010498 BP proteasomal protein catabolic process
|
16
|
1.78e-01
|
1.94e-01
|
4.34e-01
|
GO:0051899 BP membrane depolarization
|
17
|
1.66e-01
|
-1.94e-01
|
4.16e-01
|
GO:0046339 BP diacylglycerol metabolic process
|
11
|
2.65e-01
|
-1.94e-01
|
5.36e-01
|
GO:0032212 BP positive regulation of telomere maintenance via telomerase
|
34
|
5.02e-02
|
1.94e-01
|
2.09e-01
|
GO:0007389 BP pattern specification process
|
18
|
1.54e-01
|
-1.94e-01
|
3.97e-01
|
GO:0043588 BP skin development
|
22
|
1.15e-01
|
-1.94e-01
|
3.42e-01
|
GO:2000406 BP positive regulation of T cell migration
|
13
|
2.27e-01
|
-1.94e-01
|
4.94e-01
|
GO:0035556 BP intracellular signal transduction
|
285
|
1.94e-08
|
-1.94e-01
|
1.59e-06
|
GO:0035024 BP negative regulation of Rho protein signal transduction
|
20
|
1.34e-01
|
-1.93e-01
|
3.68e-01
|
GO:0051457 BP maintenance of protein location in nucleus
|
13
|
2.28e-01
|
1.93e-01
|
4.95e-01
|
GO:0043280 BP positive regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
33
|
5.51e-02
|
1.93e-01
|
2.21e-01
|
GO:0007417 BP central nervous system development
|
83
|
2.44e-03
|
-1.93e-01
|
2.74e-02
|
GO:0045070 BP positive regulation of viral genome replication
|
26
|
8.95e-02
|
1.92e-01
|
2.93e-01
|
GO:0032801 BP receptor catabolic process
|
13
|
2.30e-01
|
-1.92e-01
|
4.98e-01
|
GO:0007405 BP neuroblast proliferation
|
27
|
8.42e-02
|
-1.92e-01
|
2.82e-01
|
GO:0050766 BP positive regulation of phagocytosis
|
24
|
1.05e-01
|
-1.91e-01
|
3.24e-01
|
GO:0051963 BP regulation of synapse assembly
|
11
|
2.72e-01
|
-1.91e-01
|
5.43e-01
|
GO:0061635 BP regulation of protein complex stability
|
13
|
2.33e-01
|
1.91e-01
|
5.01e-01
|
GO:0001938 BP positive regulation of endothelial cell proliferation
|
51
|
1.82e-02
|
-1.91e-01
|
1.13e-01
|
GO:0002082 BP regulation of oxidative phosphorylation
|
12
|
2.53e-01
|
1.91e-01
|
5.20e-01
|
GO:0048741 BP skeletal muscle fiber development
|
21
|
1.31e-01
|
1.90e-01
|
3.62e-01
|
GO:0045727 BP positive regulation of translation
|
68
|
6.65e-03
|
1.90e-01
|
5.58e-02
|
GO:0030183 BP B cell differentiation
|
49
|
2.15e-02
|
-1.90e-01
|
1.24e-01
|
GO:0007190 BP activation of adenylate cyclase activity
|
11
|
2.75e-01
|
-1.90e-01
|
5.47e-01
|
GO:0006446 BP regulation of translational initiation
|
31
|
6.77e-02
|
1.90e-01
|
2.49e-01
|
GO:0048593 BP camera-type eye morphogenesis
|
15
|
2.04e-01
|
1.89e-01
|
4.67e-01
|
GO:0002223 BP stimulatory C-type lectin receptor signaling pathway
|
13
|
2.37e-01
|
-1.89e-01
|
5.07e-01
|
GO:0048863 BP stem cell differentiation
|
32
|
6.39e-02
|
1.89e-01
|
2.42e-01
|
GO:0015718 BP monocarboxylic acid transport
|
11
|
2.78e-01
|
-1.89e-01
|
5.47e-01
|
GO:0006968 BP cellular defense response
|
20
|
1.44e-01
|
-1.89e-01
|
3.80e-01
|
GO:0043388 BP positive regulation of DNA binding
|
16
|
1.91e-01
|
1.89e-01
|
4.51e-01
|
GO:0030099 BP myeloid cell differentiation
|
18
|
1.66e-01
|
-1.89e-01
|
4.16e-01
|
GO:0006264 BP mitochondrial DNA replication
|
11
|
2.79e-01
|
1.89e-01
|
5.47e-01
|
GO:0007292 BP female gamete generation
|
11
|
2.79e-01
|
-1.89e-01
|
5.47e-01
|
GO:0090161 BP Golgi ribbon formation
|
11
|
2.80e-01
|
-1.88e-01
|
5.47e-01
|
GO:0060088 BP auditory receptor cell stereocilium organization
|
13
|
2.40e-01
|
-1.88e-01
|
5.08e-01
|
GO:0008593 BP regulation of Notch signaling pathway
|
16
|
1.93e-01
|
-1.88e-01
|
4.51e-01
|
GO:0016540 BP protein autoprocessing
|
17
|
1.81e-01
|
-1.88e-01
|
4.37e-01
|
GO:0043161 BP proteasome-mediated ubiquitin-dependent protein catabolic process
|
208
|
3.22e-06
|
1.87e-01
|
1.37e-04
|
GO:0009792 BP embryo development ending in birth or egg hatching
|
14
|
2.25e-01
|
1.87e-01
|
4.92e-01
|
GO:0071479 BP cellular response to ionizing radiation
|
37
|
4.86e-02
|
1.87e-01
|
2.07e-01
|
GO:2000049 BP positive regulation of cell-cell adhesion mediated by cadherin
|
10
|
3.05e-01
|
-1.87e-01
|
5.79e-01
|
GO:0000729 BP DNA double-strand break processing
|
10
|
3.05e-01
|
1.87e-01
|
5.79e-01
|
GO:0006289 BP nucleotide-excision repair
|
38
|
4.64e-02
|
1.87e-01
|
2.01e-01
|
GO:0007608 BP sensory perception of smell
|
13
|
2.44e-01
|
1.87e-01
|
5.11e-01
|
GO:0007267 BP cell-cell signaling
|
97
|
1.53e-03
|
-1.86e-01
|
1.93e-02
|
GO:0006099 BP tricarboxylic acid cycle
|
31
|
7.27e-02
|
1.86e-01
|
2.58e-01
|
GO:0045597 BP positive regulation of cell differentiation
|
46
|
2.91e-02
|
1.86e-01
|
1.48e-01
|
GO:0120009 BP intermembrane lipid transfer
|
41
|
3.95e-02
|
-1.86e-01
|
1.82e-01
|
GO:0006890 BP retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum
|
47
|
2.76e-02
|
1.86e-01
|
1.43e-01
|
GO:0006306 BP DNA methylation
|
26
|
1.01e-01
|
1.86e-01
|
3.17e-01
|
GO:0050773 BP regulation of dendrite development
|
12
|
2.66e-01
|
1.86e-01
|
5.36e-01
|
GO:0032435 BP negative regulation of proteasomal ubiquitin-dependent protein catabolic process
|
32
|
6.99e-02
|
1.85e-01
|
2.53e-01
|
GO:0072332 BP intrinsic apoptotic signaling pathway by p53 class mediator
|
25
|
1.10e-01
|
1.84e-01
|
3.35e-01
|
GO:0060339 BP negative regulation of type I interferon-mediated signaling pathway
|
22
|
1.35e-01
|
1.84e-01
|
3.68e-01
|
GO:0048169 BP regulation of long-term neuronal synaptic plasticity
|
10
|
3.13e-01
|
-1.84e-01
|
5.87e-01
|
GO:0034620 BP cellular response to unfolded protein
|
15
|
2.17e-01
|
1.84e-01
|
4.85e-01
|
GO:0015012 BP heparan sulfate proteoglycan biosynthetic process
|
13
|
2.51e-01
|
-1.84e-01
|
5.20e-01
|
GO:0050731 BP positive regulation of peptidyl-tyrosine phosphorylation
|
59
|
1.45e-02
|
-1.84e-01
|
9.72e-02
|
GO:0009058 BP biosynthetic process
|
12
|
2.71e-01
|
1.84e-01
|
5.42e-01
|
GO:0097284 BP hepatocyte apoptotic process
|
13
|
2.52e-01
|
1.83e-01
|
5.20e-01
|
GO:0007205 BP protein kinase C-activating G protein-coupled receptor signaling pathway
|
17
|
1.91e-01
|
-1.83e-01
|
4.51e-01
|
GO:0045591 BP positive regulation of regulatory T cell differentiation
|
10
|
3.16e-01
|
1.83e-01
|
5.89e-01
|
GO:0006911 BP phagocytosis, engulfment
|
15
|
2.20e-01
|
-1.83e-01
|
4.87e-01
|
GO:0045773 BP positive regulation of axon extension
|
26
|
1.07e-01
|
-1.83e-01
|
3.28e-01
|
GO:0002052 BP positive regulation of neuroblast proliferation
|
23
|
1.29e-01
|
-1.83e-01
|
3.60e-01
|
GO:0012501 BP programmed cell death
|
10
|
3.18e-01
|
-1.83e-01
|
5.91e-01
|
GO:0007416 BP synapse assembly
|
37
|
5.48e-02
|
-1.82e-01
|
2.20e-01
|
GO:0001569 BP branching involved in blood vessel morphogenesis
|
23
|
1.30e-01
|
-1.82e-01
|
3.60e-01
|
GO:0071277 BP cellular response to calcium ion
|
64
|
1.16e-02
|
-1.82e-01
|
8.17e-02
|
GO:0031047 BP regulatory ncRNA-mediated gene silencing
|
15
|
2.22e-01
|
1.82e-01
|
4.89e-01
|
GO:0006887 BP exocytosis
|
79
|
5.16e-03
|
-1.82e-01
|
4.65e-02
|
GO:0050776 BP regulation of immune response
|
18
|
1.82e-01
|
-1.82e-01
|
4.39e-01
|
GO:0007520 BP myoblast fusion
|
20
|
1.60e-01
|
-1.81e-01
|
4.08e-01
|
GO:0033148 BP positive regulation of intracellular estrogen receptor signaling pathway
|
10
|
3.21e-01
|
-1.81e-01
|
5.94e-01
|
GO:0035023 BP regulation of Rho protein signal transduction
|
22
|
1.42e-01
|
-1.81e-01
|
3.77e-01
|
GO:0055089 BP fatty acid homeostasis
|
12
|
2.78e-01
|
-1.81e-01
|
5.47e-01
|
GO:0060325 BP face morphogenesis
|
26
|
1.11e-01
|
-1.80e-01
|
3.36e-01
|
GO:1902166 BP negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator
|
15
|
2.26e-01
|
1.80e-01
|
4.94e-01
|
GO:0045740 BP positive regulation of DNA replication
|
29
|
9.31e-02
|
1.80e-01
|
2.99e-01
|
GO:0001649 BP osteoblast differentiation
|
99
|
1.97e-03
|
1.80e-01
|
2.30e-02
|
GO:1900242 BP regulation of synaptic vesicle endocytosis
|
13
|
2.61e-01
|
-1.80e-01
|
5.32e-01
|
GO:0006287 BP base-excision repair, gap-filling
|
14
|
2.44e-01
|
1.80e-01
|
5.11e-01
|
GO:0045921 BP positive regulation of exocytosis
|
17
|
1.99e-01
|
-1.80e-01
|
4.58e-01
|
GO:0045596 BP negative regulation of cell differentiation
|
28
|
1.00e-01
|
1.80e-01
|
3.15e-01
|
GO:0043085 BP positive regulation of catalytic activity
|
19
|
1.75e-01
|
1.80e-01
|
4.30e-01
|
GO:0060765 BP regulation of androgen receptor signaling pathway
|
13
|
2.63e-01
|
1.79e-01
|
5.33e-01
|
GO:0036211 BP protein modification process
|
80
|
5.61e-03
|
1.79e-01
|
4.95e-02
|
GO:0006366 BP transcription by RNA polymerase II
|
175
|
4.57e-05
|
1.79e-01
|
1.26e-03
|
GO:0021895 BP cerebral cortex neuron differentiation
|
11
|
3.05e-01
|
-1.79e-01
|
5.79e-01
|
GO:0006378 BP mRNA polyadenylation
|
18
|
1.90e-01
|
1.79e-01
|
4.50e-01
|
GO:0035372 BP protein localization to microtubule
|
10
|
3.28e-01
|
1.78e-01
|
6.02e-01
|
GO:0031295 BP T cell costimulation
|
23
|
1.39e-01
|
-1.78e-01
|
3.73e-01
|
GO:0042073 BP intraciliary transport
|
29
|
9.69e-02
|
1.78e-01
|
3.08e-01
|
GO:0007051 BP spindle organization
|
18
|
1.91e-01
|
1.78e-01
|
4.51e-01
|
GO:0007339 BP binding of sperm to zona pellucida
|
19
|
1.80e-01
|
1.78e-01
|
4.36e-01
|
GO:0030326 BP embryonic limb morphogenesis
|
26
|
1.17e-01
|
-1.78e-01
|
3.44e-01
|
GO:0001678 BP intracellular glucose homeostasis
|
18
|
1.93e-01
|
-1.77e-01
|
4.51e-01
|
GO:0005978 BP glycogen biosynthetic process
|
19
|
1.81e-01
|
1.77e-01
|
4.37e-01
|
GO:0007166 BP cell surface receptor signaling pathway
|
108
|
1.48e-03
|
-1.77e-01
|
1.89e-02
|
GO:0032956 BP regulation of actin cytoskeleton organization
|
78
|
6.95e-03
|
-1.77e-01
|
5.65e-02
|
GO:0048821 BP erythrocyte development
|
15
|
2.36e-01
|
1.77e-01
|
5.07e-01
|
GO:0060347 BP heart trabecula formation
|
10
|
3.34e-01
|
1.76e-01
|
6.08e-01
|
GO:0022900 BP electron transport chain
|
41
|
5.07e-02
|
1.76e-01
|
2.11e-01
|
GO:0032211 BP negative regulation of telomere maintenance via telomerase
|
21
|
1.62e-01
|
1.76e-01
|
4.12e-01
|
GO:0061014 BP positive regulation of mRNA catabolic process
|
12
|
2.91e-01
|
1.76e-01
|
5.61e-01
|
GO:2000001 BP regulation of DNA damage checkpoint
|
15
|
2.38e-01
|
1.76e-01
|
5.07e-01
|
GO:0050877 BP nervous system process
|
24
|
1.36e-01
|
-1.76e-01
|
3.70e-01
|
GO:2001243 BP negative regulation of intrinsic apoptotic signaling pathway
|
23
|
1.44e-01
|
1.76e-01
|
3.80e-01
|
GO:0033574 BP response to testosterone
|
24
|
1.36e-01
|
1.76e-01
|
3.70e-01
|
GO:0070102 BP interleukin-6-mediated signaling pathway
|
12
|
2.93e-01
|
-1.75e-01
|
5.64e-01
|
GO:0043518 BP negative regulation of DNA damage response, signal transduction by p53 class mediator
|
15
|
2.41e-01
|
1.75e-01
|
5.08e-01
|
GO:0050853 BP B cell receptor signaling pathway
|
22
|
1.58e-01
|
-1.74e-01
|
4.04e-01
|
GO:0006633 BP fatty acid biosynthetic process
|
29
|
1.05e-01
|
-1.74e-01
|
3.24e-01
|
GO:0035721 BP intraciliary retrograde transport
|
14
|
2.61e-01
|
-1.74e-01
|
5.32e-01
|
GO:0001881 BP receptor recycling
|
10
|
3.42e-01
|
-1.74e-01
|
6.17e-01
|
GO:0051216 BP cartilage development
|
41
|
5.46e-02
|
-1.74e-01
|
2.20e-01
|
GO:0008203 BP cholesterol metabolic process
|
53
|
2.90e-02
|
-1.73e-01
|
1.48e-01
|
GO:0007229 BP integrin-mediated signaling pathway
|
75
|
9.57e-03
|
-1.73e-01
|
7.06e-02
|
GO:0033147 BP negative regulation of intracellular estrogen receptor signaling pathway
|
13
|
2.80e-01
|
1.73e-01
|
5.47e-01
|
GO:0045869 BP negative regulation of single stranded viral RNA replication via double stranded DNA intermediate
|
13
|
2.80e-01
|
-1.73e-01
|
5.47e-01
|
GO:0000724 BP double-strand break repair via homologous recombination
|
96
|
3.43e-03
|
1.73e-01
|
3.48e-02
|
GO:0048754 BP branching morphogenesis of an epithelial tube
|
16
|
2.31e-01
|
-1.73e-01
|
4.99e-01
|
GO:0006816 BP calcium ion transport
|
43
|
5.00e-02
|
-1.73e-01
|
2.09e-01
|
GO:0051453 BP regulation of intracellular pH
|
18
|
2.04e-01
|
-1.73e-01
|
4.67e-01
|
GO:0048015 BP phosphatidylinositol-mediated signaling
|
20
|
1.81e-01
|
-1.73e-01
|
4.37e-01
|
GO:0050708 BP regulation of protein secretion
|
11
|
3.22e-01
|
-1.72e-01
|
5.96e-01
|
GO:0031032 BP actomyosin structure organization
|
26
|
1.29e-01
|
-1.72e-01
|
3.60e-01
|
GO:0007179 BP transforming growth factor beta receptor signaling pathway
|
74
|
1.05e-02
|
-1.72e-01
|
7.53e-02
|
GO:0038180 BP nerve growth factor signaling pathway
|
11
|
3.23e-01
|
1.72e-01
|
5.96e-01
|
GO:0031122 BP cytoplasmic microtubule organization
|
43
|
5.13e-02
|
-1.72e-01
|
2.12e-01
|
GO:0048813 BP dendrite morphogenesis
|
30
|
1.04e-01
|
-1.71e-01
|
3.23e-01
|
GO:0007601 BP visual perception
|
91
|
4.75e-03
|
-1.71e-01
|
4.43e-02
|
GO:0006509 BP membrane protein ectodomain proteolysis
|
22
|
1.64e-01
|
1.71e-01
|
4.15e-01
|
GO:1904707 BP positive regulation of vascular associated smooth muscle cell proliferation
|
28
|
1.17e-01
|
-1.71e-01
|
3.44e-01
|
GO:0006897 BP endocytosis
|
154
|
2.49e-04
|
-1.71e-01
|
4.97e-03
|
GO:0042311 BP vasodilation
|
23
|
1.56e-01
|
-1.71e-01
|
4.02e-01
|
GO:0090162 BP establishment of epithelial cell polarity
|
13
|
2.87e-01
|
-1.71e-01
|
5.54e-01
|
GO:0051642 BP centrosome localization
|
16
|
2.37e-01
|
-1.71e-01
|
5.07e-01
|
GO:0035329 BP hippo signaling
|
16
|
2.37e-01
|
-1.71e-01
|
5.07e-01
|
GO:0009953 BP dorsal/ventral pattern formation
|
27
|
1.25e-01
|
-1.71e-01
|
3.53e-01
|
GO:0051149 BP positive regulation of muscle cell differentiation
|
12
|
3.07e-01
|
-1.70e-01
|
5.80e-01
|
GO:0035249 BP synaptic transmission, glutamatergic
|
25
|
1.41e-01
|
-1.70e-01
|
3.77e-01
|
GO:0002376 BP immune system process
|
23
|
1.58e-01
|
-1.70e-01
|
4.05e-01
|
GO:0055117 BP regulation of cardiac muscle contraction
|
13
|
2.89e-01
|
1.70e-01
|
5.58e-01
|
GO:0007049 BP cell cycle
|
260
|
2.47e-06
|
1.70e-01
|
1.17e-04
|
GO:0007338 BP single fertilization
|
38
|
7.02e-02
|
-1.70e-01
|
2.54e-01
|
GO:0060766 BP negative regulation of androgen receptor signaling pathway
|
14
|
2.71e-01
|
-1.70e-01
|
5.43e-01
|
GO:0046761 BP viral budding from plasma membrane
|
13
|
2.91e-01
|
1.69e-01
|
5.61e-01
|
GO:0007035 BP vacuolar acidification
|
21
|
1.81e-01
|
1.69e-01
|
4.37e-01
|
GO:0048168 BP regulation of neuronal synaptic plasticity
|
14
|
2.75e-01
|
-1.68e-01
|
5.47e-01
|
GO:0030178 BP negative regulation of Wnt signaling pathway
|
29
|
1.17e-01
|
-1.68e-01
|
3.44e-01
|
GO:0061709 BP reticulophagy
|
18
|
2.17e-01
|
-1.68e-01
|
4.85e-01
|
GO:0048278 BP vesicle docking
|
20
|
1.94e-01
|
-1.68e-01
|
4.53e-01
|
GO:0060397 BP growth hormone receptor signaling pathway via JAK-STAT
|
10
|
3.59e-01
|
-1.68e-01
|
6.29e-01
|
GO:0016241 BP regulation of macroautophagy
|
54
|
3.33e-02
|
1.67e-01
|
1.61e-01
|
GO:0035338 BP long-chain fatty-acyl-CoA biosynthetic process
|
15
|
2.62e-01
|
-1.67e-01
|
5.32e-01
|
GO:0051302 BP regulation of cell division
|
19
|
2.07e-01
|
1.67e-01
|
4.72e-01
|
GO:0042327 BP positive regulation of phosphorylation
|
20
|
1.96e-01
|
1.67e-01
|
4.55e-01
|
GO:2000648 BP positive regulation of stem cell proliferation
|
20
|
1.96e-01
|
1.67e-01
|
4.55e-01
|
GO:0048705 BP skeletal system morphogenesis
|
26
|
1.42e-01
|
-1.67e-01
|
3.77e-01
|
GO:0051897 BP positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
113
|
2.25e-03
|
-1.66e-01
|
2.57e-02
|
GO:0001944 BP vasculature development
|
12
|
3.18e-01
|
1.66e-01
|
5.91e-01
|
GO:0032727 BP positive regulation of interferon-alpha production
|
19
|
2.09e-01
|
1.66e-01
|
4.75e-01
|
GO:0030335 BP positive regulation of cell migration
|
177
|
1.38e-04
|
-1.66e-01
|
3.18e-03
|
GO:0030168 BP platelet activation
|
41
|
6.63e-02
|
-1.66e-01
|
2.46e-01
|
GO:0051146 BP striated muscle cell differentiation
|
14
|
2.84e-01
|
1.65e-01
|
5.52e-01
|
GO:0031334 BP positive regulation of protein-containing complex assembly
|
38
|
7.83e-02
|
1.65e-01
|
2.69e-01
|
GO:0042594 BP response to starvation
|
27
|
1.38e-01
|
-1.65e-01
|
3.72e-01
|
GO:0000002 BP mitochondrial genome maintenance
|
11
|
3.44e-01
|
1.65e-01
|
6.19e-01
|
GO:0006096 BP glycolytic process
|
31
|
1.13e-01
|
1.64e-01
|
3.38e-01
|
GO:0010613 BP positive regulation of cardiac muscle hypertrophy
|
17
|
2.41e-01
|
-1.64e-01
|
5.08e-01
|
GO:1901673 BP regulation of mitotic spindle assembly
|
22
|
1.84e-01
|
1.64e-01
|
4.41e-01
|
GO:1900016 BP negative regulation of cytokine production involved in inflammatory response
|
16
|
2.58e-01
|
-1.63e-01
|
5.28e-01
|
GO:0007052 BP mitotic spindle organization
|
51
|
4.36e-02
|
1.63e-01
|
1.94e-01
|
GO:0044794 BP positive regulation by host of viral process
|
12
|
3.28e-01
|
1.63e-01
|
6.01e-01
|
GO:0006325 BP chromatin organization
|
152
|
5.21e-04
|
1.63e-01
|
9.08e-03
|
GO:0030073 BP insulin secretion
|
19
|
2.19e-01
|
-1.63e-01
|
4.86e-01
|
GO:0045746 BP negative regulation of Notch signaling pathway
|
32
|
1.11e-01
|
-1.63e-01
|
3.36e-01
|
GO:0040018 BP positive regulation of multicellular organism growth
|
20
|
2.08e-01
|
-1.63e-01
|
4.73e-01
|
GO:0031167 BP rRNA methylation
|
14
|
2.92e-01
|
1.63e-01
|
5.63e-01
|
GO:0007605 BP sensory perception of sound
|
91
|
7.44e-03
|
-1.62e-01
|
5.90e-02
|
GO:0032743 BP positive regulation of interleukin-2 production
|
23
|
1.78e-01
|
1.62e-01
|
4.33e-01
|
GO:0042981 BP regulation of apoptotic process
|
139
|
9.72e-04
|
1.62e-01
|
1.44e-02
|
GO:0007129 BP homologous chromosome pairing at meiosis
|
14
|
2.94e-01
|
1.62e-01
|
5.64e-01
|
GO:0051649 BP establishment of localization in cell
|
62
|
2.75e-02
|
-1.62e-01
|
1.43e-01
|
GO:0001654 BP eye development
|
28
|
1.39e-01
|
-1.62e-01
|
3.73e-01
|
GO:0006605 BP protein targeting
|
36
|
9.39e-02
|
1.61e-01
|
3.01e-01
|
GO:0046847 BP filopodium assembly
|
18
|
2.37e-01
|
-1.61e-01
|
5.07e-01
|
GO:0045214 BP sarcomere organization
|
26
|
1.55e-01
|
-1.61e-01
|
3.99e-01
|
GO:0003198 BP epithelial to mesenchymal transition involved in endocardial cushion formation
|
10
|
3.79e-01
|
-1.61e-01
|
6.52e-01
|
GO:0030902 BP hindbrain development
|
11
|
3.57e-01
|
-1.61e-01
|
6.29e-01
|
GO:0030318 BP melanocyte differentiation
|
11
|
3.58e-01
|
-1.60e-01
|
6.29e-01
|
GO:0001675 BP acrosome assembly
|
14
|
2.99e-01
|
-1.60e-01
|
5.73e-01
|
GO:0006476 BP protein deacetylation
|
12
|
3.37e-01
|
-1.60e-01
|
6.12e-01
|
GO:0090656 BP t-circle formation
|
12
|
3.38e-01
|
1.60e-01
|
6.13e-01
|
GO:0051443 BP positive regulation of ubiquitin-protein transferase activity
|
10
|
3.82e-01
|
1.60e-01
|
6.55e-01
|
GO:0000038 BP very long-chain fatty acid metabolic process
|
14
|
3.01e-01
|
-1.60e-01
|
5.75e-01
|
GO:0015813 BP L-glutamate transmembrane transport
|
13
|
3.20e-01
|
1.59e-01
|
5.94e-01
|
GO:0001778 BP plasma membrane repair
|
22
|
1.96e-01
|
1.59e-01
|
4.55e-01
|
GO:0010212 BP response to ionizing radiation
|
40
|
8.17e-02
|
1.59e-01
|
2.77e-01
|
GO:0007141 BP male meiosis I
|
15
|
2.86e-01
|
1.59e-01
|
5.54e-01
|
GO:0007019 BP microtubule depolymerization
|
13
|
3.21e-01
|
1.59e-01
|
5.95e-01
|
GO:0006631 BP fatty acid metabolic process
|
64
|
2.80e-02
|
-1.59e-01
|
1.44e-01
|
GO:0044314 BP protein K27-linked ubiquitination
|
10
|
3.86e-01
|
1.58e-01
|
6.60e-01
|
GO:0034122 BP negative regulation of toll-like receptor signaling pathway
|
11
|
3.64e-01
|
1.58e-01
|
6.36e-01
|
GO:0034383 BP low-density lipoprotein particle clearance
|
11
|
3.65e-01
|
1.58e-01
|
6.36e-01
|
GO:0007062 BP sister chromatid cohesion
|
18
|
2.47e-01
|
1.58e-01
|
5.15e-01
|
GO:0061952 BP midbody abscission
|
17
|
2.62e-01
|
1.57e-01
|
5.32e-01
|
GO:0043525 BP positive regulation of neuron apoptotic process
|
46
|
6.53e-02
|
1.57e-01
|
2.44e-01
|
GO:0034145 BP positive regulation of toll-like receptor 4 signaling pathway
|
12
|
3.47e-01
|
-1.57e-01
|
6.22e-01
|
GO:0010165 BP response to X-ray
|
17
|
2.63e-01
|
1.57e-01
|
5.34e-01
|
GO:0006493 BP protein O-linked glycosylation
|
55
|
4.44e-02
|
-1.57e-01
|
1.97e-01
|
GO:0060907 BP positive regulation of macrophage cytokine production
|
18
|
2.51e-01
|
-1.56e-01
|
5.20e-01
|
GO:2000147 BP positive regulation of cell motility
|
17
|
2.66e-01
|
1.56e-01
|
5.36e-01
|
GO:0070085 BP glycosylation
|
16
|
2.80e-01
|
-1.56e-01
|
5.47e-01
|
GO:0007213 BP G protein-coupled acetylcholine receptor signaling pathway
|
10
|
3.94e-01
|
-1.56e-01
|
6.63e-01
|
GO:0001676 BP long-chain fatty acid metabolic process
|
19
|
2.40e-01
|
-1.56e-01
|
5.08e-01
|
GO:0032940 BP secretion by cell
|
10
|
3.94e-01
|
-1.56e-01
|
6.63e-01
|
GO:0035902 BP response to immobilization stress
|
18
|
2.53e-01
|
-1.56e-01
|
5.20e-01
|
GO:0090102 BP cochlea development
|
19
|
2.40e-01
|
1.56e-01
|
5.08e-01
|
GO:0071392 BP cellular response to estradiol stimulus
|
27
|
1.62e-01
|
1.55e-01
|
4.12e-01
|
GO:0001656 BP metanephros development
|
19
|
2.41e-01
|
-1.55e-01
|
5.08e-01
|
GO:0045616 BP regulation of keratinocyte differentiation
|
10
|
3.96e-01
|
-1.55e-01
|
6.65e-01
|
GO:0046330 BP positive regulation of JNK cascade
|
76
|
1.98e-02
|
-1.55e-01
|
1.17e-01
|
GO:0031668 BP cellular response to extracellular stimulus
|
12
|
3.55e-01
|
1.54e-01
|
6.28e-01
|
GO:0002720 BP positive regulation of cytokine production involved in immune response
|
10
|
3.99e-01
|
-1.54e-01
|
6.67e-01
|
GO:0033539 BP fatty acid beta-oxidation using acyl-CoA dehydrogenase
|
10
|
3.99e-01
|
-1.54e-01
|
6.67e-01
|
GO:0030162 BP regulation of proteolysis
|
10
|
3.99e-01
|
-1.54e-01
|
6.67e-01
|
GO:0060037 BP pharyngeal system development
|
13
|
3.38e-01
|
-1.53e-01
|
6.13e-01
|
GO:0001935 BP endothelial cell proliferation
|
20
|
2.35e-01
|
-1.53e-01
|
5.05e-01
|
GO:0070498 BP interleukin-1-mediated signaling pathway
|
19
|
2.47e-01
|
1.53e-01
|
5.15e-01
|
GO:0048011 BP neurotrophin TRK receptor signaling pathway
|
12
|
3.58e-01
|
-1.53e-01
|
6.29e-01
|
GO:0016339 BP calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules
|
18
|
2.61e-01
|
1.53e-01
|
5.32e-01
|
GO:0061621 BP canonical glycolysis
|
14
|
3.23e-01
|
1.53e-01
|
5.96e-01
|
GO:0006836 BP neurotransmitter transport
|
22
|
2.15e-01
|
-1.53e-01
|
4.83e-01
|
GO:0051726 BP regulation of cell cycle
|
199
|
2.12e-04
|
1.52e-01
|
4.39e-03
|
GO:0140467 BP integrated stress response signaling
|
20
|
2.38e-01
|
1.52e-01
|
5.07e-01
|
GO:0032760 BP positive regulation of tumor necrosis factor production
|
67
|
3.14e-02
|
-1.52e-01
|
1.57e-01
|
GO:0006879 BP intracellular iron ion homeostasis
|
56
|
4.91e-02
|
1.52e-01
|
2.08e-01
|
GO:0060079 BP excitatory postsynaptic potential
|
34
|
1.25e-01
|
-1.52e-01
|
3.53e-01
|
GO:0000184 BP nuclear-transcribed mRNA catabolic process, nonsense-mediated decay
|
35
|
1.20e-01
|
1.52e-01
|
3.46e-01
|
GO:0033674 BP positive regulation of kinase activity
|
34
|
1.26e-01
|
-1.52e-01
|
3.54e-01
|
GO:0032012 BP regulation of ARF protein signal transduction
|
17
|
2.79e-01
|
-1.52e-01
|
5.47e-01
|
GO:0035418 BP protein localization to synapse
|
12
|
3.63e-01
|
-1.52e-01
|
6.36e-01
|
GO:0007010 BP cytoskeleton organization
|
106
|
7.05e-03
|
-1.52e-01
|
5.67e-02
|
GO:0046512 BP sphingosine biosynthetic process
|
12
|
3.65e-01
|
-1.51e-01
|
6.36e-01
|
GO:1904646 BP cellular response to amyloid-beta
|
32
|
1.39e-01
|
-1.51e-01
|
3.73e-01
|
GO:0001817 BP regulation of cytokine production
|
45
|
8.03e-02
|
-1.51e-01
|
2.75e-01
|
GO:0022904 BP respiratory electron transport chain
|
18
|
2.69e-01
|
1.51e-01
|
5.39e-01
|
GO:0033540 BP fatty acid beta-oxidation using acyl-CoA oxidase
|
11
|
3.88e-01
|
-1.50e-01
|
6.61e-01
|
GO:0030218 BP erythrocyte differentiation
|
41
|
9.56e-02
|
1.50e-01
|
3.05e-01
|
GO:0036503 BP ERAD pathway
|
85
|
1.66e-02
|
1.50e-01
|
1.07e-01
|
GO:0043687 BP post-translational protein modification
|
33
|
1.35e-01
|
1.50e-01
|
3.69e-01
|
GO:0006024 BP glycosaminoglycan biosynthetic process
|
14
|
3.30e-01
|
-1.50e-01
|
6.05e-01
|
GO:0035176 BP social behavior
|
32
|
1.41e-01
|
-1.50e-01
|
3.77e-01
|
GO:0000082 BP G1/S transition of mitotic cell cycle
|
60
|
4.47e-02
|
1.50e-01
|
1.98e-01
|
GO:2000378 BP negative regulation of reactive oxygen species metabolic process
|
21
|
2.36e-01
|
1.49e-01
|
5.07e-01
|
GO:0051310 BP metaphase chromosome alignment
|
13
|
3.52e-01
|
1.49e-01
|
6.25e-01
|
GO:0006303 BP double-strand break repair via nonhomologous end joining
|
37
|
1.16e-01
|
1.49e-01
|
3.44e-01
|
GO:0009566 BP fertilization
|
25
|
1.97e-01
|
-1.49e-01
|
4.56e-01
|
GO:0090263 BP positive regulation of canonical Wnt signaling pathway
|
86
|
1.70e-02
|
-1.49e-01
|
1.09e-01
|
GO:0018023 BP peptidyl-lysine trimethylation
|
11
|
3.93e-01
|
1.49e-01
|
6.63e-01
|
GO:0048665 BP neuron fate specification
|
11
|
3.93e-01
|
-1.49e-01
|
6.63e-01
|
GO:0050772 BP positive regulation of axonogenesis
|
26
|
1.90e-01
|
-1.48e-01
|
4.51e-01
|
GO:1990869 BP cellular response to chemokine
|
13
|
3.56e-01
|
1.48e-01
|
6.29e-01
|
GO:0060314 BP regulation of ryanodine-sensitive calcium-release channel activity
|
11
|
3.96e-01
|
1.48e-01
|
6.65e-01
|
GO:0009409 BP response to cold
|
20
|
2.53e-01
|
-1.48e-01
|
5.20e-01
|
GO:0006869 BP lipid transport
|
43
|
9.42e-02
|
-1.48e-01
|
3.01e-01
|
GO:2000059 BP negative regulation of ubiquitin-dependent protein catabolic process
|
18
|
2.79e-01
|
1.47e-01
|
5.47e-01
|
GO:0090103 BP cochlea morphogenesis
|
15
|
3.24e-01
|
-1.47e-01
|
5.96e-01
|
GO:0048709 BP oligodendrocyte differentiation
|
29
|
1.71e-01
|
1.47e-01
|
4.25e-01
|
GO:1900029 BP positive regulation of ruffle assembly
|
11
|
3.99e-01
|
1.47e-01
|
6.67e-01
|
GO:0035050 BP embryonic heart tube development
|
14
|
3.43e-01
|
-1.46e-01
|
6.18e-01
|
GO:0051881 BP regulation of mitochondrial membrane potential
|
30
|
1.68e-01
|
1.46e-01
|
4.19e-01
|
GO:0097190 BP apoptotic signaling pathway
|
50
|
7.51e-02
|
-1.46e-01
|
2.64e-01
|
GO:0032722 BP positive regulation of chemokine production
|
27
|
1.92e-01
|
-1.45e-01
|
4.51e-01
|
GO:0003016 BP respiratory system process
|
13
|
3.66e-01
|
1.45e-01
|
6.36e-01
|
GO:0001836 BP release of cytochrome c from mitochondria
|
22
|
2.41e-01
|
1.45e-01
|
5.08e-01
|
GO:0032418 BP lysosome localization
|
32
|
1.57e-01
|
1.45e-01
|
4.04e-01
|
GO:0030851 BP granulocyte differentiation
|
12
|
3.86e-01
|
-1.44e-01
|
6.60e-01
|
GO:0022038 BP corpus callosum development
|
15
|
3.33e-01
|
1.44e-01
|
6.08e-01
|
GO:0021549 BP cerebellum development
|
28
|
1.87e-01
|
-1.44e-01
|
4.45e-01
|
GO:0051247 BP positive regulation of protein metabolic process
|
20
|
2.65e-01
|
1.44e-01
|
5.36e-01
|
GO:0030833 BP regulation of actin filament polymerization
|
25
|
2.13e-01
|
-1.44e-01
|
4.81e-01
|
GO:0016042 BP lipid catabolic process
|
34
|
1.47e-01
|
-1.44e-01
|
3.85e-01
|
GO:0010001 BP glial cell differentiation
|
14
|
3.52e-01
|
1.44e-01
|
6.25e-01
|
GO:0009314 BP response to radiation
|
11
|
4.09e-01
|
1.44e-01
|
6.70e-01
|
GO:0090385 BP phagosome-lysosome fusion
|
12
|
3.89e-01
|
1.44e-01
|
6.62e-01
|
GO:0010944 BP negative regulation of transcription by competitive promoter binding
|
11
|
4.15e-01
|
1.42e-01
|
6.76e-01
|
GO:2000353 BP positive regulation of endothelial cell apoptotic process
|
11
|
4.16e-01
|
-1.42e-01
|
6.77e-01
|
GO:0044458 BP motile cilium assembly
|
21
|
2.61e-01
|
1.42e-01
|
5.32e-01
|
GO:0070059 BP intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
30
|
1.80e-01
|
-1.42e-01
|
4.35e-01
|
GO:0006688 BP glycosphingolipid biosynthetic process
|
10
|
4.39e-01
|
-1.41e-01
|
7.00e-01
|
GO:0016601 BP Rac protein signal transduction
|
23
|
2.43e-01
|
-1.41e-01
|
5.10e-01
|
GO:0061003 BP positive regulation of dendritic spine morphogenesis
|
15
|
3.46e-01
|
1.41e-01
|
6.22e-01
|
GO:0030307 BP positive regulation of cell growth
|
71
|
4.09e-02
|
1.40e-01
|
1.86e-01
|
GO:0010875 BP positive regulation of cholesterol efflux
|
22
|
2.55e-01
|
-1.40e-01
|
5.23e-01
|
GO:0060337 BP type I interferon-mediated signaling pathway
|
29
|
1.92e-01
|
-1.40e-01
|
4.51e-01
|
GO:0042542 BP response to hydrogen peroxide
|
29
|
1.92e-01
|
1.40e-01
|
4.51e-01
|
GO:0042474 BP middle ear morphogenesis
|
16
|
3.34e-01
|
1.40e-01
|
6.08e-01
|
GO:0043392 BP negative regulation of DNA binding
|
15
|
3.50e-01
|
1.39e-01
|
6.25e-01
|
GO:0032717 BP negative regulation of interleukin-8 production
|
12
|
4.04e-01
|
1.39e-01
|
6.69e-01
|
GO:0032024 BP positive regulation of insulin secretion
|
39
|
1.34e-01
|
-1.39e-01
|
3.68e-01
|
GO:0098719 BP sodium ion import across plasma membrane
|
13
|
3.87e-01
|
-1.39e-01
|
6.60e-01
|
GO:0006686 BP sphingomyelin biosynthetic process
|
11
|
4.27e-01
|
-1.38e-01
|
6.88e-01
|
GO:0046037 BP GMP metabolic process
|
10
|
4.49e-01
|
-1.38e-01
|
7.08e-01
|
GO:0048872 BP homeostasis of number of cells
|
15
|
3.54e-01
|
1.38e-01
|
6.27e-01
|
GO:0018105 BP peptidyl-serine phosphorylation
|
143
|
4.40e-03
|
-1.38e-01
|
4.18e-02
|
GO:0009791 BP post-embryonic development
|
60
|
6.45e-02
|
-1.38e-01
|
2.43e-01
|
GO:0055093 BP response to hyperoxia
|
11
|
4.28e-01
|
1.38e-01
|
6.89e-01
|
GO:0001934 BP positive regulation of protein phosphorylation
|
139
|
5.02e-03
|
-1.38e-01
|
4.55e-02
|
GO:0006958 BP complement activation, classical pathway
|
16
|
3.40e-01
|
-1.38e-01
|
6.15e-01
|
GO:0031573 BP mitotic intra-S DNA damage checkpoint signaling
|
16
|
3.40e-01
|
1.38e-01
|
6.16e-01
|
GO:0048703 BP embryonic viscerocranium morphogenesis
|
10
|
4.52e-01
|
1.37e-01
|
7.11e-01
|
GO:0016180 BP snRNA processing
|
15
|
3.57e-01
|
1.37e-01
|
6.29e-01
|
GO:0031054 BP pre-miRNA processing
|
13
|
3.91e-01
|
-1.37e-01
|
6.63e-01
|
GO:0006749 BP glutathione metabolic process
|
25
|
2.34e-01
|
1.37e-01
|
5.04e-01
|
GO:0098887 BP neurotransmitter receptor transport, endosome to postsynaptic membrane
|
10
|
4.52e-01
|
1.37e-01
|
7.11e-01
|
GO:0035924 BP cellular response to vascular endothelial growth factor stimulus
|
21
|
2.76e-01
|
1.37e-01
|
5.47e-01
|
GO:2000811 BP negative regulation of anoikis
|
16
|
3.42e-01
|
-1.37e-01
|
6.17e-01
|
GO:0030214 BP hyaluronan catabolic process
|
12
|
4.11e-01
|
-1.37e-01
|
6.72e-01
|
GO:0006636 BP unsaturated fatty acid biosynthetic process
|
14
|
3.76e-01
|
-1.37e-01
|
6.48e-01
|
GO:0009887 BP animal organ morphogenesis
|
63
|
6.07e-02
|
1.37e-01
|
2.33e-01
|
GO:0032963 BP collagen metabolic process
|
12
|
4.12e-01
|
-1.37e-01
|
6.74e-01
|
GO:0031648 BP protein destabilization
|
44
|
1.18e-01
|
1.36e-01
|
3.44e-01
|
GO:0010467 BP gene expression
|
91
|
2.49e-02
|
-1.36e-01
|
1.34e-01
|
GO:0042789 BP mRNA transcription by RNA polymerase II
|
44
|
1.19e-01
|
1.36e-01
|
3.44e-01
|
GO:0010762 BP regulation of fibroblast migration
|
13
|
3.97e-01
|
1.36e-01
|
6.65e-01
|
GO:0007616 BP long-term memory
|
24
|
2.50e-01
|
-1.36e-01
|
5.20e-01
|
GO:0030177 BP positive regulation of Wnt signaling pathway
|
31
|
1.92e-01
|
-1.35e-01
|
4.51e-01
|
GO:0045668 BP negative regulation of osteoblast differentiation
|
38
|
1.49e-01
|
-1.35e-01
|
3.89e-01
|
GO:0045104 BP intermediate filament cytoskeleton organization
|
14
|
3.81e-01
|
-1.35e-01
|
6.54e-01
|
GO:0046849 BP bone remodeling
|
11
|
4.39e-01
|
-1.35e-01
|
7.00e-01
|
GO:0090399 BP replicative senescence
|
13
|
4.01e-01
|
-1.35e-01
|
6.67e-01
|
GO:0035082 BP axoneme assembly
|
18
|
3.23e-01
|
1.35e-01
|
5.96e-01
|
GO:0031629 BP synaptic vesicle fusion to presynaptic active zone membrane
|
11
|
4.40e-01
|
-1.35e-01
|
7.01e-01
|
GO:0009267 BP cellular response to starvation
|
61
|
6.94e-02
|
-1.34e-01
|
2.52e-01
|
GO:0006952 BP defense response
|
40
|
1.41e-01
|
-1.34e-01
|
3.77e-01
|
GO:0034446 BP substrate adhesion-dependent cell spreading
|
41
|
1.37e-01
|
-1.34e-01
|
3.71e-01
|
GO:0051014 BP actin filament severing
|
10
|
4.63e-01
|
-1.34e-01
|
7.12e-01
|
GO:1903377 BP negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway
|
10
|
4.63e-01
|
1.34e-01
|
7.12e-01
|
GO:0006629 BP lipid metabolic process
|
117
|
1.25e-02
|
-1.34e-01
|
8.57e-02
|
GO:0070374 BP positive regulation of ERK1 and ERK2 cascade
|
120
|
1.17e-02
|
-1.33e-01
|
8.19e-02
|
GO:0034341 BP response to type II interferon
|
19
|
3.15e-01
|
-1.33e-01
|
5.89e-01
|
GO:0090051 BP negative regulation of cell migration involved in sprouting angiogenesis
|
13
|
4.06e-01
|
1.33e-01
|
6.69e-01
|
GO:0009653 BP anatomical structure morphogenesis
|
83
|
3.66e-02
|
-1.33e-01
|
1.73e-01
|
GO:0006338 BP chromatin remodeling
|
291
|
1.00e-04
|
1.33e-01
|
2.44e-03
|
GO:0010880 BP regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum
|
12
|
4.26e-01
|
1.33e-01
|
6.88e-01
|
GO:0016485 BP protein processing
|
60
|
7.58e-02
|
-1.33e-01
|
2.65e-01
|
GO:0040019 BP positive regulation of embryonic development
|
12
|
4.27e-01
|
1.33e-01
|
6.88e-01
|
GO:0070986 BP left/right axis specification
|
13
|
4.08e-01
|
1.33e-01
|
6.70e-01
|
GO:0006654 BP phosphatidic acid biosynthetic process
|
28
|
2.25e-01
|
-1.32e-01
|
4.92e-01
|
GO:0016125 BP sterol metabolic process
|
11
|
4.47e-01
|
1.32e-01
|
7.07e-01
|
GO:0001503 BP ossification
|
47
|
1.17e-01
|
-1.32e-01
|
3.44e-01
|
GO:2000060 BP positive regulation of ubiquitin-dependent protein catabolic process
|
25
|
2.53e-01
|
-1.32e-01
|
5.20e-01
|
GO:0050427 BP 3’-phosphoadenosine 5’-phosphosulfate metabolic process
|
11
|
4.48e-01
|
-1.32e-01
|
7.07e-01
|
GO:0030534 BP adult behavior
|
20
|
3.07e-01
|
-1.32e-01
|
5.80e-01
|
GO:0030334 BP regulation of cell migration
|
68
|
6.04e-02
|
-1.32e-01
|
2.33e-01
|
GO:0030048 BP actin filament-based movement
|
14
|
3.94e-01
|
-1.32e-01
|
6.63e-01
|
GO:0048596 BP embryonic camera-type eye morphogenesis
|
10
|
4.72e-01
|
-1.32e-01
|
7.18e-01
|
GO:0035987 BP endodermal cell differentiation
|
28
|
2.29e-01
|
-1.31e-01
|
4.96e-01
|
GO:0034976 BP response to endoplasmic reticulum stress
|
81
|
4.14e-02
|
1.31e-01
|
1.87e-01
|
GO:0046907 BP intracellular transport
|
34
|
1.86e-01
|
-1.31e-01
|
4.44e-01
|
GO:2000377 BP regulation of reactive oxygen species metabolic process
|
19
|
3.24e-01
|
1.31e-01
|
5.96e-01
|
GO:0006953 BP acute-phase response
|
20
|
3.12e-01
|
-1.31e-01
|
5.85e-01
|
GO:0036158 BP outer dynein arm assembly
|
15
|
3.82e-01
|
1.30e-01
|
6.55e-01
|
GO:0002224 BP toll-like receptor signaling pathway
|
19
|
3.26e-01
|
1.30e-01
|
6.00e-01
|
GO:0001916 BP positive regulation of T cell mediated cytotoxicity
|
21
|
3.02e-01
|
-1.30e-01
|
5.77e-01
|
GO:0006825 BP copper ion transport
|
11
|
4.58e-01
|
-1.29e-01
|
7.11e-01
|
GO:0032091 BP negative regulation of protein binding
|
46
|
1.30e-01
|
1.29e-01
|
3.60e-01
|
GO:0045730 BP respiratory burst
|
10
|
4.80e-01
|
-1.29e-01
|
7.24e-01
|
GO:0010564 BP regulation of cell cycle process
|
11
|
4.59e-01
|
-1.29e-01
|
7.11e-01
|
GO:0090141 BP positive regulation of mitochondrial fission
|
19
|
3.33e-01
|
1.28e-01
|
6.08e-01
|
GO:0001890 BP placenta development
|
25
|
2.67e-01
|
-1.28e-01
|
5.38e-01
|
GO:0061462 BP protein localization to lysosome
|
15
|
3.90e-01
|
1.28e-01
|
6.63e-01
|
GO:0009790 BP embryo development
|
11
|
4.63e-01
|
-1.28e-01
|
7.12e-01
|
GO:0030837 BP negative regulation of actin filament polymerization
|
19
|
3.35e-01
|
-1.28e-01
|
6.10e-01
|
GO:0032355 BP response to estradiol
|
53
|
1.08e-01
|
-1.28e-01
|
3.31e-01
|
GO:0035435 BP phosphate ion transmembrane transport
|
14
|
4.09e-01
|
-1.27e-01
|
6.70e-01
|
GO:0050673 BP epithelial cell proliferation
|
31
|
2.20e-01
|
-1.27e-01
|
4.87e-01
|
GO:0051895 BP negative regulation of focal adhesion assembly
|
12
|
4.45e-01
|
1.27e-01
|
7.05e-01
|
GO:0050847 BP progesterone receptor signaling pathway
|
11
|
4.65e-01
|
-1.27e-01
|
7.14e-01
|
GO:2001234 BP negative regulation of apoptotic signaling pathway
|
25
|
2.71e-01
|
1.27e-01
|
5.43e-01
|
GO:0050730 BP regulation of peptidyl-tyrosine phosphorylation
|
17
|
3.64e-01
|
-1.27e-01
|
6.36e-01
|
GO:0007219 BP Notch signaling pathway
|
89
|
3.84e-02
|
-1.27e-01
|
1.78e-01
|
GO:0046039 BP GTP metabolic process
|
12
|
4.46e-01
|
-1.27e-01
|
7.07e-01
|
GO:0008625 BP extrinsic apoptotic signaling pathway via death domain receptors
|
38
|
1.77e-01
|
1.27e-01
|
4.31e-01
|
GO:0031116 BP positive regulation of microtubule polymerization
|
24
|
2.83e-01
|
1.27e-01
|
5.50e-01
|
GO:0014003 BP oligodendrocyte development
|
17
|
3.67e-01
|
1.26e-01
|
6.39e-01
|
GO:0016477 BP cell migration
|
200
|
2.10e-03
|
-1.26e-01
|
2.43e-02
|
GO:0000226 BP microtubule cytoskeleton organization
|
110
|
2.26e-02
|
1.26e-01
|
1.27e-01
|
GO:0060828 BP regulation of canonical Wnt signaling pathway
|
22
|
3.07e-01
|
1.26e-01
|
5.80e-01
|
GO:0032469 BP endoplasmic reticulum calcium ion homeostasis
|
17
|
3.69e-01
|
1.26e-01
|
6.40e-01
|
GO:0061098 BP positive regulation of protein tyrosine kinase activity
|
15
|
4.00e-01
|
-1.26e-01
|
6.67e-01
|
GO:0048488 BP synaptic vesicle endocytosis
|
29
|
2.42e-01
|
-1.26e-01
|
5.08e-01
|
GO:0016266 BP O-glycan processing
|
34
|
2.05e-01
|
-1.26e-01
|
4.69e-01
|
GO:0006915 BP apoptotic process
|
431
|
8.54e-06
|
1.25e-01
|
3.26e-04
|
GO:0006886 BP intracellular protein transport
|
233
|
9.97e-04
|
1.25e-01
|
1.46e-02
|
GO:0030522 BP intracellular receptor signaling pathway
|
27
|
2.60e-01
|
-1.25e-01
|
5.32e-01
|
GO:0046777 BP protein autophosphorylation
|
118
|
1.88e-02
|
-1.25e-01
|
1.14e-01
|
GO:0007189 BP adenylate cyclase-activating G protein-coupled receptor signaling pathway
|
52
|
1.19e-01
|
-1.25e-01
|
3.44e-01
|
GO:0045806 BP negative regulation of endocytosis
|
12
|
4.53e-01
|
-1.25e-01
|
7.11e-01
|
GO:0007259 BP receptor signaling pathway via JAK-STAT
|
29
|
2.44e-01
|
-1.25e-01
|
5.11e-01
|
GO:0048814 BP regulation of dendrite morphogenesis
|
18
|
3.59e-01
|
-1.25e-01
|
6.29e-01
|
GO:0035666 BP TRIF-dependent toll-like receptor signaling pathway
|
10
|
4.94e-01
|
-1.25e-01
|
7.31e-01
|
GO:0044331 BP cell-cell adhesion mediated by cadherin
|
13
|
4.36e-01
|
-1.25e-01
|
6.96e-01
|
GO:0006641 BP triglyceride metabolic process
|
19
|
3.48e-01
|
-1.24e-01
|
6.23e-01
|
GO:0007218 BP neuropeptide signaling pathway
|
29
|
2.47e-01
|
-1.24e-01
|
5.15e-01
|
GO:0048678 BP response to axon injury
|
23
|
3.03e-01
|
1.24e-01
|
5.77e-01
|
GO:0006865 BP amino acid transport
|
22
|
3.13e-01
|
-1.24e-01
|
5.87e-01
|
GO:0036342 BP post-anal tail morphogenesis
|
13
|
4.38e-01
|
1.24e-01
|
7.00e-01
|
GO:0046889 BP positive regulation of lipid biosynthetic process
|
15
|
4.06e-01
|
-1.24e-01
|
6.69e-01
|
GO:1901223 BP negative regulation of non-canonical NF-kappaB signal transduction
|
18
|
3.63e-01
|
1.24e-01
|
6.36e-01
|
GO:0048662 BP negative regulation of smooth muscle cell proliferation
|
16
|
3.93e-01
|
1.23e-01
|
6.63e-01
|
GO:0001974 BP blood vessel remodeling
|
26
|
2.76e-01
|
-1.23e-01
|
5.47e-01
|
GO:0003376 BP sphingosine-1-phosphate receptor signaling pathway
|
10
|
5.00e-01
|
1.23e-01
|
7.36e-01
|
GO:1904355 BP positive regulation of telomere capping
|
16
|
3.94e-01
|
1.23e-01
|
6.63e-01
|
GO:0046426 BP negative regulation of receptor signaling pathway via JAK-STAT
|
12
|
4.60e-01
|
-1.23e-01
|
7.11e-01
|
GO:0046854 BP phosphatidylinositol phosphate biosynthetic process
|
42
|
1.67e-01
|
-1.23e-01
|
4.19e-01
|
GO:0071498 BP cellular response to fluid shear stress
|
12
|
4.60e-01
|
-1.23e-01
|
7.11e-01
|
GO:0045618 BP positive regulation of keratinocyte differentiation
|
14
|
4.27e-01
|
-1.23e-01
|
6.88e-01
|
GO:0043410 BP positive regulation of MAPK cascade
|
110
|
2.68e-02
|
-1.22e-01
|
1.41e-01
|
GO:2001240 BP negative regulation of extrinsic apoptotic signaling pathway in absence of ligand
|
26
|
2.82e-01
|
1.22e-01
|
5.49e-01
|
GO:0050901 BP leukocyte tethering or rolling
|
15
|
4.17e-01
|
-1.21e-01
|
6.79e-01
|
GO:0034244 BP negative regulation of transcription elongation by RNA polymerase II
|
20
|
3.49e-01
|
1.21e-01
|
6.24e-01
|
GO:1904357 BP negative regulation of telomere maintenance via telomere lengthening
|
10
|
5.08e-01
|
-1.21e-01
|
7.44e-01
|
GO:0015909 BP long-chain fatty acid transport
|
12
|
4.69e-01
|
-1.21e-01
|
7.18e-01
|
GO:0071456 BP cellular response to hypoxia
|
99
|
3.84e-02
|
1.20e-01
|
1.78e-01
|
GO:0072091 BP regulation of stem cell proliferation
|
10
|
5.10e-01
|
1.20e-01
|
7.45e-01
|
GO:0031468 BP nuclear membrane reassembly
|
17
|
3.90e-01
|
1.20e-01
|
6.63e-01
|
GO:0048266 BP behavioral response to pain
|
10
|
5.12e-01
|
1.20e-01
|
7.46e-01
|
GO:0007264 BP small GTPase-mediated signal transduction
|
70
|
8.34e-02
|
-1.20e-01
|
2.80e-01
|
GO:0007095 BP mitotic G2 DNA damage checkpoint signaling
|
37
|
2.08e-01
|
-1.20e-01
|
4.73e-01
|
GO:1903358 BP regulation of Golgi organization
|
13
|
4.56e-01
|
-1.20e-01
|
7.11e-01
|
GO:0030100 BP regulation of endocytosis
|
24
|
3.12e-01
|
-1.19e-01
|
5.86e-01
|
GO:0010389 BP regulation of G2/M transition of mitotic cell cycle
|
11
|
4.94e-01
|
1.19e-01
|
7.31e-01
|
GO:0046677 BP response to antibiotic
|
16
|
4.10e-01
|
-1.19e-01
|
6.72e-01
|
GO:0071773 BP cellular response to BMP stimulus
|
18
|
3.84e-01
|
-1.18e-01
|
6.58e-01
|
GO:0044346 BP fibroblast apoptotic process
|
10
|
5.17e-01
|
1.18e-01
|
7.52e-01
|
GO:0007041 BP lysosomal transport
|
20
|
3.60e-01
|
-1.18e-01
|
6.31e-01
|
GO:0070266 BP necroptotic process
|
13
|
4.60e-01
|
1.18e-01
|
7.11e-01
|
GO:0030278 BP regulation of ossification
|
12
|
4.78e-01
|
1.18e-01
|
7.23e-01
|
GO:0032688 BP negative regulation of interferon-beta production
|
13
|
4.61e-01
|
-1.18e-01
|
7.11e-01
|
GO:0010592 BP positive regulation of lamellipodium assembly
|
24
|
3.16e-01
|
1.18e-01
|
5.89e-01
|
GO:0031397 BP negative regulation of protein ubiquitination
|
53
|
1.38e-01
|
1.18e-01
|
3.72e-01
|
GO:0045807 BP positive regulation of endocytosis
|
16
|
4.14e-01
|
-1.18e-01
|
6.76e-01
|
GO:0033689 BP negative regulation of osteoblast proliferation
|
10
|
5.19e-01
|
1.18e-01
|
7.53e-01
|
GO:0097320 BP plasma membrane tubulation
|
11
|
5.00e-01
|
1.18e-01
|
7.36e-01
|
GO:0048856 BP anatomical structure development
|
29
|
2.73e-01
|
-1.18e-01
|
5.45e-01
|
GO:0060041 BP retina development in camera-type eye
|
38
|
2.11e-01
|
-1.17e-01
|
4.78e-01
|
GO:0051591 BP response to cAMP
|
25
|
3.10e-01
|
1.17e-01
|
5.83e-01
|
GO:0060441 BP epithelial tube branching involved in lung morphogenesis
|
12
|
4.84e-01
|
-1.17e-01
|
7.27e-01
|
GO:0035331 BP negative regulation of hippo signaling
|
14
|
4.51e-01
|
-1.16e-01
|
7.10e-01
|
GO:0047496 BP vesicle transport along microtubule
|
15
|
4.35e-01
|
-1.16e-01
|
6.96e-01
|
GO:0006730 BP one-carbon metabolic process
|
24
|
3.24e-01
|
1.16e-01
|
5.96e-01
|
GO:0043011 BP myeloid dendritic cell differentiation
|
12
|
4.86e-01
|
-1.16e-01
|
7.28e-01
|
GO:0042552 BP myelination
|
46
|
1.73e-01
|
-1.16e-01
|
4.27e-01
|
GO:0003181 BP atrioventricular valve morphogenesis
|
12
|
4.87e-01
|
1.16e-01
|
7.29e-01
|
GO:0007517 BP muscle organ development
|
73
|
8.72e-02
|
-1.16e-01
|
2.89e-01
|
GO:0050770 BP regulation of axonogenesis
|
16
|
4.23e-01
|
-1.16e-01
|
6.86e-01
|
GO:0099175 BP regulation of postsynapse organization
|
25
|
3.17e-01
|
-1.16e-01
|
5.90e-01
|
GO:0002021 BP response to dietary excess
|
10
|
5.27e-01
|
-1.16e-01
|
7.62e-01
|
GO:0120162 BP positive regulation of cold-induced thermogenesis
|
71
|
9.22e-02
|
-1.16e-01
|
2.97e-01
|
GO:0035196 BP miRNA processing
|
14
|
4.55e-01
|
1.15e-01
|
7.11e-01
|
GO:1903076 BP regulation of protein localization to plasma membrane
|
18
|
3.97e-01
|
1.15e-01
|
6.65e-01
|
GO:0048666 BP neuron development
|
41
|
2.03e-01
|
1.15e-01
|
4.65e-01
|
GO:0070536 BP protein K63-linked deubiquitination
|
28
|
2.93e-01
|
-1.15e-01
|
5.63e-01
|
GO:0071383 BP cellular response to steroid hormone stimulus
|
16
|
4.26e-01
|
1.15e-01
|
6.88e-01
|
GO:0060384 BP innervation
|
12
|
4.91e-01
|
-1.15e-01
|
7.31e-01
|
GO:0046676 BP negative regulation of insulin secretion
|
22
|
3.52e-01
|
-1.15e-01
|
6.26e-01
|
GO:0048708 BP astrocyte differentiation
|
10
|
5.31e-01
|
-1.15e-01
|
7.63e-01
|
GO:0030225 BP macrophage differentiation
|
25
|
3.23e-01
|
-1.14e-01
|
5.96e-01
|
GO:0071407 BP cellular response to organic cyclic compound
|
23
|
3.44e-01
|
1.14e-01
|
6.19e-01
|
GO:0045672 BP positive regulation of osteoclast differentiation
|
15
|
4.45e-01
|
1.14e-01
|
7.05e-01
|
GO:0034599 BP cellular response to oxidative stress
|
84
|
7.13e-02
|
1.14e-01
|
2.55e-01
|
GO:0035264 BP multicellular organism growth
|
71
|
9.76e-02
|
1.14e-01
|
3.10e-01
|
GO:0006511 BP ubiquitin-dependent protein catabolic process
|
197
|
6.04e-03
|
1.14e-01
|
5.16e-02
|
GO:0033630 BP positive regulation of cell adhesion mediated by integrin
|
10
|
5.34e-01
|
1.14e-01
|
7.63e-01
|
GO:0045595 BP regulation of cell differentiation
|
28
|
3.00e-01
|
1.13e-01
|
5.73e-01
|
GO:0006812 BP monoatomic cation transport
|
12
|
4.97e-01
|
-1.13e-01
|
7.35e-01
|
GO:0050790 BP regulation of catalytic activity
|
10
|
5.35e-01
|
-1.13e-01
|
7.64e-01
|
GO:0099072 BP regulation of postsynaptic membrane neurotransmitter receptor levels
|
18
|
4.06e-01
|
1.13e-01
|
6.69e-01
|
GO:0006891 BP intra-Golgi vesicle-mediated transport
|
27
|
3.09e-01
|
1.13e-01
|
5.83e-01
|
GO:0071560 BP cellular response to transforming growth factor beta stimulus
|
48
|
1.76e-01
|
-1.13e-01
|
4.30e-01
|
GO:0010832 BP negative regulation of myotube differentiation
|
13
|
4.81e-01
|
-1.13e-01
|
7.26e-01
|
GO:0061436 BP establishment of skin barrier
|
27
|
3.10e-01
|
1.13e-01
|
5.84e-01
|
GO:0006590 BP thyroid hormone generation
|
10
|
5.37e-01
|
-1.13e-01
|
7.64e-01
|
GO:0060333 BP type II interferon-mediated signaling pathway
|
11
|
5.18e-01
|
-1.13e-01
|
7.52e-01
|
GO:0051480 BP regulation of cytosolic calcium ion concentration
|
19
|
3.96e-01
|
1.12e-01
|
6.65e-01
|
GO:0043407 BP negative regulation of MAP kinase activity
|
28
|
3.04e-01
|
1.12e-01
|
5.78e-01
|
GO:1901524 BP regulation of mitophagy
|
11
|
5.20e-01
|
1.12e-01
|
7.54e-01
|
GO:0010839 BP negative regulation of keratinocyte proliferation
|
17
|
4.25e-01
|
1.12e-01
|
6.88e-01
|
GO:0071364 BP cellular response to epidermal growth factor stimulus
|
39
|
2.28e-01
|
1.12e-01
|
4.95e-01
|
GO:0090630 BP activation of GTPase activity
|
77
|
9.06e-02
|
-1.12e-01
|
2.94e-01
|
GO:0006986 BP response to unfolded protein
|
50
|
1.73e-01
|
1.12e-01
|
4.27e-01
|
GO:0008340 BP determination of adult lifespan
|
28
|
3.07e-01
|
1.11e-01
|
5.80e-01
|
GO:1902230 BP negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage
|
13
|
4.87e-01
|
1.11e-01
|
7.29e-01
|
GO:0006955 BP immune response
|
141
|
2.25e-02
|
-1.11e-01
|
1.27e-01
|
GO:0007411 BP axon guidance
|
116
|
3.84e-02
|
-1.11e-01
|
1.78e-01
|
GO:0033628 BP regulation of cell adhesion mediated by integrin
|
11
|
5.23e-01
|
-1.11e-01
|
7.58e-01
|
GO:0045736 BP negative regulation of cyclin-dependent protein serine/threonine kinase activity
|
19
|
4.02e-01
|
-1.11e-01
|
6.67e-01
|
GO:0006487 BP protein N-linked glycosylation
|
46
|
1.92e-01
|
1.11e-01
|
4.51e-01
|
GO:0070555 BP response to interleukin-1
|
25
|
3.37e-01
|
-1.11e-01
|
6.12e-01
|
GO:0050767 BP regulation of neurogenesis
|
28
|
3.10e-01
|
-1.11e-01
|
5.83e-01
|
GO:1900227 BP positive regulation of NLRP3 inflammasome complex assembly
|
18
|
4.17e-01
|
1.11e-01
|
6.78e-01
|
GO:0007169 BP transmembrane receptor protein tyrosine kinase signaling pathway
|
59
|
1.42e-01
|
-1.11e-01
|
3.77e-01
|
GO:0070527 BP platelet aggregation
|
36
|
2.52e-01
|
1.10e-01
|
5.20e-01
|
GO:1905564 BP positive regulation of vascular endothelial cell proliferation
|
15
|
4.59e-01
|
-1.10e-01
|
7.11e-01
|
GO:0032332 BP positive regulation of chondrocyte differentiation
|
10
|
5.45e-01
|
-1.10e-01
|
7.68e-01
|
GO:0008643 BP carbohydrate transport
|
20
|
3.94e-01
|
1.10e-01
|
6.63e-01
|
GO:0007186 BP G protein-coupled receptor signaling pathway
|
213
|
5.65e-03
|
-1.10e-01
|
4.96e-02
|
GO:0030968 BP endoplasmic reticulum unfolded protein response
|
43
|
2.12e-01
|
1.10e-01
|
4.80e-01
|
GO:0060213 BP positive regulation of nuclear-transcribed mRNA poly(A) tail shortening
|
13
|
4.93e-01
|
-1.10e-01
|
7.31e-01
|
GO:0007565 BP female pregnancy
|
41
|
2.25e-01
|
-1.09e-01
|
4.92e-01
|
GO:0001843 BP neural tube closure
|
68
|
1.19e-01
|
1.09e-01
|
3.44e-01
|
GO:0051225 BP spindle assembly
|
33
|
2.77e-01
|
1.09e-01
|
5.47e-01
|
GO:0060576 BP intestinal epithelial cell development
|
10
|
5.49e-01
|
-1.09e-01
|
7.71e-01
|
GO:0003073 BP regulation of systemic arterial blood pressure
|
10
|
5.49e-01
|
1.09e-01
|
7.71e-01
|
GO:0048268 BP clathrin coat assembly
|
14
|
4.79e-01
|
-1.09e-01
|
7.24e-01
|
GO:0071380 BP cellular response to prostaglandin E stimulus
|
14
|
4.80e-01
|
-1.09e-01
|
7.25e-01
|
GO:0090200 BP positive regulation of release of cytochrome c from mitochondria
|
20
|
3.99e-01
|
1.09e-01
|
6.67e-01
|
GO:0070936 BP protein K48-linked ubiquitination
|
76
|
1.01e-01
|
1.09e-01
|
3.17e-01
|
GO:0036258 BP multivesicular body assembly
|
31
|
2.95e-01
|
1.09e-01
|
5.66e-01
|
GO:0008360 BP regulation of cell shape
|
106
|
5.32e-02
|
-1.09e-01
|
2.16e-01
|
GO:0051469 BP vesicle fusion with vacuole
|
11
|
5.33e-01
|
1.09e-01
|
7.63e-01
|
GO:0061763 BP multivesicular body-lysosome fusion
|
11
|
5.33e-01
|
1.09e-01
|
7.63e-01
|
GO:0031667 BP response to nutrient levels
|
18
|
4.25e-01
|
-1.09e-01
|
6.88e-01
|
GO:0060218 BP hematopoietic stem cell differentiation
|
16
|
4.52e-01
|
1.09e-01
|
7.11e-01
|
GO:0045893 BP positive regulation of DNA-templated transcription
|
562
|
1.17e-05
|
1.09e-01
|
4.09e-04
|
GO:0045732 BP positive regulation of protein catabolic process
|
70
|
1.17e-01
|
1.08e-01
|
3.44e-01
|
GO:0032148 BP activation of protein kinase B activity
|
14
|
4.83e-01
|
1.08e-01
|
7.27e-01
|
GO:0048699 BP generation of neurons
|
10
|
5.54e-01
|
1.08e-01
|
7.74e-01
|
GO:0006302 BP double-strand break repair
|
74
|
1.08e-01
|
1.08e-01
|
3.31e-01
|
GO:0045429 BP positive regulation of nitric oxide biosynthetic process
|
29
|
3.15e-01
|
-1.08e-01
|
5.89e-01
|
GO:0032967 BP positive regulation of collagen biosynthetic process
|
20
|
4.04e-01
|
-1.08e-01
|
6.69e-01
|
GO:0034067 BP protein localization to Golgi apparatus
|
18
|
4.29e-01
|
-1.08e-01
|
6.90e-01
|
GO:1901029 BP negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway
|
13
|
5.02e-01
|
1.08e-01
|
7.38e-01
|
GO:0007031 BP peroxisome organization
|
20
|
4.05e-01
|
-1.08e-01
|
6.69e-01
|
GO:0060627 BP regulation of vesicle-mediated transport
|
13
|
5.03e-01
|
-1.07e-01
|
7.39e-01
|
GO:0031623 BP receptor internalization
|
36
|
2.65e-01
|
1.07e-01
|
5.36e-01
|
GO:0042104 BP positive regulation of activated T cell proliferation
|
15
|
4.72e-01
|
-1.07e-01
|
7.18e-01
|
GO:0070242 BP thymocyte apoptotic process
|
11
|
5.38e-01
|
-1.07e-01
|
7.64e-01
|
GO:0001837 BP epithelial to mesenchymal transition
|
47
|
2.04e-01
|
-1.07e-01
|
4.67e-01
|
GO:0043536 BP positive regulation of blood vessel endothelial cell migration
|
35
|
2.73e-01
|
-1.07e-01
|
5.44e-01
|
GO:2001238 BP positive regulation of extrinsic apoptotic signaling pathway
|
23
|
3.74e-01
|
1.07e-01
|
6.47e-01
|
GO:0048566 BP embryonic digestive tract development
|
11
|
5.39e-01
|
1.07e-01
|
7.64e-01
|
GO:0006103 BP 2-oxoglutarate metabolic process
|
15
|
4.74e-01
|
1.07e-01
|
7.20e-01
|
GO:0006506 BP GPI anchor biosynthetic process
|
26
|
3.47e-01
|
1.07e-01
|
6.22e-01
|
GO:0055085 BP transmembrane transport
|
122
|
4.24e-02
|
-1.06e-01
|
1.90e-01
|
GO:0032486 BP Rap protein signal transduction
|
10
|
5.61e-01
|
1.06e-01
|
7.80e-01
|
GO:0070371 BP ERK1 and ERK2 cascade
|
37
|
2.65e-01
|
-1.06e-01
|
5.36e-01
|
GO:0071346 BP cellular response to type II interferon
|
56
|
1.71e-01
|
1.06e-01
|
4.25e-01
|
GO:0034058 BP endosomal vesicle fusion
|
11
|
5.44e-01
|
1.06e-01
|
7.67e-01
|
GO:0009952 BP anterior/posterior pattern specification
|
68
|
1.33e-01
|
-1.05e-01
|
3.67e-01
|
GO:0046716 BP muscle cell cellular homeostasis
|
20
|
4.15e-01
|
1.05e-01
|
6.76e-01
|
GO:2000300 BP regulation of synaptic vesicle exocytosis
|
22
|
3.94e-01
|
-1.05e-01
|
6.63e-01
|
GO:0071300 BP cellular response to retinoic acid
|
46
|
2.18e-01
|
-1.05e-01
|
4.85e-01
|
GO:0042592 BP homeostatic process
|
10
|
5.66e-01
|
-1.05e-01
|
7.83e-01
|
GO:0090660 BP cerebrospinal fluid circulation
|
12
|
5.30e-01
|
-1.05e-01
|
7.63e-01
|
GO:0006974 BP DNA damage response
|
262
|
3.59e-03
|
1.05e-01
|
3.60e-02
|
GO:0021702 BP cerebellar Purkinje cell differentiation
|
10
|
5.67e-01
|
-1.05e-01
|
7.83e-01
|
GO:0072520 BP seminiferous tubule development
|
15
|
4.84e-01
|
-1.04e-01
|
7.27e-01
|
GO:0055074 BP calcium ion homeostasis
|
19
|
4.32e-01
|
-1.04e-01
|
6.92e-01
|
GO:0019369 BP arachidonic acid metabolic process
|
23
|
3.88e-01
|
-1.04e-01
|
6.61e-01
|
GO:0007026 BP negative regulation of microtubule depolymerization
|
25
|
3.68e-01
|
-1.04e-01
|
6.39e-01
|
GO:0055010 BP ventricular cardiac muscle tissue morphogenesis
|
10
|
5.70e-01
|
-1.04e-01
|
7.86e-01
|
GO:0008610 BP lipid biosynthetic process
|
13
|
5.17e-01
|
-1.04e-01
|
7.52e-01
|
GO:2001256 BP regulation of store-operated calcium entry
|
10
|
5.70e-01
|
-1.04e-01
|
7.86e-01
|
GO:0051604 BP protein maturation
|
33
|
3.03e-01
|
1.04e-01
|
5.78e-01
|
GO:0006979 BP response to oxidative stress
|
92
|
8.67e-02
|
1.03e-01
|
2.88e-01
|
GO:1902042 BP negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
|
22
|
4.02e-01
|
1.03e-01
|
6.67e-01
|
GO:0045663 BP positive regulation of myoblast differentiation
|
31
|
3.21e-01
|
1.03e-01
|
5.94e-01
|
GO:0071539 BP protein localization to centrosome
|
23
|
3.92e-01
|
-1.03e-01
|
6.63e-01
|
GO:0050896 BP response to stimulus
|
24
|
3.83e-01
|
-1.03e-01
|
6.56e-01
|
GO:0006888 BP endoplasmic reticulum to Golgi vesicle-mediated transport
|
114
|
5.81e-02
|
1.03e-01
|
2.29e-01
|
GO:0008306 BP associative learning
|
22
|
4.05e-01
|
-1.03e-01
|
6.69e-01
|
GO:0045766 BP positive regulation of angiogenesis
|
97
|
8.11e-02
|
-1.03e-01
|
2.76e-01
|
GO:0016559 BP peroxisome fission
|
10
|
5.75e-01
|
-1.03e-01
|
7.88e-01
|
GO:0009312 BP oligosaccharide biosynthetic process
|
15
|
4.92e-01
|
-1.02e-01
|
7.31e-01
|
GO:0045860 BP positive regulation of protein kinase activity
|
37
|
2.81e-01
|
-1.02e-01
|
5.48e-01
|
GO:0016079 BP synaptic vesicle exocytosis
|
15
|
4.94e-01
|
-1.02e-01
|
7.31e-01
|
GO:0015914 BP phospholipid transport
|
28
|
3.50e-01
|
-1.02e-01
|
6.25e-01
|
GO:0051898 BP negative regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
43
|
2.49e-01
|
-1.02e-01
|
5.18e-01
|
GO:0006909 BP phagocytosis
|
51
|
2.10e-01
|
-1.01e-01
|
4.77e-01
|
GO:0006110 BP regulation of glycolytic process
|
12
|
5.44e-01
|
1.01e-01
|
7.67e-01
|
GO:0007155 BP cell adhesion
|
264
|
4.69e-03
|
-1.01e-01
|
4.40e-02
|
GO:1990000 BP amyloid fibril formation
|
20
|
4.34e-01
|
-1.01e-01
|
6.95e-01
|
GO:0007157 BP heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules
|
28
|
3.56e-01
|
-1.01e-01
|
6.29e-01
|
GO:0001525 BP angiogenesis
|
177
|
2.11e-02
|
-1.01e-01
|
1.23e-01
|
GO:0043491 BP phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
64
|
1.65e-01
|
-1.00e-01
|
4.15e-01
|
GO:0070269 BP pyroptosis
|
19
|
4.50e-01
|
-1.00e-01
|
7.09e-01
|
GO:1900271 BP regulation of long-term synaptic potentiation
|
10
|
5.84e-01
|
-1.00e-01
|
7.97e-01
|
GO:0060395 BP SMAD protein signal transduction
|
25
|
3.87e-01
|
9.99e-02
|
6.61e-01
|
GO:0009416 BP response to light stimulus
|
12
|
5.51e-01
|
9.94e-02
|
7.73e-01
|
GO:0030217 BP T cell differentiation
|
32
|
3.32e-01
|
-9.92e-02
|
6.06e-01
|
GO:0001894 BP tissue homeostasis
|
19
|
4.55e-01
|
-9.90e-02
|
7.11e-01
|
GO:1901526 BP positive regulation of mitophagy
|
10
|
5.88e-01
|
9.90e-02
|
8.00e-01
|
GO:0045165 BP cell fate commitment
|
30
|
3.48e-01
|
-9.90e-02
|
6.23e-01
|
GO:0045717 BP negative regulation of fatty acid biosynthetic process
|
13
|
5.37e-01
|
-9.89e-02
|
7.64e-01
|
GO:0006006 BP glucose metabolic process
|
45
|
2.53e-01
|
-9.86e-02
|
5.20e-01
|
GO:0007030 BP Golgi organization
|
109
|
7.63e-02
|
-9.84e-02
|
2.65e-01
|
GO:0045197 BP establishment or maintenance of epithelial cell apical/basal polarity
|
24
|
4.06e-01
|
-9.79e-02
|
6.69e-01
|
GO:0035094 BP response to nicotine
|
24
|
4.07e-01
|
9.79e-02
|
6.69e-01
|
GO:0030705 BP cytoskeleton-dependent intracellular transport
|
19
|
4.61e-01
|
9.78e-02
|
7.11e-01
|
GO:0001942 BP hair follicle development
|
30
|
3.54e-01
|
-9.77e-02
|
6.27e-01
|
GO:0009749 BP response to glucose
|
42
|
2.74e-01
|
-9.76e-02
|
5.45e-01
|
GO:0098693 BP regulation of synaptic vesicle cycle
|
12
|
5.59e-01
|
-9.73e-02
|
7.79e-01
|
GO:0043032 BP positive regulation of macrophage activation
|
12
|
5.60e-01
|
9.73e-02
|
7.79e-01
|
GO:0045071 BP negative regulation of viral genome replication
|
34
|
3.27e-01
|
-9.72e-02
|
6.00e-01
|
GO:0009617 BP response to bacterium
|
49
|
2.39e-01
|
-9.72e-02
|
5.08e-01
|
GO:0032206 BP positive regulation of telomere maintenance
|
17
|
4.90e-01
|
-9.67e-02
|
7.31e-01
|
GO:0042098 BP T cell proliferation
|
29
|
3.68e-01
|
-9.66e-02
|
6.39e-01
|
GO:0035278 BP miRNA-mediated gene silencing by inhibition of translation
|
17
|
4.91e-01
|
9.64e-02
|
7.31e-01
|
GO:0042476 BP odontogenesis
|
20
|
4.56e-01
|
-9.63e-02
|
7.11e-01
|
GO:0007098 BP centrosome cycle
|
43
|
2.77e-01
|
9.59e-02
|
5.47e-01
|
GO:0031113 BP regulation of microtubule polymerization
|
10
|
6.00e-01
|
-9.59e-02
|
8.12e-01
|
GO:0001501 BP skeletal system development
|
79
|
1.41e-01
|
-9.58e-02
|
3.77e-01
|
GO:0031016 BP pancreas development
|
14
|
5.35e-01
|
9.58e-02
|
7.64e-01
|
GO:0003351 BP epithelial cilium movement involved in extracellular fluid movement
|
15
|
5.21e-01
|
9.57e-02
|
7.55e-01
|
GO:0006904 BP vesicle docking involved in exocytosis
|
29
|
3.73e-01
|
-9.56e-02
|
6.45e-01
|
GO:0006694 BP steroid biosynthetic process
|
12
|
5.67e-01
|
9.55e-02
|
7.83e-01
|
GO:0006750 BP glutathione biosynthetic process
|
11
|
5.84e-01
|
-9.55e-02
|
7.97e-01
|
GO:0001764 BP neuron migration
|
85
|
1.29e-01
|
-9.53e-02
|
3.60e-01
|
GO:0007584 BP response to nutrient
|
37
|
3.16e-01
|
9.52e-02
|
5.89e-01
|
GO:0002040 BP sprouting angiogenesis
|
29
|
3.75e-01
|
-9.52e-02
|
6.48e-01
|
GO:0015810 BP aspartate transmembrane transport
|
10
|
6.03e-01
|
9.50e-02
|
8.16e-01
|
GO:0032481 BP positive regulation of type I interferon production
|
30
|
3.69e-01
|
9.48e-02
|
6.39e-01
|
GO:0008104 BP protein localization
|
101
|
1.00e-01
|
-9.47e-02
|
3.15e-01
|
GO:0035458 BP cellular response to interferon-beta
|
20
|
4.64e-01
|
9.47e-02
|
7.12e-01
|
GO:0034314 BP Arp2/3 complex-mediated actin nucleation
|
15
|
5.27e-01
|
9.44e-02
|
7.62e-01
|
GO:1904903 BP ESCRT III complex disassembly
|
10
|
6.06e-01
|
9.43e-02
|
8.16e-01
|
GO:0034198 BP cellular response to amino acid starvation
|
45
|
2.74e-01
|
-9.43e-02
|
5.45e-01
|
GO:0006874 BP intracellular calcium ion homeostasis
|
50
|
2.49e-01
|
-9.42e-02
|
5.18e-01
|
GO:0018107 BP peptidyl-threonine phosphorylation
|
52
|
2.41e-01
|
-9.40e-02
|
5.08e-01
|
GO:0048147 BP negative regulation of fibroblast proliferation
|
31
|
3.65e-01
|
9.40e-02
|
6.36e-01
|
GO:0032735 BP positive regulation of interleukin-12 production
|
23
|
4.36e-01
|
-9.39e-02
|
6.96e-01
|
GO:0006699 BP bile acid biosynthetic process
|
20
|
4.68e-01
|
-9.37e-02
|
7.17e-01
|
GO:0043123 BP positive regulation of canonical NF-kappaB signal transduction
|
173
|
3.41e-02
|
9.35e-02
|
1.64e-01
|
GO:0071526 BP semaphorin-plexin signaling pathway
|
30
|
3.78e-01
|
-9.31e-02
|
6.50e-01
|
GO:0043149 BP stress fiber assembly
|
20
|
4.72e-01
|
-9.29e-02
|
7.18e-01
|
GO:0007156 BP homophilic cell adhesion via plasma membrane adhesion molecules
|
73
|
1.70e-01
|
-9.29e-02
|
4.25e-01
|
GO:0035194 BP regulatory ncRNA-mediated post-transcriptional gene silencing
|
13
|
5.63e-01
|
9.27e-02
|
7.81e-01
|
GO:0009411 BP response to UV
|
41
|
3.05e-01
|
9.26e-02
|
5.79e-01
|
GO:0007005 BP mitochondrion organization
|
92
|
1.25e-01
|
9.26e-02
|
3.53e-01
|
GO:0032689 BP negative regulation of type II interferon production
|
20
|
4.74e-01
|
9.24e-02
|
7.20e-01
|
GO:0032703 BP negative regulation of interleukin-2 production
|
15
|
5.37e-01
|
9.22e-02
|
7.64e-01
|
GO:0000281 BP mitotic cytokinesis
|
60
|
2.17e-01
|
9.22e-02
|
4.85e-01
|
GO:0006661 BP phosphatidylinositol biosynthetic process
|
41
|
3.08e-01
|
-9.20e-02
|
5.82e-01
|
GO:0045724 BP positive regulation of cilium assembly
|
18
|
5.00e-01
|
-9.19e-02
|
7.36e-01
|
GO:0061053 BP somite development
|
10
|
6.15e-01
|
9.18e-02
|
8.21e-01
|
GO:0051384 BP response to glucocorticoid
|
26
|
4.19e-01
|
-9.15e-02
|
6.81e-01
|
GO:0006884 BP cell volume homeostasis
|
21
|
4.69e-01
|
-9.13e-02
|
7.17e-01
|
GO:0045879 BP negative regulation of smoothened signaling pathway
|
27
|
4.12e-01
|
9.12e-02
|
6.73e-01
|
GO:0033138 BP positive regulation of peptidyl-serine phosphorylation
|
60
|
2.22e-01
|
9.12e-02
|
4.89e-01
|
GO:0043330 BP response to exogenous dsRNA
|
15
|
5.41e-01
|
9.11e-02
|
7.66e-01
|
GO:0021675 BP nerve development
|
16
|
5.29e-01
|
9.10e-02
|
7.63e-01
|
GO:2000773 BP negative regulation of cellular senescence
|
21
|
4.72e-01
|
9.08e-02
|
7.18e-01
|
GO:0006695 BP cholesterol biosynthetic process
|
31
|
3.83e-01
|
9.06e-02
|
6.56e-01
|
GO:0060155 BP platelet dense granule organization
|
22
|
4.62e-01
|
9.05e-02
|
7.12e-01
|
GO:0036444 BP calcium import into the mitochondrion
|
10
|
6.21e-01
|
9.03e-02
|
8.24e-01
|
GO:0016311 BP dephosphorylation
|
48
|
2.79e-01
|
9.03e-02
|
5.47e-01
|
GO:0043066 BP negative regulation of apoptotic process
|
349
|
3.90e-03
|
9.01e-02
|
3.77e-02
|
GO:0045721 BP negative regulation of gluconeogenesis
|
15
|
5.47e-01
|
-8.99e-02
|
7.69e-01
|
GO:0042574 BP retinal metabolic process
|
11
|
6.06e-01
|
8.98e-02
|
8.16e-01
|
GO:0008361 BP regulation of cell size
|
24
|
4.47e-01
|
-8.97e-02
|
7.07e-01
|
GO:0042178 BP xenobiotic catabolic process
|
14
|
5.61e-01
|
-8.97e-02
|
7.80e-01
|
GO:0006497 BP protein lipidation
|
10
|
6.25e-01
|
8.92e-02
|
8.27e-01
|
GO:0007175 BP negative regulation of epidermal growth factor-activated receptor activity
|
12
|
5.93e-01
|
-8.92e-02
|
8.04e-01
|
GO:0051017 BP actin filament bundle assembly
|
29
|
4.06e-01
|
-8.92e-02
|
6.69e-01
|
GO:0035904 BP aorta development
|
19
|
5.01e-01
|
-8.91e-02
|
7.38e-01
|
GO:0072583 BP clathrin-dependent endocytosis
|
25
|
4.41e-01
|
-8.91e-02
|
7.01e-01
|
GO:0035640 BP exploration behavior
|
12
|
5.93e-01
|
-8.91e-02
|
8.04e-01
|
GO:0042982 BP amyloid precursor protein metabolic process
|
11
|
6.09e-01
|
8.90e-02
|
8.16e-01
|
GO:2000114 BP regulation of establishment of cell polarity
|
16
|
5.38e-01
|
-8.89e-02
|
7.64e-01
|
GO:0097193 BP intrinsic apoptotic signaling pathway
|
30
|
4.00e-01
|
8.87e-02
|
6.67e-01
|
GO:0045348 BP positive regulation of MHC class II biosynthetic process
|
11
|
6.11e-01
|
-8.86e-02
|
8.17e-01
|
GO:0038061 BP non-canonical NF-kappaB signal transduction
|
20
|
4.93e-01
|
-8.85e-02
|
7.31e-01
|
GO:0043010 BP camera-type eye development
|
29
|
4.11e-01
|
-8.83e-02
|
6.72e-01
|
GO:0008154 BP actin polymerization or depolymerization
|
15
|
5.54e-01
|
-8.82e-02
|
7.74e-01
|
GO:0044344 BP cellular response to fibroblast growth factor stimulus
|
24
|
4.55e-01
|
8.82e-02
|
7.11e-01
|
GO:0008284 BP positive regulation of cell population proliferation
|
319
|
6.93e-03
|
8.81e-02
|
5.65e-02
|
GO:0006805 BP xenobiotic metabolic process
|
67
|
2.13e-01
|
8.79e-02
|
4.81e-01
|
GO:0050680 BP negative regulation of epithelial cell proliferation
|
39
|
3.42e-01
|
-8.79e-02
|
6.17e-01
|
GO:1900181 BP negative regulation of protein localization to nucleus
|
17
|
5.32e-01
|
-8.76e-02
|
7.63e-01
|
GO:2000179 BP positive regulation of neural precursor cell proliferation
|
14
|
5.71e-01
|
-8.75e-02
|
7.86e-01
|
GO:0022011 BP myelination in peripheral nervous system
|
13
|
5.85e-01
|
8.75e-02
|
7.98e-01
|
GO:0050890 BP cognition
|
30
|
4.07e-01
|
-8.74e-02
|
6.69e-01
|
GO:0007163 BP establishment or maintenance of cell polarity
|
36
|
3.65e-01
|
8.72e-02
|
6.36e-01
|
GO:0043647 BP inositol phosphate metabolic process
|
14
|
5.72e-01
|
-8.72e-02
|
7.87e-01
|
GO:0099022 BP vesicle tethering
|
16
|
5.47e-01
|
8.71e-02
|
7.69e-01
|
GO:0097192 BP extrinsic apoptotic signaling pathway in absence of ligand
|
28
|
4.26e-01
|
8.70e-02
|
6.88e-01
|
GO:0001779 BP natural killer cell differentiation
|
14
|
5.73e-01
|
8.70e-02
|
7.87e-01
|
GO:0035195 BP miRNA-mediated post-transcriptional gene silencing
|
31
|
4.02e-01
|
-8.70e-02
|
6.67e-01
|
GO:0006357 BP regulation of transcription by RNA polymerase II
|
1108
|
1.39e-06
|
-8.65e-02
|
7.35e-05
|
GO:0002230 BP positive regulation of defense response to virus by host
|
24
|
4.63e-01
|
-8.65e-02
|
7.12e-01
|
GO:0046580 BP negative regulation of Ras protein signal transduction
|
20
|
5.04e-01
|
-8.64e-02
|
7.39e-01
|
GO:0010881 BP regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion
|
14
|
5.76e-01
|
8.63e-02
|
7.89e-01
|
GO:0050796 BP regulation of insulin secretion
|
25
|
4.56e-01
|
-8.62e-02
|
7.11e-01
|
GO:0022604 BP regulation of cell morphogenesis
|
22
|
4.84e-01
|
8.61e-02
|
7.27e-01
|
GO:0050862 BP positive regulation of T cell receptor signaling pathway
|
14
|
5.78e-01
|
-8.58e-02
|
7.91e-01
|
GO:0099170 BP postsynaptic modulation of chemical synaptic transmission
|
11
|
6.22e-01
|
8.58e-02
|
8.25e-01
|
GO:0043122 BP regulation of canonical NF-kappaB signal transduction
|
25
|
4.58e-01
|
-8.58e-02
|
7.11e-01
|
GO:0006811 BP monoatomic ion transport
|
60
|
2.51e-01
|
-8.58e-02
|
5.20e-01
|
GO:0043524 BP negative regulation of neuron apoptotic process
|
105
|
1.29e-01
|
-8.57e-02
|
3.60e-01
|
GO:0021819 BP layer formation in cerebral cortex
|
10
|
6.39e-01
|
-8.57e-02
|
8.39e-01
|
GO:0042100 BP B cell proliferation
|
17
|
5.41e-01
|
-8.56e-02
|
7.66e-01
|
GO:0033189 BP response to vitamin A
|
10
|
6.40e-01
|
8.55e-02
|
8.39e-01
|
GO:0030330 BP DNA damage response, signal transduction by p53 class mediator
|
18
|
5.31e-01
|
-8.52e-02
|
7.63e-01
|
GO:0007612 BP learning
|
39
|
3.57e-01
|
-8.52e-02
|
6.29e-01
|
GO:0070534 BP protein K63-linked ubiquitination
|
50
|
2.98e-01
|
8.51e-02
|
5.71e-01
|
GO:0070207 BP protein homotrimerization
|
10
|
6.42e-01
|
8.49e-02
|
8.40e-01
|
GO:0051298 BP centrosome duplication
|
16
|
5.58e-01
|
8.46e-02
|
7.79e-01
|
GO:0000722 BP telomere maintenance via recombination
|
10
|
6.44e-01
|
-8.45e-02
|
8.40e-01
|
GO:0035456 BP response to interferon-beta
|
10
|
6.44e-01
|
-8.45e-02
|
8.40e-01
|
GO:0045664 BP regulation of neuron differentiation
|
23
|
4.84e-01
|
-8.43e-02
|
7.27e-01
|
GO:0002009 BP morphogenesis of an epithelium
|
11
|
6.29e-01
|
8.42e-02
|
8.30e-01
|
GO:0070922 BP RISC complex assembly
|
10
|
6.46e-01
|
8.40e-02
|
8.40e-01
|
GO:0007271 BP synaptic transmission, cholinergic
|
14
|
5.87e-01
|
-8.39e-02
|
7.99e-01
|
GO:0050870 BP positive regulation of T cell activation
|
14
|
5.87e-01
|
8.39e-02
|
7.99e-01
|
GO:0000165 BP MAPK cascade
|
97
|
1.55e-01
|
-8.36e-02
|
3.99e-01
|
GO:1990830 BP cellular response to leukemia inhibitory factor
|
82
|
1.91e-01
|
8.35e-02
|
4.51e-01
|
GO:0007202 BP activation of phospholipase C activity
|
12
|
6.18e-01
|
-8.31e-02
|
8.23e-01
|
GO:0000045 BP autophagosome assembly
|
61
|
2.62e-01
|
-8.30e-02
|
5.33e-01
|
GO:2000737 BP negative regulation of stem cell differentiation
|
16
|
5.65e-01
|
8.30e-02
|
7.83e-01
|
GO:0050729 BP positive regulation of inflammatory response
|
60
|
2.66e-01
|
-8.30e-02
|
5.36e-01
|
GO:0030032 BP lamellipodium assembly
|
28
|
4.48e-01
|
-8.29e-02
|
7.07e-01
|
GO:0003333 BP amino acid transmembrane transport
|
13
|
6.05e-01
|
8.28e-02
|
8.16e-01
|
GO:0034504 BP protein localization to nucleus
|
36
|
3.91e-01
|
8.26e-02
|
6.63e-01
|
GO:0030500 BP regulation of bone mineralization
|
13
|
6.06e-01
|
-8.26e-02
|
8.16e-01
|
GO:0044818 BP mitotic G2/M transition checkpoint
|
19
|
5.34e-01
|
8.25e-02
|
7.63e-01
|
GO:0036010 BP protein localization to endosome
|
10
|
6.52e-01
|
8.25e-02
|
8.44e-01
|
GO:0045747 BP positive regulation of Notch signaling pathway
|
34
|
4.06e-01
|
-8.23e-02
|
6.69e-01
|
GO:0042752 BP regulation of circadian rhythm
|
58
|
2.79e-01
|
8.22e-02
|
5.47e-01
|
GO:0050687 BP negative regulation of defense response to virus
|
10
|
6.53e-01
|
8.21e-02
|
8.46e-01
|
GO:0045880 BP positive regulation of smoothened signaling pathway
|
31
|
4.29e-01
|
8.20e-02
|
6.90e-01
|
GO:0030501 BP positive regulation of bone mineralization
|
31
|
4.30e-01
|
-8.20e-02
|
6.90e-01
|
GO:0002062 BP chondrocyte differentiation
|
39
|
3.76e-01
|
-8.19e-02
|
6.49e-01
|
GO:0007276 BP gamete generation
|
17
|
5.59e-01
|
8.18e-02
|
7.79e-01
|
GO:0030509 BP BMP signaling pathway
|
51
|
3.12e-01
|
-8.18e-02
|
5.86e-01
|
GO:0048013 BP ephrin receptor signaling pathway
|
43
|
3.54e-01
|
-8.18e-02
|
6.27e-01
|
GO:0051382 BP kinetochore assembly
|
13
|
6.11e-01
|
8.15e-02
|
8.17e-01
|
GO:0097191 BP extrinsic apoptotic signaling pathway
|
44
|
3.51e-01
|
8.13e-02
|
6.25e-01
|
GO:0050830 BP defense response to Gram-positive bacterium
|
43
|
3.56e-01
|
-8.13e-02
|
6.29e-01
|
GO:0061036 BP positive regulation of cartilage development
|
12
|
6.26e-01
|
-8.13e-02
|
8.28e-01
|
GO:0034472 BP snRNA 3’-end processing
|
10
|
6.56e-01
|
8.12e-02
|
8.48e-01
|
GO:0051966 BP regulation of synaptic transmission, glutamatergic
|
20
|
5.30e-01
|
-8.12e-02
|
7.63e-01
|
GO:0070301 BP cellular response to hydrogen peroxide
|
60
|
2.80e-01
|
8.07e-02
|
5.47e-01
|
GO:0035970 BP peptidyl-threonine dephosphorylation
|
17
|
5.66e-01
|
8.05e-02
|
7.83e-01
|
GO:0001707 BP mesoderm formation
|
26
|
4.78e-01
|
-8.04e-02
|
7.23e-01
|
GO:0010719 BP negative regulation of epithelial to mesenchymal transition
|
25
|
4.87e-01
|
-8.04e-02
|
7.29e-01
|
GO:0048870 BP cell motility
|
27
|
4.71e-01
|
-8.01e-02
|
7.18e-01
|
GO:0045861 BP negative regulation of proteolysis
|
17
|
5.68e-01
|
-8.00e-02
|
7.84e-01
|
GO:0060322 BP head development
|
13
|
6.18e-01
|
-7.98e-02
|
8.23e-01
|
GO:0030514 BP negative regulation of BMP signaling pathway
|
37
|
4.02e-01
|
-7.97e-02
|
6.67e-01
|
GO:0010821 BP regulation of mitochondrion organization
|
21
|
5.28e-01
|
7.96e-02
|
7.62e-01
|
GO:0045184 BP establishment of protein localization
|
28
|
4.66e-01
|
7.96e-02
|
7.14e-01
|
GO:2001224 BP positive regulation of neuron migration
|
16
|
5.82e-01
|
-7.94e-02
|
7.96e-01
|
GO:0050769 BP positive regulation of neurogenesis
|
20
|
5.39e-01
|
7.93e-02
|
7.64e-01
|
GO:0019226 BP transmission of nerve impulse
|
10
|
6.64e-01
|
7.92e-02
|
8.53e-01
|
GO:0008283 BP cell population proliferation
|
105
|
1.62e-01
|
7.91e-02
|
4.11e-01
|
GO:0031175 BP neuron projection development
|
93
|
1.88e-01
|
-7.90e-02
|
4.48e-01
|
GO:0006520 BP amino acid metabolic process
|
14
|
6.09e-01
|
7.90e-02
|
8.16e-01
|
GO:2000786 BP positive regulation of autophagosome assembly
|
19
|
5.52e-01
|
-7.87e-02
|
7.74e-01
|
GO:0042127 BP regulation of cell population proliferation
|
105
|
1.64e-01
|
-7.86e-02
|
4.15e-01
|
GO:0030317 BP flagellated sperm motility
|
42
|
3.78e-01
|
-7.86e-02
|
6.51e-01
|
GO:0008277 BP regulation of G protein-coupled receptor signaling pathway
|
30
|
4.58e-01
|
-7.83e-02
|
7.11e-01
|
GO:0010508 BP positive regulation of autophagy
|
67
|
2.68e-01
|
-7.83e-02
|
5.39e-01
|
GO:0019222 BP regulation of metabolic process
|
10
|
6.68e-01
|
-7.82e-02
|
8.55e-01
|
GO:0034142 BP toll-like receptor 4 signaling pathway
|
26
|
4.91e-01
|
7.80e-02
|
7.31e-01
|
GO:0044849 BP estrous cycle
|
13
|
6.27e-01
|
-7.78e-02
|
8.29e-01
|
GO:0008585 BP female gonad development
|
14
|
6.16e-01
|
7.75e-02
|
8.21e-01
|
GO:0042307 BP positive regulation of protein import into nucleus
|
35
|
4.28e-01
|
7.75e-02
|
6.89e-01
|
GO:0045444 BP fat cell differentiation
|
63
|
2.89e-01
|
-7.73e-02
|
5.58e-01
|
GO:0010968 BP regulation of microtubule nucleation
|
10
|
6.72e-01
|
7.72e-02
|
8.56e-01
|
GO:0030857 BP negative regulation of epithelial cell differentiation
|
10
|
6.74e-01
|
-7.69e-02
|
8.57e-01
|
GO:0033173 BP calcineurin-NFAT signaling cascade
|
12
|
6.45e-01
|
7.69e-02
|
8.40e-01
|
GO:0031640 BP killing of cells of another organism
|
13
|
6.32e-01
|
7.68e-02
|
8.32e-01
|
GO:0048873 BP homeostasis of number of cells within a tissue
|
21
|
5.43e-01
|
7.66e-02
|
7.67e-01
|
GO:0014044 BP Schwann cell development
|
14
|
6.21e-01
|
7.64e-02
|
8.24e-01
|
GO:0016192 BP vesicle-mediated transport
|
144
|
1.16e-01
|
7.60e-02
|
3.43e-01
|
GO:0001933 BP negative regulation of protein phosphorylation
|
70
|
2.72e-01
|
-7.60e-02
|
5.43e-01
|
GO:0008584 BP male gonad development
|
71
|
2.69e-01
|
7.60e-02
|
5.39e-01
|
GO:0051402 BP neuron apoptotic process
|
66
|
2.86e-01
|
-7.59e-02
|
5.54e-01
|
GO:0010332 BP response to gamma radiation
|
22
|
5.38e-01
|
7.58e-02
|
7.64e-01
|
GO:0097150 BP neuronal stem cell population maintenance
|
21
|
5.49e-01
|
7.55e-02
|
7.71e-01
|
GO:2000145 BP regulation of cell motility
|
15
|
6.14e-01
|
-7.52e-02
|
8.20e-01
|
GO:0034612 BP response to tumor necrosis factor
|
26
|
5.09e-01
|
-7.49e-02
|
7.44e-01
|
GO:0043434 BP response to peptide hormone
|
32
|
4.64e-01
|
7.49e-02
|
7.12e-01
|
GO:0030194 BP positive regulation of blood coagulation
|
15
|
6.16e-01
|
-7.47e-02
|
8.21e-01
|
GO:0008542 BP visual learning
|
33
|
4.58e-01
|
-7.47e-02
|
7.11e-01
|
GO:0030948 BP negative regulation of vascular endothelial growth factor receptor signaling pathway
|
10
|
6.83e-01
|
7.46e-02
|
8.61e-01
|
GO:0045471 BP response to ethanol
|
55
|
3.40e-01
|
7.45e-02
|
6.15e-01
|
GO:0099173 BP postsynapse organization
|
14
|
6.30e-01
|
-7.43e-02
|
8.31e-01
|
GO:0019221 BP cytokine-mediated signaling pathway
|
79
|
2.54e-01
|
-7.43e-02
|
5.22e-01
|
GO:0019216 BP regulation of lipid metabolic process
|
26
|
5.12e-01
|
-7.42e-02
|
7.46e-01
|
GO:0061564 BP axon development
|
16
|
6.09e-01
|
-7.38e-02
|
8.16e-01
|
GO:0095500 BP acetylcholine receptor signaling pathway
|
11
|
6.72e-01
|
-7.38e-02
|
8.56e-01
|
GO:1904019 BP epithelial cell apoptotic process
|
16
|
6.10e-01
|
7.38e-02
|
8.16e-01
|
GO:0000731 BP DNA synthesis involved in DNA repair
|
14
|
6.33e-01
|
7.37e-02
|
8.33e-01
|
GO:0060391 BP positive regulation of SMAD protein signal transduction
|
29
|
4.92e-01
|
-7.37e-02
|
7.31e-01
|
GO:0048536 BP spleen development
|
30
|
4.85e-01
|
-7.37e-02
|
7.28e-01
|
GO:0051145 BP smooth muscle cell differentiation
|
11
|
6.72e-01
|
-7.36e-02
|
8.56e-01
|
GO:0008206 BP bile acid metabolic process
|
12
|
6.61e-01
|
7.31e-02
|
8.50e-01
|
GO:0140588 BP chromatin looping
|
12
|
6.61e-01
|
-7.31e-02
|
8.50e-01
|
GO:0070373 BP negative regulation of ERK1 and ERK2 cascade
|
50
|
3.72e-01
|
7.31e-02
|
6.43e-01
|
GO:0031100 BP animal organ regeneration
|
23
|
5.45e-01
|
-7.29e-02
|
7.68e-01
|
GO:0048511 BP rhythmic process
|
57
|
3.42e-01
|
7.28e-02
|
6.17e-01
|
GO:0097178 BP ruffle assembly
|
12
|
6.63e-01
|
-7.27e-02
|
8.52e-01
|
GO:0016486 BP peptide hormone processing
|
10
|
6.92e-01
|
-7.25e-02
|
8.65e-01
|
GO:0009966 BP regulation of signal transduction
|
29
|
5.00e-01
|
7.24e-02
|
7.36e-01
|
GO:0006091 BP generation of precursor metabolites and energy
|
34
|
4.66e-01
|
7.23e-02
|
7.14e-01
|
GO:0042308 BP negative regulation of protein import into nucleus
|
13
|
6.54e-01
|
-7.19e-02
|
8.46e-01
|
GO:0030154 BP cell differentiation
|
352
|
2.12e-02
|
-7.17e-02
|
1.23e-01
|
GO:0070050 BP neuron cellular homeostasis
|
24
|
5.44e-01
|
7.16e-02
|
7.67e-01
|
GO:0006977 BP DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest
|
17
|
6.10e-01
|
-7.15e-02
|
8.16e-01
|
GO:0045892 BP negative regulation of DNA-templated transcription
|
454
|
9.23e-03
|
7.15e-02
|
6.92e-02
|
GO:0030866 BP cortical actin cytoskeleton organization
|
23
|
5.53e-01
|
7.15e-02
|
7.74e-01
|
GO:0001701 BP in utero embryonic development
|
177
|
1.01e-01
|
7.14e-02
|
3.17e-01
|
GO:0001953 BP negative regulation of cell-matrix adhesion
|
14
|
6.45e-01
|
-7.10e-02
|
8.40e-01
|
GO:0051489 BP regulation of filopodium assembly
|
12
|
6.71e-01
|
7.08e-02
|
8.56e-01
|
GO:0002053 BP positive regulation of mesenchymal cell proliferation
|
16
|
6.25e-01
|
7.06e-02
|
8.27e-01
|
GO:1903232 BP melanosome assembly
|
18
|
6.05e-01
|
7.04e-02
|
8.16e-01
|
GO:0048384 BP retinoic acid receptor signaling pathway
|
14
|
6.49e-01
|
7.03e-02
|
8.43e-01
|
GO:0021915 BP neural tube development
|
24
|
5.52e-01
|
7.02e-02
|
7.73e-01
|
GO:0006508 BP proteolysis
|
286
|
4.20e-02
|
-7.00e-02
|
1.88e-01
|
GO:0048513 BP animal organ development
|
10
|
7.02e-01
|
6.99e-02
|
8.70e-01
|
GO:0030010 BP establishment of cell polarity
|
29
|
5.16e-01
|
6.98e-02
|
7.50e-01
|
GO:0042953 BP lipoprotein transport
|
11
|
6.89e-01
|
-6.98e-02
|
8.63e-01
|
GO:0022409 BP positive regulation of cell-cell adhesion
|
11
|
6.89e-01
|
-6.98e-02
|
8.63e-01
|
GO:0003281 BP ventricular septum development
|
27
|
5.32e-01
|
-6.95e-02
|
7.63e-01
|
GO:0032872 BP regulation of stress-activated MAPK cascade
|
10
|
7.04e-01
|
6.93e-02
|
8.71e-01
|
GO:0006635 BP fatty acid beta-oxidation
|
41
|
4.45e-01
|
-6.90e-02
|
7.05e-01
|
GO:0007413 BP axonal fasciculation
|
10
|
7.06e-01
|
6.89e-02
|
8.71e-01
|
GO:0007422 BP peripheral nervous system development
|
19
|
6.05e-01
|
-6.86e-02
|
8.16e-01
|
GO:0030030 BP cell projection organization
|
33
|
4.96e-01
|
-6.84e-02
|
7.34e-01
|
GO:0006665 BP sphingolipid metabolic process
|
19
|
6.06e-01
|
-6.84e-02
|
8.16e-01
|
GO:1990090 BP cellular response to nerve growth factor stimulus
|
28
|
5.31e-01
|
6.84e-02
|
7.63e-01
|
GO:0000077 BP DNA damage checkpoint signaling
|
37
|
4.72e-01
|
6.84e-02
|
7.18e-01
|
GO:1903955 BP positive regulation of protein targeting to mitochondrion
|
31
|
5.12e-01
|
6.81e-02
|
7.46e-01
|
GO:0048715 BP negative regulation of oligodendrocyte differentiation
|
12
|
6.84e-01
|
-6.80e-02
|
8.61e-01
|
GO:0071222 BP cellular response to lipopolysaccharide
|
111
|
2.17e-01
|
6.78e-02
|
4.85e-01
|
GO:0043537 BP negative regulation of blood vessel endothelial cell migration
|
13
|
6.73e-01
|
6.77e-02
|
8.56e-01
|
GO:0008630 BP intrinsic apoptotic signaling pathway in response to DNA damage
|
40
|
4.59e-01
|
-6.76e-02
|
7.11e-01
|
GO:0048714 BP positive regulation of oligodendrocyte differentiation
|
19
|
6.11e-01
|
6.75e-02
|
8.17e-01
|
GO:0010718 BP positive regulation of epithelial to mesenchymal transition
|
43
|
4.47e-01
|
-6.70e-02
|
7.07e-01
|
GO:0055008 BP cardiac muscle tissue morphogenesis
|
10
|
7.14e-01
|
6.68e-02
|
8.75e-01
|
GO:0030206 BP chondroitin sulfate biosynthetic process
|
18
|
6.24e-01
|
-6.68e-02
|
8.27e-01
|
GO:0032868 BP response to insulin
|
45
|
4.40e-01
|
-6.66e-02
|
7.01e-01
|
GO:0032874 BP positive regulation of stress-activated MAPK cascade
|
15
|
6.57e-01
|
6.63e-02
|
8.48e-01
|
GO:0071356 BP cellular response to tumor necrosis factor
|
87
|
2.86e-01
|
6.62e-02
|
5.54e-01
|
GO:0032007 BP negative regulation of TOR signaling
|
30
|
5.30e-01
|
-6.62e-02
|
7.63e-01
|
GO:0007249 BP canonical NF-kappaB signal transduction
|
36
|
4.92e-01
|
-6.61e-02
|
7.31e-01
|
GO:0065003 BP protein-containing complex assembly
|
111
|
2.29e-01
|
6.61e-02
|
4.96e-01
|
GO:0046328 BP regulation of JNK cascade
|
15
|
6.58e-01
|
-6.61e-02
|
8.48e-01
|
GO:0050728 BP negative regulation of inflammatory response
|
68
|
3.47e-01
|
-6.59e-02
|
6.22e-01
|
GO:0042113 BP B cell activation
|
21
|
6.04e-01
|
-6.54e-02
|
8.16e-01
|
GO:0046579 BP positive regulation of Ras protein signal transduction
|
11
|
7.07e-01
|
-6.53e-02
|
8.71e-01
|
GO:0010975 BP regulation of neuron projection development
|
25
|
5.72e-01
|
-6.53e-02
|
7.87e-01
|
GO:0022008 BP neurogenesis
|
46
|
4.44e-01
|
6.52e-02
|
7.05e-01
|
GO:0007519 BP skeletal muscle tissue development
|
31
|
5.30e-01
|
6.52e-02
|
7.63e-01
|
GO:0002091 BP negative regulation of receptor internalization
|
11
|
7.08e-01
|
6.52e-02
|
8.71e-01
|
GO:0030282 BP bone mineralization
|
34
|
5.11e-01
|
6.51e-02
|
7.46e-01
|
GO:0006259 BP DNA metabolic process
|
20
|
6.15e-01
|
-6.50e-02
|
8.20e-01
|
GO:0048704 BP embryonic skeletal system morphogenesis
|
30
|
5.38e-01
|
-6.50e-02
|
7.64e-01
|
GO:0035633 BP maintenance of blood-brain barrier
|
28
|
5.53e-01
|
-6.48e-02
|
7.74e-01
|
GO:0008333 BP endosome to lysosome transport
|
45
|
4.53e-01
|
-6.47e-02
|
7.11e-01
|
GO:0007288 BP sperm axoneme assembly
|
21
|
6.10e-01
|
6.44e-02
|
8.16e-01
|
GO:1903078 BP positive regulation of protein localization to plasma membrane
|
45
|
4.55e-01
|
-6.43e-02
|
7.11e-01
|
GO:0044782 BP cilium organization
|
17
|
6.47e-01
|
-6.42e-02
|
8.41e-01
|
GO:0050905 BP neuromuscular process
|
20
|
6.20e-01
|
6.41e-02
|
8.24e-01
|
GO:0032467 BP positive regulation of cytokinesis
|
26
|
5.73e-01
|
6.39e-02
|
7.87e-01
|
GO:0006814 BP sodium ion transport
|
26
|
5.73e-01
|
-6.38e-02
|
7.87e-01
|
GO:0009306 BP protein secretion
|
37
|
5.02e-01
|
-6.38e-02
|
7.38e-01
|
GO:0009611 BP response to wounding
|
46
|
4.54e-01
|
6.38e-02
|
7.11e-01
|
GO:0051091 BP positive regulation of DNA-binding transcription factor activity
|
73
|
3.46e-01
|
-6.38e-02
|
6.22e-01
|
GO:0060122 BP inner ear receptor cell stereocilium organization
|
12
|
7.03e-01
|
-6.35e-02
|
8.71e-01
|
GO:0032733 BP positive regulation of interleukin-10 production
|
24
|
5.90e-01
|
-6.35e-02
|
8.03e-01
|
GO:0097194 BP execution phase of apoptosis
|
18
|
6.42e-01
|
6.33e-02
|
8.40e-01
|
GO:0000209 BP protein polyubiquitination
|
140
|
1.96e-01
|
6.33e-02
|
4.55e-01
|
GO:0000423 BP mitophagy
|
24
|
5.92e-01
|
-6.32e-02
|
8.03e-01
|
GO:0034498 BP early endosome to Golgi transport
|
13
|
6.93e-01
|
6.31e-02
|
8.65e-01
|
GO:0003007 BP heart morphogenesis
|
34
|
5.25e-01
|
6.30e-02
|
7.60e-01
|
GO:0010666 BP positive regulation of cardiac muscle cell apoptotic process
|
10
|
7.31e-01
|
6.29e-02
|
8.81e-01
|
GO:0007398 BP ectoderm development
|
11
|
7.18e-01
|
-6.28e-02
|
8.76e-01
|
GO:0021510 BP spinal cord development
|
18
|
6.45e-01
|
-6.27e-02
|
8.40e-01
|
GO:0060425 BP lung morphogenesis
|
12
|
7.07e-01
|
6.26e-02
|
8.71e-01
|
GO:0071044 BP histone mRNA catabolic process
|
14
|
6.86e-01
|
-6.24e-02
|
8.62e-01
|
GO:0070507 BP regulation of microtubule cytoskeleton organization
|
29
|
5.62e-01
|
6.22e-02
|
7.81e-01
|
GO:0016197 BP endosomal transport
|
60
|
4.07e-01
|
6.19e-02
|
6.69e-01
|
GO:0000079 BP regulation of cyclin-dependent protein serine/threonine kinase activity
|
41
|
4.94e-01
|
6.18e-02
|
7.31e-01
|
GO:0021987 BP cerebral cortex development
|
62
|
4.02e-01
|
6.16e-02
|
6.67e-01
|
GO:0055001 BP muscle cell development
|
11
|
7.24e-01
|
6.15e-02
|
8.78e-01
|
GO:0019882 BP antigen processing and presentation
|
19
|
6.43e-01
|
-6.14e-02
|
8.40e-01
|
GO:0061024 BP membrane organization
|
28
|
5.75e-01
|
6.13e-02
|
7.88e-01
|
GO:0000712 BP resolution of meiotic recombination intermediates
|
14
|
6.92e-01
|
6.12e-02
|
8.65e-01
|
GO:0042475 BP odontogenesis of dentin-containing tooth
|
41
|
4.98e-01
|
-6.12e-02
|
7.35e-01
|
GO:0060045 BP positive regulation of cardiac muscle cell proliferation
|
16
|
6.72e-01
|
6.11e-02
|
8.56e-01
|
GO:0002092 BP positive regulation of receptor internalization
|
19
|
6.45e-01
|
-6.10e-02
|
8.40e-01
|
GO:0002076 BP osteoblast development
|
13
|
7.04e-01
|
6.09e-02
|
8.71e-01
|
GO:0001921 BP positive regulation of receptor recycling
|
12
|
7.15e-01
|
-6.08e-02
|
8.75e-01
|
GO:0051492 BP regulation of stress fiber assembly
|
16
|
6.76e-01
|
6.04e-02
|
8.57e-01
|
GO:0007613 BP memory
|
51
|
4.56e-01
|
-6.03e-02
|
7.11e-01
|
GO:0019896 BP axonal transport of mitochondrion
|
10
|
7.42e-01
|
-6.02e-02
|
8.86e-01
|
GO:0060287 BP epithelial cilium movement involved in determination of left/right asymmetry
|
11
|
7.30e-01
|
-6.00e-02
|
8.81e-01
|
GO:0043542 BP endothelial cell migration
|
25
|
6.04e-01
|
-6.00e-02
|
8.16e-01
|
GO:1902018 BP negative regulation of cilium assembly
|
19
|
6.51e-01
|
5.99e-02
|
8.44e-01
|
GO:0001819 BP positive regulation of cytokine production
|
35
|
5.41e-01
|
5.98e-02
|
7.65e-01
|
GO:0042572 BP retinol metabolic process
|
31
|
5.65e-01
|
-5.98e-02
|
7.83e-01
|
GO:0006468 BP protein phosphorylation
|
326
|
6.43e-02
|
-5.97e-02
|
2.43e-01
|
GO:0007018 BP microtubule-based movement
|
51
|
4.61e-01
|
-5.97e-02
|
7.12e-01
|
GO:0071363 BP cellular response to growth factor stimulus
|
45
|
4.89e-01
|
-5.96e-02
|
7.31e-01
|
GO:0043276 BP anoikis
|
12
|
7.21e-01
|
5.96e-02
|
8.77e-01
|
GO:2000573 BP positive regulation of DNA biosynthetic process
|
11
|
7.33e-01
|
-5.94e-02
|
8.81e-01
|
GO:0031103 BP axon regeneration
|
12
|
7.22e-01
|
5.93e-02
|
8.78e-01
|
GO:1900026 BP positive regulation of substrate adhesion-dependent cell spreading
|
36
|
5.39e-01
|
5.92e-02
|
7.64e-01
|
GO:0001657 BP ureteric bud development
|
28
|
5.88e-01
|
5.92e-02
|
8.00e-01
|
GO:0032729 BP positive regulation of type II interferon production
|
42
|
5.08e-01
|
5.90e-02
|
7.44e-01
|
GO:0031929 BP TOR signaling
|
21
|
6.40e-01
|
5.90e-02
|
8.39e-01
|
GO:0032736 BP positive regulation of interleukin-13 production
|
11
|
7.35e-01
|
-5.89e-02
|
8.82e-01
|
GO:0031954 BP positive regulation of protein autophosphorylation
|
21
|
6.40e-01
|
5.89e-02
|
8.39e-01
|
GO:0032930 BP positive regulation of superoxide anion generation
|
12
|
7.24e-01
|
5.89e-02
|
8.78e-01
|
GO:0007187 BP G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger
|
15
|
6.93e-01
|
5.88e-02
|
8.65e-01
|
GO:0009615 BP response to virus
|
76
|
3.76e-01
|
5.87e-02
|
6.49e-01
|
GO:1904262 BP negative regulation of TORC1 signaling
|
43
|
5.06e-01
|
5.87e-02
|
7.41e-01
|
GO:0051260 BP protein homooligomerization
|
85
|
3.51e-01
|
-5.86e-02
|
6.25e-01
|
GO:0032495 BP response to muramyl dipeptide
|
12
|
7.25e-01
|
-5.86e-02
|
8.79e-01
|
GO:0006612 BP protein targeting to membrane
|
42
|
5.12e-01
|
-5.85e-02
|
7.46e-01
|
GO:0030878 BP thyroid gland development
|
24
|
6.20e-01
|
-5.85e-02
|
8.24e-01
|
GO:0071294 BP cellular response to zinc ion
|
12
|
7.26e-01
|
-5.85e-02
|
8.79e-01
|
GO:0048260 BP positive regulation of receptor-mediated endocytosis
|
16
|
6.86e-01
|
5.84e-02
|
8.62e-01
|
GO:0051497 BP negative regulation of stress fiber assembly
|
22
|
6.37e-01
|
5.81e-02
|
8.37e-01
|
GO:0090398 BP cellular senescence
|
50
|
4.78e-01
|
5.80e-02
|
7.23e-01
|
GO:0016050 BP vesicle organization
|
13
|
7.17e-01
|
5.80e-02
|
8.76e-01
|
GO:0031669 BP cellular response to nutrient levels
|
31
|
5.76e-01
|
5.80e-02
|
7.89e-01
|
GO:0060324 BP face development
|
17
|
6.79e-01
|
5.79e-02
|
8.59e-01
|
GO:0032436 BP positive regulation of proteasomal ubiquitin-dependent protein catabolic process
|
70
|
4.03e-01
|
5.79e-02
|
6.68e-01
|
GO:0030308 BP negative regulation of cell growth
|
96
|
3.29e-01
|
5.77e-02
|
6.02e-01
|
GO:0006351 BP DNA-templated transcription
|
65
|
4.21e-01
|
5.77e-02
|
6.84e-01
|
GO:0032753 BP positive regulation of interleukin-4 production
|
13
|
7.19e-01
|
-5.76e-02
|
8.76e-01
|
GO:0010506 BP regulation of autophagy
|
66
|
4.19e-01
|
-5.75e-02
|
6.81e-01
|
GO:0014002 BP astrocyte development
|
11
|
7.42e-01
|
-5.74e-02
|
8.86e-01
|
GO:0050860 BP negative regulation of T cell receptor signaling pathway
|
19
|
6.68e-01
|
-5.69e-02
|
8.54e-01
|
GO:0032088 BP negative regulation of NF-kappaB transcription factor activity
|
49
|
4.91e-01
|
5.68e-02
|
7.31e-01
|
GO:0002862 BP negative regulation of inflammatory response to antigenic stimulus
|
13
|
7.23e-01
|
5.68e-02
|
8.78e-01
|
GO:0051560 BP mitochondrial calcium ion homeostasis
|
15
|
7.04e-01
|
5.67e-02
|
8.71e-01
|
GO:0090309 BP positive regulation of DNA methylation-dependent heterochromatin formation
|
11
|
7.45e-01
|
-5.67e-02
|
8.88e-01
|
GO:0016236 BP macroautophagy
|
65
|
4.30e-01
|
-5.66e-02
|
6.90e-01
|
GO:0035773 BP insulin secretion involved in cellular response to glucose stimulus
|
10
|
7.57e-01
|
5.65e-02
|
8.94e-01
|
GO:0040014 BP regulation of multicellular organism growth
|
20
|
6.65e-01
|
5.59e-02
|
8.53e-01
|
GO:0042472 BP inner ear morphogenesis
|
28
|
6.10e-01
|
-5.58e-02
|
8.16e-01
|
GO:0006936 BP muscle contraction
|
42
|
5.33e-01
|
5.56e-02
|
7.63e-01
|
GO:0032502 BP developmental process
|
10
|
7.61e-01
|
5.55e-02
|
8.96e-01
|
GO:0021756 BP striatum development
|
14
|
7.20e-01
|
-5.54e-02
|
8.76e-01
|
GO:0002437 BP inflammatory response to antigenic stimulus
|
12
|
7.40e-01
|
5.53e-02
|
8.85e-01
|
GO:0043001 BP Golgi to plasma membrane protein transport
|
27
|
6.22e-01
|
5.49e-02
|
8.25e-01
|
GO:0031146 BP SCF-dependent proteasomal ubiquitin-dependent protein catabolic process
|
42
|
5.39e-01
|
-5.48e-02
|
7.64e-01
|
GO:0099149 BP regulation of postsynaptic neurotransmitter receptor internalization
|
13
|
7.32e-01
|
5.48e-02
|
8.81e-01
|
GO:0045445 BP myoblast differentiation
|
19
|
6.80e-01
|
5.47e-02
|
8.59e-01
|
GO:0045665 BP negative regulation of neuron differentiation
|
37
|
5.65e-01
|
-5.46e-02
|
7.83e-01
|
GO:0001937 BP negative regulation of endothelial cell proliferation
|
19
|
6.81e-01
|
5.46e-02
|
8.59e-01
|
GO:0007165 BP signal transduction
|
695
|
1.51e-02
|
-5.43e-02
|
1.01e-01
|
GO:0030324 BP lung development
|
57
|
4.78e-01
|
-5.43e-02
|
7.23e-01
|
GO:0051092 BP positive regulation of NF-kappaB transcription factor activity
|
107
|
3.33e-01
|
-5.42e-02
|
6.08e-01
|
GO:0033687 BP osteoblast proliferation
|
10
|
7.68e-01
|
5.38e-02
|
9.00e-01
|
GO:0043029 BP T cell homeostasis
|
23
|
6.56e-01
|
-5.37e-02
|
8.48e-01
|
GO:1904263 BP positive regulation of TORC1 signaling
|
50
|
5.12e-01
|
5.36e-02
|
7.46e-01
|
GO:0010804 BP negative regulation of tumor necrosis factor-mediated signaling pathway
|
19
|
6.86e-01
|
5.36e-02
|
8.62e-01
|
GO:0002755 BP MyD88-dependent toll-like receptor signaling pathway
|
12
|
7.48e-01
|
5.36e-02
|
8.89e-01
|
GO:0048010 BP vascular endothelial growth factor receptor signaling pathway
|
22
|
6.67e-01
|
-5.30e-02
|
8.53e-01
|
GO:0060307 BP regulation of ventricular cardiac muscle cell membrane repolarization
|
13
|
7.41e-01
|
-5.30e-02
|
8.85e-01
|
GO:0010812 BP negative regulation of cell-substrate adhesion
|
12
|
7.51e-01
|
-5.30e-02
|
8.92e-01
|
GO:2000010 BP positive regulation of protein localization to cell surface
|
14
|
7.32e-01
|
5.29e-02
|
8.81e-01
|
GO:0002753 BP cytoplasmic pattern recognition receptor signaling pathway
|
16
|
7.14e-01
|
-5.29e-02
|
8.75e-01
|
GO:0051000 BP positive regulation of nitric-oxide synthase activity
|
12
|
7.51e-01
|
5.29e-02
|
8.92e-01
|
GO:0010631 BP epithelial cell migration
|
11
|
7.62e-01
|
-5.28e-02
|
8.96e-01
|
GO:0051965 BP positive regulation of synapse assembly
|
33
|
6.00e-01
|
-5.28e-02
|
8.12e-01
|
GO:0060252 BP positive regulation of glial cell proliferation
|
17
|
7.06e-01
|
-5.28e-02
|
8.71e-01
|
GO:0032740 BP positive regulation of interleukin-17 production
|
16
|
7.15e-01
|
-5.27e-02
|
8.75e-01
|
GO:0003161 BP cardiac conduction system development
|
12
|
7.52e-01
|
5.26e-02
|
8.92e-01
|
GO:0030182 BP neuron differentiation
|
106
|
3.51e-01
|
-5.25e-02
|
6.25e-01
|
GO:0007224 BP smoothened signaling pathway
|
64
|
4.71e-01
|
5.21e-02
|
7.18e-01
|
GO:0071260 BP cellular response to mechanical stimulus
|
63
|
4.75e-01
|
-5.20e-02
|
7.21e-01
|
GO:1902774 BP late endosome to lysosome transport
|
17
|
7.11e-01
|
5.20e-02
|
8.74e-01
|
GO:0071345 BP cellular response to cytokine stimulus
|
20
|
6.88e-01
|
-5.19e-02
|
8.63e-01
|
GO:0007265 BP Ras protein signal transduction
|
66
|
4.68e-01
|
-5.17e-02
|
7.17e-01
|
GO:0006906 BP vesicle fusion
|
22
|
6.76e-01
|
-5.16e-02
|
8.57e-01
|
GO:0048589 BP developmental growth
|
19
|
7.00e-01
|
5.11e-02
|
8.69e-01
|
GO:0051491 BP positive regulation of filopodium assembly
|
24
|
6.65e-01
|
5.10e-02
|
8.53e-01
|
GO:0033235 BP positive regulation of protein sumoylation
|
12
|
7.60e-01
|
5.10e-02
|
8.96e-01
|
GO:0061178 BP regulation of insulin secretion involved in cellular response to glucose stimulus
|
15
|
7.33e-01
|
5.09e-02
|
8.81e-01
|
GO:0018345 BP protein palmitoylation
|
22
|
6.80e-01
|
5.07e-02
|
8.59e-01
|
GO:0043113 BP receptor clustering
|
20
|
6.96e-01
|
-5.05e-02
|
8.66e-01
|
GO:0035855 BP megakaryocyte development
|
16
|
7.26e-01
|
5.05e-02
|
8.79e-01
|
GO:0010800 BP positive regulation of peptidyl-threonine phosphorylation
|
22
|
6.82e-01
|
5.05e-02
|
8.61e-01
|
GO:0007131 BP reciprocal meiotic recombination
|
22
|
6.83e-01
|
5.04e-02
|
8.61e-01
|
GO:0006809 BP nitric oxide biosynthetic process
|
16
|
7.28e-01
|
5.02e-02
|
8.79e-01
|
GO:0031398 BP positive regulation of protein ubiquitination
|
67
|
4.78e-01
|
5.02e-02
|
7.23e-01
|
GO:0007281 BP germ cell development
|
23
|
6.77e-01
|
5.01e-02
|
8.58e-01
|
GO:0044772 BP mitotic cell cycle phase transition
|
15
|
7.37e-01
|
-5.01e-02
|
8.83e-01
|
GO:0071549 BP cellular response to dexamethasone stimulus
|
23
|
6.78e-01
|
-5.00e-02
|
8.58e-01
|
GO:0090110 BP COPII-coated vesicle cargo loading
|
14
|
7.46e-01
|
5.00e-02
|
8.89e-01
|
GO:0032922 BP circadian regulation of gene expression
|
60
|
5.04e-01
|
-4.99e-02
|
7.39e-01
|
GO:0045669 BP positive regulation of osteoblast differentiation
|
54
|
5.27e-01
|
-4.97e-02
|
7.62e-01
|
GO:0010595 BP positive regulation of endothelial cell migration
|
52
|
5.37e-01
|
4.96e-02
|
7.64e-01
|
GO:0003151 BP outflow tract morphogenesis
|
36
|
6.09e-01
|
4.92e-02
|
8.16e-01
|
GO:0033077 BP T cell differentiation in thymus
|
31
|
6.35e-01
|
-4.92e-02
|
8.36e-01
|
GO:0030879 BP mammary gland development
|
17
|
7.27e-01
|
4.89e-02
|
8.79e-01
|
GO:0097062 BP dendritic spine maintenance
|
10
|
7.89e-01
|
-4.89e-02
|
9.11e-01
|
GO:0044342 BP type B pancreatic cell proliferation
|
10
|
7.89e-01
|
-4.89e-02
|
9.11e-01
|
GO:1900153 BP positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay
|
13
|
7.61e-01
|
-4.86e-02
|
8.96e-01
|
GO:0043200 BP response to amino acid
|
14
|
7.53e-01
|
4.86e-02
|
8.92e-01
|
GO:0006098 BP pentose-phosphate shunt
|
11
|
7.80e-01
|
4.86e-02
|
9.08e-01
|
GO:0071333 BP cellular response to glucose stimulus
|
44
|
5.78e-01
|
4.85e-02
|
7.91e-01
|
GO:0045722 BP positive regulation of gluconeogenesis
|
16
|
7.38e-01
|
4.84e-02
|
8.83e-01
|
GO:0008202 BP steroid metabolic process
|
19
|
7.16e-01
|
4.83e-02
|
8.75e-01
|
GO:0043171 BP peptide catabolic process
|
13
|
7.65e-01
|
-4.80e-02
|
8.97e-01
|
GO:0051894 BP positive regulation of focal adhesion assembly
|
22
|
6.97e-01
|
-4.79e-02
|
8.67e-01
|
GO:0003148 BP outflow tract septum morphogenesis
|
21
|
7.04e-01
|
4.78e-02
|
8.71e-01
|
GO:0010468 BP regulation of gene expression
|
122
|
3.63e-01
|
4.77e-02
|
6.36e-01
|
GO:0072659 BP protein localization to plasma membrane
|
128
|
3.53e-01
|
-4.76e-02
|
6.26e-01
|
GO:1900017 BP positive regulation of cytokine production involved in inflammatory response
|
18
|
7.28e-01
|
4.74e-02
|
8.79e-01
|
GO:0090190 BP positive regulation of branching involved in ureteric bud morphogenesis
|
16
|
7.44e-01
|
-4.72e-02
|
8.87e-01
|
GO:0010867 BP positive regulation of triglyceride biosynthetic process
|
11
|
7.87e-01
|
-4.71e-02
|
9.11e-01
|
GO:0006941 BP striated muscle contraction
|
10
|
7.97e-01
|
-4.71e-02
|
9.17e-01
|
GO:0030036 BP actin cytoskeleton organization
|
165
|
2.99e-01
|
-4.69e-02
|
5.73e-01
|
GO:0007498 BP mesoderm development
|
19
|
7.24e-01
|
4.68e-02
|
8.78e-01
|
GO:0001835 BP blastocyst hatching
|
23
|
6.98e-01
|
-4.68e-02
|
8.67e-01
|
GO:0030033 BP microvillus assembly
|
14
|
7.62e-01
|
-4.67e-02
|
8.96e-01
|
GO:0007212 BP dopamine receptor signaling pathway
|
14
|
7.62e-01
|
-4.67e-02
|
8.96e-01
|
GO:0080111 BP DNA demethylation
|
15
|
7.55e-01
|
4.66e-02
|
8.92e-01
|
GO:0007096 BP regulation of exit from mitosis
|
11
|
7.89e-01
|
4.65e-02
|
9.11e-01
|
GO:0008543 BP fibroblast growth factor receptor signaling pathway
|
34
|
6.39e-01
|
4.65e-02
|
8.39e-01
|
GO:0030220 BP platelet formation
|
16
|
7.48e-01
|
4.65e-02
|
8.89e-01
|
GO:0030513 BP positive regulation of BMP signaling pathway
|
25
|
6.88e-01
|
4.64e-02
|
8.63e-01
|
GO:0060292 BP long-term synaptic depression
|
13
|
7.72e-01
|
-4.64e-02
|
9.03e-01
|
GO:0098586 BP cellular response to virus
|
48
|
5.79e-01
|
4.63e-02
|
7.92e-01
|
GO:0061025 BP membrane fusion
|
27
|
6.78e-01
|
4.62e-02
|
8.58e-01
|
GO:0015937 BP coenzyme A biosynthetic process
|
10
|
8.01e-01
|
-4.61e-02
|
9.21e-01
|
GO:0010039 BP response to iron ion
|
12
|
7.83e-01
|
-4.60e-02
|
9.10e-01
|
GO:0006622 BP protein targeting to lysosome
|
25
|
6.95e-01
|
-4.53e-02
|
8.66e-01
|
GO:1903077 BP negative regulation of protein localization to plasma membrane
|
19
|
7.33e-01
|
-4.53e-02
|
8.81e-01
|
GO:0060216 BP definitive hemopoiesis
|
12
|
7.88e-01
|
-4.49e-02
|
9.11e-01
|
GO:0002548 BP monocyte chemotaxis
|
12
|
7.88e-01
|
-4.49e-02
|
9.11e-01
|
GO:0046513 BP ceramide biosynthetic process
|
26
|
6.92e-01
|
4.48e-02
|
8.65e-01
|
GO:0045648 BP positive regulation of erythrocyte differentiation
|
27
|
6.87e-01
|
4.48e-02
|
8.63e-01
|
GO:0048745 BP smooth muscle tissue development
|
12
|
7.89e-01
|
-4.46e-02
|
9.11e-01
|
GO:1902894 BP negative regulation of miRNA transcription
|
23
|
7.11e-01
|
-4.46e-02
|
8.74e-01
|
GO:0035825 BP homologous recombination
|
10
|
8.07e-01
|
4.45e-02
|
9.24e-01
|
GO:0090148 BP membrane fission
|
40
|
6.30e-01
|
4.40e-02
|
8.31e-01
|
GO:0060340 BP positive regulation of type I interferon-mediated signaling pathway
|
17
|
7.54e-01
|
-4.40e-02
|
8.92e-01
|
GO:0071391 BP cellular response to estrogen stimulus
|
14
|
7.76e-01
|
4.39e-02
|
9.06e-01
|
GO:0043951 BP negative regulation of cAMP-mediated signaling
|
10
|
8.10e-01
|
-4.39e-02
|
9.24e-01
|
GO:0010764 BP negative regulation of fibroblast migration
|
10
|
8.10e-01
|
-4.38e-02
|
9.24e-01
|
GO:0006470 BP protein dephosphorylation
|
98
|
4.55e-01
|
4.37e-02
|
7.11e-01
|
GO:0042177 BP negative regulation of protein catabolic process
|
37
|
6.47e-01
|
4.36e-02
|
8.41e-01
|
GO:1905515 BP non-motile cilium assembly
|
51
|
5.91e-01
|
-4.35e-02
|
8.03e-01
|
GO:1904888 BP cranial skeletal system development
|
11
|
8.03e-01
|
4.34e-02
|
9.22e-01
|
GO:0014898 BP cardiac muscle hypertrophy in response to stress
|
10
|
8.13e-01
|
4.32e-02
|
9.26e-01
|
GO:0003222 BP ventricular trabecula myocardium morphogenesis
|
13
|
7.88e-01
|
4.31e-02
|
9.11e-01
|
GO:0006637 BP acyl-CoA metabolic process
|
15
|
7.73e-01
|
-4.31e-02
|
9.03e-01
|
GO:0050918 BP positive chemotaxis
|
26
|
7.06e-01
|
-4.27e-02
|
8.71e-01
|
GO:0008544 BP epidermis development
|
38
|
6.49e-01
|
-4.27e-02
|
8.43e-01
|
GO:0042116 BP macrophage activation
|
10
|
8.15e-01
|
-4.26e-02
|
9.26e-01
|
GO:2000679 BP positive regulation of transcription regulatory region DNA binding
|
10
|
8.16e-01
|
4.26e-02
|
9.26e-01
|
GO:0001508 BP action potential
|
11
|
8.08e-01
|
-4.24e-02
|
9.24e-01
|
GO:0033209 BP tumor necrosis factor-mediated signaling pathway
|
43
|
6.31e-01
|
-4.23e-02
|
8.32e-01
|
GO:1903265 BP positive regulation of tumor necrosis factor-mediated signaling pathway
|
12
|
8.01e-01
|
-4.20e-02
|
9.21e-01
|
GO:0003341 BP cilium movement
|
27
|
7.07e-01
|
4.19e-02
|
8.71e-01
|
GO:0001666 BP response to hypoxia
|
122
|
4.30e-01
|
-4.14e-02
|
6.90e-01
|
GO:0032880 BP regulation of protein localization
|
64
|
5.67e-01
|
-4.14e-02
|
7.84e-01
|
GO:0045931 BP positive regulation of mitotic cell cycle
|
30
|
6.95e-01
|
4.13e-02
|
8.66e-01
|
GO:0007595 BP lactation
|
28
|
7.06e-01
|
-4.12e-02
|
8.71e-01
|
GO:0019731 BP antibacterial humoral response
|
14
|
7.90e-01
|
-4.12e-02
|
9.11e-01
|
GO:2000146 BP negative regulation of cell motility
|
11
|
8.13e-01
|
4.11e-02
|
9.26e-01
|
GO:0042593 BP glucose homeostasis
|
73
|
5.44e-01
|
-4.11e-02
|
7.67e-01
|
GO:0051493 BP regulation of cytoskeleton organization
|
18
|
7.63e-01
|
4.11e-02
|
8.97e-01
|
GO:0035542 BP regulation of SNARE complex assembly
|
11
|
8.15e-01
|
-4.08e-02
|
9.26e-01
|
GO:0071901 BP negative regulation of protein serine/threonine kinase activity
|
12
|
8.07e-01
|
-4.07e-02
|
9.24e-01
|
GO:0005977 BP glycogen metabolic process
|
24
|
7.31e-01
|
4.05e-02
|
8.81e-01
|
GO:0006954 BP inflammatory response
|
225
|
2.99e-01
|
-4.02e-02
|
5.73e-01
|
GO:0007015 BP actin filament organization
|
102
|
4.84e-01
|
-4.02e-02
|
7.27e-01
|
GO:0043508 BP negative regulation of JUN kinase activity
|
11
|
8.18e-01
|
4.01e-02
|
9.27e-01
|
GO:0007254 BP JNK cascade
|
50
|
6.24e-01
|
4.00e-02
|
8.27e-01
|
GO:0045814 BP negative regulation of gene expression, epigenetic
|
33
|
6.93e-01
|
3.97e-02
|
8.65e-01
|
GO:0019915 BP lipid storage
|
19
|
7.65e-01
|
-3.97e-02
|
8.97e-01
|
GO:0048490 BP anterograde synaptic vesicle transport
|
16
|
7.85e-01
|
3.94e-02
|
9.11e-01
|
GO:0009612 BP response to mechanical stimulus
|
38
|
6.75e-01
|
3.94e-02
|
8.57e-01
|
GO:0044790 BP suppression of viral release by host
|
15
|
7.93e-01
|
-3.91e-02
|
9.14e-01
|
GO:0006515 BP protein quality control for misfolded or incompletely synthesized proteins
|
16
|
7.87e-01
|
-3.90e-02
|
9.11e-01
|
GO:0007611 BP learning or memory
|
41
|
6.66e-01
|
-3.90e-02
|
8.53e-01
|
GO:0032720 BP negative regulation of tumor necrosis factor production
|
35
|
6.92e-01
|
-3.88e-02
|
8.65e-01
|
GO:0000122 BP negative regulation of transcription by RNA polymerase II
|
718
|
7.88e-02
|
3.87e-02
|
2.70e-01
|
GO:0090160 BP Golgi to lysosome transport
|
11
|
8.25e-01
|
3.86e-02
|
9.31e-01
|
GO:0070213 BP protein auto-ADP-ribosylation
|
11
|
8.26e-01
|
3.84e-02
|
9.31e-01
|
GO:0042733 BP embryonic digit morphogenesis
|
40
|
6.76e-01
|
3.83e-02
|
8.57e-01
|
GO:0006469 BP negative regulation of protein kinase activity
|
46
|
6.54e-01
|
3.82e-02
|
8.46e-01
|
GO:0030199 BP collagen fibril organization
|
44
|
6.63e-01
|
-3.80e-02
|
8.52e-01
|
GO:0043065 BP positive regulation of apoptotic process
|
236
|
3.16e-01
|
3.80e-02
|
5.89e-01
|
GO:0045055 BP regulated exocytosis
|
17
|
7.87e-01
|
3.79e-02
|
9.11e-01
|
GO:0030163 BP protein catabolic process
|
50
|
6.43e-01
|
-3.79e-02
|
8.40e-01
|
GO:0035627 BP ceramide transport
|
10
|
8.36e-01
|
3.78e-02
|
9.36e-01
|
GO:0006810 BP transport
|
13
|
8.14e-01
|
-3.77e-02
|
9.26e-01
|
GO:0001975 BP response to amphetamine
|
23
|
7.55e-01
|
-3.76e-02
|
8.92e-01
|
GO:0048009 BP insulin-like growth factor receptor signaling pathway
|
29
|
7.26e-01
|
-3.76e-02
|
8.79e-01
|
GO:0034497 BP protein localization to phagophore assembly site
|
15
|
8.01e-01
|
-3.75e-02
|
9.21e-01
|
GO:0042795 BP snRNA transcription by RNA polymerase II
|
11
|
8.30e-01
|
-3.74e-02
|
9.33e-01
|
GO:0043254 BP regulation of protein-containing complex assembly
|
19
|
7.78e-01
|
3.74e-02
|
9.06e-01
|
GO:0045022 BP early endosome to late endosome transport
|
25
|
7.47e-01
|
3.73e-02
|
8.89e-01
|
GO:0046627 BP negative regulation of insulin receptor signaling pathway
|
33
|
7.12e-01
|
3.72e-02
|
8.74e-01
|
GO:0010507 BP negative regulation of autophagy
|
50
|
6.50e-01
|
-3.71e-02
|
8.43e-01
|
GO:0001558 BP regulation of cell growth
|
67
|
6.02e-01
|
3.68e-02
|
8.15e-01
|
GO:0032482 BP Rab protein signal transduction
|
12
|
8.25e-01
|
-3.68e-02
|
9.31e-01
|
GO:2000278 BP regulation of DNA biosynthetic process
|
11
|
8.33e-01
|
-3.67e-02
|
9.35e-01
|
GO:0006893 BP Golgi to plasma membrane transport
|
24
|
7.56e-01
|
3.67e-02
|
8.93e-01
|
GO:0043433 BP negative regulation of DNA-binding transcription factor activity
|
49
|
6.58e-01
|
3.66e-02
|
8.48e-01
|
GO:0034614 BP cellular response to reactive oxygen species
|
38
|
6.97e-01
|
3.65e-02
|
8.67e-01
|
GO:0051496 BP positive regulation of stress fiber assembly
|
42
|
6.84e-01
|
3.63e-02
|
8.62e-01
|
GO:0007032 BP endosome organization
|
37
|
7.03e-01
|
3.62e-02
|
8.71e-01
|
GO:0042531 BP positive regulation of tyrosine phosphorylation of STAT protein
|
34
|
7.15e-01
|
-3.62e-02
|
8.75e-01
|
GO:0035994 BP response to muscle stretch
|
16
|
8.02e-01
|
3.62e-02
|
9.21e-01
|
GO:0046825 BP regulation of protein export from nucleus
|
11
|
8.36e-01
|
-3.61e-02
|
9.36e-01
|
GO:0071711 BP basement membrane organization
|
20
|
7.80e-01
|
3.61e-02
|
9.08e-01
|
GO:0030593 BP neutrophil chemotaxis
|
34
|
7.16e-01
|
-3.60e-02
|
8.76e-01
|
GO:0009954 BP proximal/distal pattern formation
|
21
|
7.78e-01
|
3.56e-02
|
9.06e-01
|
GO:0043627 BP response to estrogen
|
30
|
7.36e-01
|
-3.55e-02
|
8.83e-01
|
GO:0051923 BP sulfation
|
10
|
8.47e-01
|
-3.53e-02
|
9.41e-01
|
GO:0033137 BP negative regulation of peptidyl-serine phosphorylation
|
22
|
7.74e-01
|
-3.53e-02
|
9.05e-01
|
GO:0005975 BP carbohydrate metabolic process
|
92
|
5.59e-01
|
-3.52e-02
|
7.79e-01
|
GO:0031663 BP lipopolysaccharide-mediated signaling pathway
|
24
|
7.65e-01
|
3.52e-02
|
8.98e-01
|
GO:0035909 BP aorta morphogenesis
|
14
|
8.20e-01
|
-3.51e-02
|
9.28e-01
|
GO:0051781 BP positive regulation of cell division
|
31
|
7.36e-01
|
3.49e-02
|
8.83e-01
|
GO:0048854 BP brain morphogenesis
|
20
|
7.88e-01
|
-3.47e-02
|
9.11e-01
|
GO:1902895 BP positive regulation of miRNA transcription
|
50
|
6.72e-01
|
3.46e-02
|
8.56e-01
|
GO:0099171 BP presynaptic modulation of chemical synaptic transmission
|
16
|
8.11e-01
|
-3.46e-02
|
9.24e-01
|
GO:0014850 BP response to muscle activity
|
16
|
8.11e-01
|
3.46e-02
|
9.24e-01
|
GO:0042110 BP T cell activation
|
28
|
7.52e-01
|
3.45e-02
|
8.92e-01
|
GO:0016024 BP CDP-diacylglycerol biosynthetic process
|
11
|
8.43e-01
|
3.44e-02
|
9.39e-01
|
GO:0006914 BP autophagy
|
136
|
4.88e-01
|
-3.44e-02
|
7.30e-01
|
GO:0051928 BP positive regulation of calcium ion transport
|
14
|
8.24e-01
|
3.43e-02
|
9.31e-01
|
GO:0071985 BP multivesicular body sorting pathway
|
23
|
7.76e-01
|
3.42e-02
|
9.06e-01
|
GO:0009410 BP response to xenobiotic stimulus
|
166
|
4.47e-01
|
-3.42e-02
|
7.07e-01
|
GO:0048706 BP embryonic skeletal system development
|
25
|
7.67e-01
|
-3.42e-02
|
8.99e-01
|
GO:1900182 BP positive regulation of protein localization to nucleus
|
37
|
7.19e-01
|
3.42e-02
|
8.76e-01
|
GO:0016579 BP protein deubiquitination
|
64
|
6.37e-01
|
3.41e-02
|
8.37e-01
|
GO:0071732 BP cellular response to nitric oxide
|
13
|
8.32e-01
|
3.40e-02
|
9.34e-01
|
GO:0010526 BP retrotransposon silencing
|
10
|
8.55e-01
|
3.34e-02
|
9.43e-01
|
GO:0000902 BP cell morphogenesis
|
62
|
6.51e-01
|
3.33e-02
|
8.44e-01
|
GO:0010575 BP positive regulation of vascular endothelial growth factor production
|
25
|
7.75e-01
|
3.30e-02
|
9.05e-01
|
GO:0042060 BP wound healing
|
57
|
6.67e-01
|
-3.30e-02
|
8.53e-01
|
GO:2001237 BP negative regulation of extrinsic apoptotic signaling pathway
|
32
|
7.47e-01
|
3.29e-02
|
8.89e-01
|
GO:0007043 BP cell-cell junction assembly
|
16
|
8.20e-01
|
-3.28e-02
|
9.28e-01
|
GO:0001947 BP heart looping
|
50
|
6.90e-01
|
-3.27e-02
|
8.64e-01
|
GO:0008209 BP androgen metabolic process
|
11
|
8.51e-01
|
-3.27e-02
|
9.42e-01
|
GO:0035269 BP protein O-linked mannosylation
|
18
|
8.11e-01
|
-3.26e-02
|
9.24e-01
|
GO:0055088 BP lipid homeostasis
|
36
|
7.35e-01
|
-3.26e-02
|
8.82e-01
|
GO:0045786 BP negative regulation of cell cycle
|
41
|
7.18e-01
|
-3.26e-02
|
8.76e-01
|
GO:0120163 BP negative regulation of cold-induced thermogenesis
|
41
|
7.20e-01
|
-3.23e-02
|
8.76e-01
|
GO:0016358 BP dendrite development
|
27
|
7.72e-01
|
-3.23e-02
|
9.03e-01
|
GO:0042119 BP neutrophil activation
|
10
|
8.60e-01
|
3.22e-02
|
9.45e-01
|
GO:0001570 BP vasculogenesis
|
49
|
6.97e-01
|
-3.22e-02
|
8.67e-01
|
GO:0030900 BP forebrain development
|
32
|
7.53e-01
|
3.21e-02
|
8.92e-01
|
GO:0045787 BP positive regulation of cell cycle
|
26
|
7.78e-01
|
3.20e-02
|
9.06e-01
|
GO:0071347 BP cellular response to interleukin-1
|
47
|
7.06e-01
|
-3.19e-02
|
8.71e-01
|
GO:0030336 BP negative regulation of cell migration
|
108
|
5.68e-01
|
-3.18e-02
|
7.84e-01
|
GO:0007250 BP activation of NF-kappaB-inducing kinase activity
|
13
|
8.43e-01
|
-3.18e-02
|
9.39e-01
|
GO:0043409 BP negative regulation of MAPK cascade
|
33
|
7.53e-01
|
-3.16e-02
|
8.92e-01
|
GO:0021591 BP ventricular system development
|
17
|
8.21e-01
|
-3.16e-02
|
9.29e-01
|
GO:0051281 BP positive regulation of release of sequestered calcium ion into cytosol
|
14
|
8.38e-01
|
-3.15e-02
|
9.36e-01
|
GO:0007266 BP Rho protein signal transduction
|
50
|
7.00e-01
|
-3.15e-02
|
8.69e-01
|
GO:0019725 BP cellular homeostasis
|
11
|
8.58e-01
|
-3.11e-02
|
9.45e-01
|
GO:0071548 BP response to dexamethasone
|
11
|
8.59e-01
|
-3.09e-02
|
9.45e-01
|
GO:0090050 BP positive regulation of cell migration involved in sprouting angiogenesis
|
19
|
8.16e-01
|
3.09e-02
|
9.26e-01
|
GO:0060349 BP bone morphogenesis
|
15
|
8.37e-01
|
-3.08e-02
|
9.36e-01
|
GO:0042761 BP very long-chain fatty acid biosynthetic process
|
11
|
8.60e-01
|
3.07e-02
|
9.45e-01
|
GO:0007507 BP heart development
|
159
|
5.07e-01
|
-3.05e-02
|
7.43e-01
|
GO:0007566 BP embryo implantation
|
31
|
7.69e-01
|
3.05e-02
|
9.00e-01
|
GO:0046597 BP negative regulation of viral entry into host cell
|
16
|
8.35e-01
|
-3.01e-02
|
9.35e-01
|
GO:0042908 BP xenobiotic transport
|
20
|
8.16e-01
|
3.00e-02
|
9.26e-01
|
GO:0010629 BP negative regulation of gene expression
|
195
|
4.73e-01
|
2.99e-02
|
7.19e-01
|
GO:0048041 BP focal adhesion assembly
|
25
|
7.97e-01
|
-2.97e-02
|
9.18e-01
|
GO:0045087 BP innate immune response
|
286
|
3.93e-01
|
2.94e-02
|
6.63e-01
|
GO:0009636 BP response to toxic substance
|
51
|
7.18e-01
|
2.92e-02
|
8.76e-01
|
GO:0002027 BP regulation of heart rate
|
18
|
8.31e-01
|
2.91e-02
|
9.33e-01
|
GO:0030512 BP negative regulation of transforming growth factor beta receptor signaling pathway
|
72
|
6.71e-01
|
2.90e-02
|
8.56e-01
|
GO:0050911 BP detection of chemical stimulus involved in sensory perception of smell
|
10
|
8.75e-01
|
-2.88e-02
|
9.56e-01
|
GO:0006851 BP mitochondrial calcium ion transmembrane transport
|
12
|
8.63e-01
|
2.88e-02
|
9.47e-01
|
GO:0046326 BP positive regulation of glucose import
|
25
|
8.04e-01
|
-2.87e-02
|
9.22e-01
|
GO:0090557 BP establishment of endothelial intestinal barrier
|
15
|
8.48e-01
|
-2.86e-02
|
9.41e-01
|
GO:0032008 BP positive regulation of TOR signaling
|
29
|
7.91e-01
|
-2.85e-02
|
9.12e-01
|
GO:0042147 BP retrograde transport, endosome to Golgi
|
72
|
6.78e-01
|
-2.83e-02
|
8.58e-01
|
GO:0010737 BP protein kinase A signaling
|
10
|
8.77e-01
|
-2.82e-02
|
9.56e-01
|
GO:0045947 BP negative regulation of translational initiation
|
17
|
8.40e-01
|
2.82e-02
|
9.38e-01
|
GO:0016558 BP protein import into peroxisome matrix
|
12
|
8.66e-01
|
-2.81e-02
|
9.50e-01
|
GO:0001662 BP behavioral fear response
|
23
|
8.17e-01
|
-2.79e-02
|
9.26e-01
|
GO:0046697 BP decidualization
|
19
|
8.34e-01
|
-2.78e-02
|
9.35e-01
|
GO:0051924 BP regulation of calcium ion transport
|
14
|
8.57e-01
|
-2.78e-02
|
9.45e-01
|
GO:1902017 BP regulation of cilium assembly
|
47
|
7.42e-01
|
-2.78e-02
|
8.86e-01
|
GO:0031333 BP negative regulation of protein-containing complex assembly
|
27
|
8.03e-01
|
-2.77e-02
|
9.22e-01
|
GO:0140374 BP antiviral innate immune response
|
42
|
7.56e-01
|
-2.77e-02
|
8.93e-01
|
GO:0035567 BP non-canonical Wnt signaling pathway
|
21
|
8.27e-01
|
-2.76e-02
|
9.31e-01
|
GO:0006693 BP prostaglandin metabolic process
|
17
|
8.44e-01
|
2.76e-02
|
9.39e-01
|
GO:2001034 BP positive regulation of double-strand break repair via nonhomologous end joining
|
15
|
8.54e-01
|
2.75e-02
|
9.43e-01
|
GO:0006656 BP phosphatidylcholine biosynthetic process
|
16
|
8.49e-01
|
-2.75e-02
|
9.41e-01
|
GO:0043153 BP entrainment of circadian clock by photoperiod
|
21
|
8.29e-01
|
-2.72e-02
|
9.32e-01
|
GO:1901379 BP regulation of potassium ion transmembrane transport
|
10
|
8.83e-01
|
-2.68e-02
|
9.57e-01
|
GO:0071466 BP cellular response to xenobiotic stimulus
|
50
|
7.44e-01
|
2.67e-02
|
8.87e-01
|
GO:0001822 BP kidney development
|
91
|
6.62e-01
|
-2.65e-02
|
8.52e-01
|
GO:0050678 BP regulation of epithelial cell proliferation
|
12
|
8.74e-01
|
-2.65e-02
|
9.55e-01
|
GO:0060996 BP dendritic spine development
|
11
|
8.80e-01
|
2.63e-02
|
9.57e-01
|
GO:0008089 BP anterograde axonal transport
|
29
|
8.07e-01
|
2.63e-02
|
9.24e-01
|
GO:0009755 BP hormone-mediated signaling pathway
|
27
|
8.14e-01
|
2.61e-02
|
9.26e-01
|
GO:0051289 BP protein homotetramerization
|
45
|
7.63e-01
|
2.59e-02
|
8.97e-01
|
GO:0042417 BP dopamine metabolic process
|
11
|
8.82e-01
|
-2.59e-02
|
9.57e-01
|
GO:0070198 BP protein localization to chromosome, telomeric region
|
11
|
8.82e-01
|
2.59e-02
|
9.57e-01
|
GO:0048771 BP tissue remodeling
|
10
|
8.88e-01
|
2.56e-02
|
9.60e-01
|
GO:0070098 BP chemokine-mediated signaling pathway
|
18
|
8.51e-01
|
-2.56e-02
|
9.42e-01
|
GO:0010977 BP negative regulation of neuron projection development
|
56
|
7.40e-01
|
2.56e-02
|
8.85e-01
|
GO:0042742 BP defense response to bacterium
|
59
|
7.34e-01
|
-2.56e-02
|
8.82e-01
|
GO:2000785 BP regulation of autophagosome assembly
|
14
|
8.68e-01
|
2.56e-02
|
9.52e-01
|
GO:0038084 BP vascular endothelial growth factor signaling pathway
|
11
|
8.84e-01
|
-2.54e-02
|
9.57e-01
|
GO:0006111 BP regulation of gluconeogenesis
|
13
|
8.74e-01
|
2.54e-02
|
9.55e-01
|
GO:0006473 BP protein acetylation
|
13
|
8.74e-01
|
-2.54e-02
|
9.55e-01
|
GO:0007033 BP vacuole organization
|
10
|
8.91e-01
|
-2.51e-02
|
9.60e-01
|
GO:0031293 BP membrane protein intracellular domain proteolysis
|
13
|
8.77e-01
|
-2.48e-02
|
9.56e-01
|
GO:0048844 BP artery morphogenesis
|
20
|
8.49e-01
|
-2.46e-02
|
9.41e-01
|
GO:1990138 BP neuron projection extension
|
19
|
8.53e-01
|
-2.46e-02
|
9.43e-01
|
GO:0051893 BP regulation of focal adhesion assembly
|
22
|
8.42e-01
|
2.46e-02
|
9.39e-01
|
GO:0032755 BP positive regulation of interleukin-6 production
|
65
|
7.32e-01
|
-2.45e-02
|
8.81e-01
|
GO:0030890 BP positive regulation of B cell proliferation
|
25
|
8.32e-01
|
-2.45e-02
|
9.34e-01
|
GO:0002063 BP chondrocyte development
|
11
|
8.88e-01
|
-2.44e-02
|
9.60e-01
|
GO:0071320 BP cellular response to cAMP
|
33
|
8.09e-01
|
-2.43e-02
|
9.24e-01
|
GO:0098656 BP monoatomic anion transmembrane transport
|
24
|
8.37e-01
|
-2.43e-02
|
9.36e-01
|
GO:0060716 BP labyrinthine layer blood vessel development
|
17
|
8.62e-01
|
2.43e-02
|
9.47e-01
|
GO:0035914 BP skeletal muscle cell differentiation
|
33
|
8.11e-01
|
2.40e-02
|
9.24e-01
|
GO:0042276 BP error-prone translesion synthesis
|
11
|
8.91e-01
|
2.39e-02
|
9.60e-01
|
GO:0015031 BP protein transport
|
334
|
4.59e-01
|
-2.36e-02
|
7.11e-01
|
GO:0090314 BP positive regulation of protein targeting to membrane
|
25
|
8.38e-01
|
-2.36e-02
|
9.36e-01
|
GO:0003091 BP renal water homeostasis
|
11
|
8.92e-01
|
-2.36e-02
|
9.61e-01
|
GO:0035115 BP embryonic forelimb morphogenesis
|
25
|
8.39e-01
|
-2.35e-02
|
9.36e-01
|
GO:0046427 BP positive regulation of receptor signaling pathway via JAK-STAT
|
22
|
8.49e-01
|
2.35e-02
|
9.41e-01
|
GO:0050872 BP white fat cell differentiation
|
13
|
8.84e-01
|
-2.34e-02
|
9.57e-01
|
GO:0045216 BP cell-cell junction organization
|
18
|
8.64e-01
|
2.33e-02
|
9.48e-01
|
GO:0000302 BP response to reactive oxygen species
|
11
|
8.94e-01
|
-2.32e-02
|
9.61e-01
|
GO:0046329 BP negative regulation of JNK cascade
|
25
|
8.42e-01
|
-2.30e-02
|
9.39e-01
|
GO:0032456 BP endocytic recycling
|
61
|
7.59e-01
|
2.27e-02
|
8.95e-01
|
GO:0032204 BP regulation of telomere maintenance
|
21
|
8.57e-01
|
2.27e-02
|
9.45e-01
|
GO:0061484 BP hematopoietic stem cell homeostasis
|
17
|
8.72e-01
|
-2.25e-02
|
9.55e-01
|
GO:0090316 BP positive regulation of intracellular protein transport
|
21
|
8.58e-01
|
-2.25e-02
|
9.45e-01
|
GO:0140627 BP ubiquitin-dependent protein catabolic process via the C-end degron rule pathway
|
12
|
8.93e-01
|
2.24e-02
|
9.61e-01
|
GO:0060348 BP bone development
|
45
|
7.96e-01
|
-2.23e-02
|
9.17e-01
|
GO:0061512 BP protein localization to cilium
|
33
|
8.25e-01
|
-2.22e-02
|
9.31e-01
|
GO:0048839 BP inner ear development
|
25
|
8.48e-01
|
2.21e-02
|
9.41e-01
|
GO:0016233 BP telomere capping
|
11
|
8.99e-01
|
2.21e-02
|
9.64e-01
|
GO:0001709 BP cell fate determination
|
13
|
8.91e-01
|
2.20e-02
|
9.60e-01
|
GO:0015804 BP neutral amino acid transport
|
12
|
8.95e-01
|
-2.20e-02
|
9.62e-01
|
GO:0043328 BP protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
|
15
|
8.83e-01
|
2.19e-02
|
9.57e-01
|
GO:0045088 BP regulation of innate immune response
|
17
|
8.80e-01
|
-2.11e-02
|
9.57e-01
|
GO:0019082 BP viral protein processing
|
29
|
8.45e-01
|
2.09e-02
|
9.41e-01
|
GO:0032092 BP positive regulation of protein binding
|
44
|
8.11e-01
|
-2.08e-02
|
9.24e-01
|
GO:0060612 BP adipose tissue development
|
28
|
8.50e-01
|
-2.07e-02
|
9.41e-01
|
GO:0043406 BP positive regulation of MAP kinase activity
|
37
|
8.29e-01
|
2.05e-02
|
9.32e-01
|
GO:0008344 BP adult locomotory behavior
|
38
|
8.27e-01
|
2.05e-02
|
9.31e-01
|
GO:0045765 BP regulation of angiogenesis
|
29
|
8.49e-01
|
2.05e-02
|
9.41e-01
|
GO:0051258 BP protein polymerization
|
13
|
8.99e-01
|
-2.04e-02
|
9.64e-01
|
GO:0008285 BP negative regulation of cell population proliferation
|
293
|
5.55e-01
|
-2.01e-02
|
7.74e-01
|
GO:0045944 BP positive regulation of transcription by RNA polymerase II
|
912
|
3.07e-01
|
2.01e-02
|
5.80e-01
|
GO:0007409 BP axonogenesis
|
65
|
7.84e-01
|
1.97e-02
|
9.11e-01
|
GO:0042325 BP regulation of phosphorylation
|
10
|
9.14e-01
|
1.96e-02
|
9.71e-01
|
GO:0071398 BP cellular response to fatty acid
|
13
|
9.03e-01
|
-1.95e-02
|
9.66e-01
|
GO:0003407 BP neural retina development
|
10
|
9.16e-01
|
1.94e-02
|
9.71e-01
|
GO:0030301 BP cholesterol transport
|
16
|
8.94e-01
|
1.93e-02
|
9.61e-01
|
GO:0031290 BP retinal ganglion cell axon guidance
|
12
|
9.08e-01
|
-1.92e-02
|
9.69e-01
|
GO:0010759 BP positive regulation of macrophage chemotaxis
|
11
|
9.13e-01
|
1.89e-02
|
9.71e-01
|
GO:0043124 BP negative regulation of canonical NF-kappaB signal transduction
|
45
|
8.27e-01
|
1.89e-02
|
9.31e-01
|
GO:0045198 BP establishment of epithelial cell apical/basal polarity
|
15
|
9.01e-01
|
1.86e-02
|
9.65e-01
|
GO:0048701 BP embryonic cranial skeleton morphogenesis
|
23
|
8.78e-01
|
-1.85e-02
|
9.57e-01
|
GO:0045667 BP regulation of osteoblast differentiation
|
10
|
9.20e-01
|
-1.83e-02
|
9.72e-01
|
GO:0050804 BP modulation of chemical synaptic transmission
|
48
|
8.28e-01
|
-1.81e-02
|
9.32e-01
|
GO:0001523 BP retinoid metabolic process
|
16
|
9.01e-01
|
1.80e-02
|
9.65e-01
|
GO:0070885 BP negative regulation of calcineurin-NFAT signaling cascade
|
11
|
9.18e-01
|
1.79e-02
|
9.72e-01
|
GO:0008589 BP regulation of smoothened signaling pathway
|
17
|
8.98e-01
|
1.79e-02
|
9.64e-01
|
GO:0048565 BP digestive tract development
|
13
|
9.11e-01
|
1.79e-02
|
9.70e-01
|
GO:1903826 BP L-arginine transmembrane transport
|
12
|
9.16e-01
|
1.75e-02
|
9.71e-01
|
GO:0060586 BP multicellular organismal-level iron ion homeostasis
|
21
|
8.92e-01
|
-1.71e-02
|
9.60e-01
|
GO:0045599 BP negative regulation of fat cell differentiation
|
40
|
8.51e-01
|
1.71e-02
|
9.42e-01
|
GO:0006970 BP response to osmotic stress
|
10
|
9.28e-01
|
-1.66e-02
|
9.73e-01
|
GO:0001954 BP positive regulation of cell-matrix adhesion
|
18
|
9.04e-01
|
-1.64e-02
|
9.66e-01
|
GO:0001702 BP gastrulation with mouth forming second
|
14
|
9.16e-01
|
-1.63e-02
|
9.71e-01
|
GO:0051607 BP defense response to virus
|
164
|
7.20e-01
|
-1.62e-02
|
8.76e-01
|
GO:0030838 BP positive regulation of actin filament polymerization
|
41
|
8.58e-01
|
-1.62e-02
|
9.45e-01
|
GO:0006672 BP ceramide metabolic process
|
19
|
9.03e-01
|
1.61e-02
|
9.66e-01
|
GO:0060326 BP cell chemotaxis
|
36
|
8.70e-01
|
1.58e-02
|
9.52e-01
|
GO:0030148 BP sphingolipid biosynthetic process
|
36
|
8.70e-01
|
-1.58e-02
|
9.52e-01
|
GO:0034315 BP regulation of Arp2/3 complex-mediated actin nucleation
|
17
|
9.11e-01
|
-1.57e-02
|
9.70e-01
|
GO:0055007 BP cardiac muscle cell differentiation
|
20
|
9.03e-01
|
1.57e-02
|
9.66e-01
|
GO:2000134 BP negative regulation of G1/S transition of mitotic cell cycle
|
34
|
8.75e-01
|
1.55e-02
|
9.56e-01
|
GO:0071897 BP DNA biosynthetic process
|
26
|
8.91e-01
|
1.55e-02
|
9.60e-01
|
GO:0032438 BP melanosome organization
|
20
|
9.04e-01
|
1.55e-02
|
9.66e-01
|
GO:0001756 BP somitogenesis
|
30
|
8.84e-01
|
1.54e-02
|
9.57e-01
|
GO:0016310 BP phosphorylation
|
253
|
6.75e-01
|
-1.53e-02
|
8.57e-01
|
GO:0060271 BP cilium assembly
|
193
|
7.14e-01
|
1.53e-02
|
8.75e-01
|
GO:0060412 BP ventricular septum morphogenesis
|
28
|
8.89e-01
|
1.53e-02
|
9.60e-01
|
GO:0030097 BP hemopoiesis
|
50
|
8.54e-01
|
-1.51e-02
|
9.43e-01
|
GO:0007368 BP determination of left/right symmetry
|
46
|
8.60e-01
|
1.50e-02
|
9.45e-01
|
GO:0090090 BP negative regulation of canonical Wnt signaling pathway
|
113
|
7.87e-01
|
-1.48e-02
|
9.11e-01
|
GO:0010951 BP negative regulation of endopeptidase activity
|
22
|
9.05e-01
|
1.47e-02
|
9.66e-01
|
GO:0009948 BP anterior/posterior axis specification
|
11
|
9.34e-01
|
-1.44e-02
|
9.77e-01
|
GO:0001818 BP negative regulation of cytokine production
|
21
|
9.09e-01
|
-1.44e-02
|
9.69e-01
|
GO:0015721 BP bile acid and bile salt transport
|
18
|
9.16e-01
|
1.43e-02
|
9.71e-01
|
GO:0030031 BP cell projection assembly
|
12
|
9.32e-01
|
1.42e-02
|
9.76e-01
|
GO:0007585 BP respiratory gaseous exchange by respiratory system
|
15
|
9.25e-01
|
-1.40e-02
|
9.73e-01
|
GO:0060999 BP positive regulation of dendritic spine development
|
19
|
9.19e-01
|
1.35e-02
|
9.72e-01
|
GO:0051016 BP barbed-end actin filament capping
|
16
|
9.26e-01
|
1.34e-02
|
9.73e-01
|
GO:0000422 BP autophagy of mitochondrion
|
35
|
8.91e-01
|
-1.34e-02
|
9.60e-01
|
GO:0016567 BP protein ubiquitination
|
372
|
6.59e-01
|
1.34e-02
|
8.49e-01
|
GO:0061028 BP establishment of endothelial barrier
|
17
|
9.24e-01
|
-1.33e-02
|
9.73e-01
|
GO:0001889 BP liver development
|
65
|
8.53e-01
|
1.33e-02
|
9.43e-01
|
GO:0007628 BP adult walking behavior
|
22
|
9.14e-01
|
-1.33e-02
|
9.71e-01
|
GO:0021983 BP pituitary gland development
|
14
|
9.32e-01
|
-1.32e-02
|
9.76e-01
|
GO:1901222 BP regulation of non-canonical NF-kappaB signal transduction
|
11
|
9.40e-01
|
-1.32e-02
|
9.80e-01
|
GO:0007040 BP lysosome organization
|
45
|
8.83e-01
|
1.27e-02
|
9.57e-01
|
GO:0006355 BP regulation of DNA-templated transcription
|
445
|
6.59e-01
|
-1.22e-02
|
8.49e-01
|
GO:0021766 BP hippocampus development
|
52
|
8.80e-01
|
-1.21e-02
|
9.57e-01
|
GO:0006878 BP intracellular copper ion homeostasis
|
16
|
9.35e-01
|
-1.19e-02
|
9.77e-01
|
GO:0030855 BP epithelial cell differentiation
|
55
|
8.79e-01
|
1.18e-02
|
9.57e-01
|
GO:0050727 BP regulation of inflammatory response
|
59
|
8.76e-01
|
1.18e-02
|
9.56e-01
|
GO:0048514 BP blood vessel morphogenesis
|
15
|
9.38e-01
|
1.17e-02
|
9.79e-01
|
GO:0030316 BP osteoclast differentiation
|
33
|
9.08e-01
|
1.16e-02
|
9.69e-01
|
GO:0050679 BP positive regulation of epithelial cell proliferation
|
43
|
8.96e-01
|
1.15e-02
|
9.62e-01
|
GO:0035025 BP positive regulation of Rho protein signal transduction
|
23
|
9.24e-01
|
-1.15e-02
|
9.73e-01
|
GO:0014823 BP response to activity
|
31
|
9.12e-01
|
-1.15e-02
|
9.70e-01
|
GO:0042987 BP amyloid precursor protein catabolic process
|
13
|
9.44e-01
|
1.13e-02
|
9.82e-01
|
GO:0007420 BP brain development
|
133
|
8.26e-01
|
-1.11e-02
|
9.31e-01
|
GO:0030516 BP regulation of axon extension
|
11
|
9.50e-01
|
-1.09e-02
|
9.86e-01
|
GO:1901741 BP positive regulation of myoblast fusion
|
10
|
9.52e-01
|
1.09e-02
|
9.86e-01
|
GO:0001556 BP oocyte maturation
|
14
|
9.46e-01
|
-1.06e-02
|
9.83e-01
|
GO:0048167 BP regulation of synaptic plasticity
|
39
|
9.11e-01
|
1.04e-02
|
9.70e-01
|
GO:0043162 BP ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway
|
30
|
9.22e-01
|
-1.04e-02
|
9.73e-01
|
GO:0060173 BP limb development
|
30
|
9.22e-01
|
1.03e-02
|
9.73e-01
|
GO:0042220 BP response to cocaine
|
17
|
9.41e-01
|
-1.03e-02
|
9.81e-01
|
GO:0008286 BP insulin receptor signaling pathway
|
63
|
8.88e-01
|
-1.03e-02
|
9.60e-01
|
GO:0015908 BP fatty acid transport
|
16
|
9.43e-01
|
1.02e-02
|
9.82e-01
|
GO:0032526 BP response to retinoic acid
|
33
|
9.19e-01
|
1.02e-02
|
9.72e-01
|
GO:0097202 BP activation of cysteine-type endopeptidase activity
|
11
|
9.54e-01
|
-1.01e-02
|
9.86e-01
|
GO:0007029 BP endoplasmic reticulum organization
|
33
|
9.20e-01
|
1.00e-02
|
9.72e-01
|
GO:0010803 BP regulation of tumor necrosis factor-mediated signaling pathway
|
18
|
9.42e-01
|
9.94e-03
|
9.81e-01
|
GO:0001932 BP regulation of protein phosphorylation
|
34
|
9.21e-01
|
9.85e-03
|
9.72e-01
|
GO:0032147 BP activation of protein kinase activity
|
22
|
9.37e-01
|
-9.80e-03
|
9.78e-01
|
GO:0010035 BP response to inorganic substance
|
11
|
9.55e-01
|
9.74e-03
|
9.86e-01
|
GO:0032715 BP negative regulation of interleukin-6 production
|
26
|
9.32e-01
|
-9.61e-03
|
9.76e-01
|
GO:0050852 BP T cell receptor signaling pathway
|
76
|
8.88e-01
|
9.36e-03
|
9.60e-01
|
GO:0035108 BP limb morphogenesis
|
12
|
9.55e-01
|
-9.34e-03
|
9.86e-01
|
GO:0016239 BP positive regulation of macroautophagy
|
25
|
9.36e-01
|
-9.28e-03
|
9.78e-01
|
GO:0030216 BP keratinocyte differentiation
|
37
|
9.23e-01
|
-9.23e-03
|
9.73e-01
|
GO:0039702 BP viral budding via host ESCRT complex
|
22
|
9.41e-01
|
-9.17e-03
|
9.81e-01
|
GO:0001736 BP establishment of planar polarity
|
15
|
9.52e-01
|
-9.02e-03
|
9.86e-01
|
GO:1905907 BP negative regulation of amyloid fibril formation
|
10
|
9.61e-01
|
-8.93e-03
|
9.89e-01
|
GO:0051209 BP release of sequestered calcium ion into cytosol
|
29
|
9.34e-01
|
8.93e-03
|
9.77e-01
|
GO:0060317 BP cardiac epithelial to mesenchymal transition
|
11
|
9.59e-01
|
-8.91e-03
|
9.88e-01
|
GO:0097746 BP blood vessel diameter maintenance
|
16
|
9.51e-01
|
-8.86e-03
|
9.86e-01
|
GO:0014070 BP response to organic cyclic compound
|
43
|
9.23e-01
|
8.48e-03
|
9.73e-01
|
GO:0032728 BP positive regulation of interferon-beta production
|
36
|
9.30e-01
|
8.45e-03
|
9.75e-01
|
GO:0007020 BP microtubule nucleation
|
23
|
9.46e-01
|
8.10e-03
|
9.83e-01
|
GO:1900025 BP negative regulation of substrate adhesion-dependent cell spreading
|
13
|
9.61e-01
|
7.86e-03
|
9.89e-01
|
GO:0098869 BP cellular oxidant detoxification
|
49
|
9.24e-01
|
7.85e-03
|
9.73e-01
|
GO:0042532 BP negative regulation of tyrosine phosphorylation of STAT protein
|
10
|
9.66e-01
|
-7.75e-03
|
9.89e-01
|
GO:0006935 BP chemotaxis
|
49
|
9.25e-01
|
7.73e-03
|
9.73e-01
|
GO:0010976 BP positive regulation of neuron projection development
|
86
|
9.02e-01
|
-7.69e-03
|
9.66e-01
|
GO:0032570 BP response to progesterone
|
27
|
9.45e-01
|
-7.68e-03
|
9.83e-01
|
GO:0016925 BP protein sumoylation
|
47
|
9.28e-01
|
-7.58e-03
|
9.74e-01
|
GO:0060392 BP negative regulation of SMAD protein signal transduction
|
15
|
9.59e-01
|
-7.58e-03
|
9.88e-01
|
GO:0030041 BP actin filament polymerization
|
26
|
9.47e-01
|
7.47e-03
|
9.84e-01
|
GO:0006855 BP xenobiotic transmembrane transport
|
13
|
9.63e-01
|
7.41e-03
|
9.89e-01
|
GO:0051865 BP protein autoubiquitination
|
61
|
9.20e-01
|
7.41e-03
|
9.72e-01
|
GO:0006898 BP receptor-mediated endocytosis
|
53
|
9.27e-01
|
7.30e-03
|
9.73e-01
|
GO:0032259 BP methylation
|
73
|
9.16e-01
|
7.11e-03
|
9.71e-01
|
GO:0018230 BP peptidyl-L-cysteine S-palmitoylation
|
21
|
9.55e-01
|
7.09e-03
|
9.86e-01
|
GO:0007286 BP spermatid development
|
56
|
9.27e-01
|
-7.08e-03
|
9.73e-01
|
GO:0042770 BP signal transduction in response to DNA damage
|
16
|
9.64e-01
|
6.44e-03
|
9.89e-01
|
GO:0060038 BP cardiac muscle cell proliferation
|
20
|
9.61e-01
|
6.38e-03
|
9.89e-01
|
GO:0051403 BP stress-activated MAPK cascade
|
19
|
9.63e-01
|
-6.12e-03
|
9.89e-01
|
GO:0032897 BP negative regulation of viral transcription
|
15
|
9.68e-01
|
-6.06e-03
|
9.89e-01
|
GO:0051896 BP regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction
|
20
|
9.63e-01
|
-5.99e-03
|
9.89e-01
|
GO:0034097 BP response to cytokine
|
35
|
9.52e-01
|
-5.94e-03
|
9.86e-01
|
GO:0071542 BP dopaminergic neuron differentiation
|
15
|
9.69e-01
|
-5.87e-03
|
9.89e-01
|
GO:0016055 BP Wnt signaling pathway
|
129
|
9.11e-01
|
-5.73e-03
|
9.70e-01
|
GO:0006882 BP intracellular zinc ion homeostasis
|
20
|
9.65e-01
|
5.72e-03
|
9.89e-01
|
GO:0043616 BP keratinocyte proliferation
|
17
|
9.68e-01
|
5.64e-03
|
9.89e-01
|
GO:0031641 BP regulation of myelination
|
17
|
9.69e-01
|
5.50e-03
|
9.89e-01
|
GO:0007283 BP spermatogenesis
|
241
|
8.83e-01
|
5.49e-03
|
9.57e-01
|
GO:0032731 BP positive regulation of interleukin-1 beta production
|
37
|
9.54e-01
|
5.49e-03
|
9.86e-01
|
GO:0048538 BP thymus development
|
39
|
9.53e-01
|
5.49e-03
|
9.86e-01
|
GO:0034453 BP microtubule anchoring
|
11
|
9.75e-01
|
-5.48e-03
|
9.90e-01
|
GO:0035265 BP organ growth
|
12
|
9.74e-01
|
5.42e-03
|
9.90e-01
|
GO:0060021 BP roof of mouth development
|
54
|
9.45e-01
|
-5.41e-03
|
9.83e-01
|
GO:0032331 BP negative regulation of chondrocyte differentiation
|
18
|
9.68e-01
|
5.39e-03
|
9.89e-01
|
GO:0060065 BP uterus development
|
15
|
9.71e-01
|
-5.35e-03
|
9.90e-01
|
GO:0071230 BP cellular response to amino acid stimulus
|
45
|
9.54e-01
|
5.02e-03
|
9.86e-01
|
GO:0034260 BP negative regulation of GTPase activity
|
18
|
9.71e-01
|
-5.01e-03
|
9.90e-01
|
GO:0070914 BP UV-damage excision repair
|
11
|
9.78e-01
|
-4.82e-03
|
9.91e-01
|
GO:0046718 BP symbiont entry into host cell
|
73
|
9.49e-01
|
4.36e-03
|
9.85e-01
|
GO:0071577 BP zinc ion transmembrane transport
|
18
|
9.76e-01
|
-4.16e-03
|
9.90e-01
|
GO:0002244 BP hematopoietic progenitor cell differentiation
|
53
|
9.59e-01
|
-4.12e-03
|
9.88e-01
|
GO:0006541 BP glutamine metabolic process
|
19
|
9.75e-01
|
4.09e-03
|
9.90e-01
|
GO:0031396 BP regulation of protein ubiquitination
|
18
|
9.76e-01
|
-4.09e-03
|
9.90e-01
|
GO:0060976 BP coronary vasculature development
|
20
|
9.75e-01
|
-4.02e-03
|
9.90e-01
|
GO:0035019 BP somatic stem cell population maintenance
|
43
|
9.64e-01
|
3.94e-03
|
9.89e-01
|
GO:0021542 BP dentate gyrus development
|
13
|
9.81e-01
|
3.89e-03
|
9.92e-01
|
GO:0007099 BP centriole replication
|
22
|
9.75e-01
|
-3.85e-03
|
9.90e-01
|
GO:0017157 BP regulation of exocytosis
|
26
|
9.74e-01
|
-3.72e-03
|
9.90e-01
|
GO:0042573 BP retinoic acid metabolic process
|
11
|
9.83e-01
|
3.63e-03
|
9.92e-01
|
GO:0051770 BP positive regulation of nitric-oxide synthase biosynthetic process
|
11
|
9.83e-01
|
3.63e-03
|
9.92e-01
|
GO:0045666 BP positive regulation of neuron differentiation
|
47
|
9.67e-01
|
-3.54e-03
|
9.89e-01
|
GO:0030111 BP regulation of Wnt signaling pathway
|
15
|
9.82e-01
|
-3.44e-03
|
9.92e-01
|
GO:0035584 BP calcium-mediated signaling using intracellular calcium source
|
14
|
9.82e-01
|
-3.41e-03
|
9.92e-01
|
GO:0072089 BP stem cell proliferation
|
34
|
9.73e-01
|
3.36e-03
|
9.90e-01
|
GO:0016525 BP negative regulation of angiogenesis
|
57
|
9.66e-01
|
3.31e-03
|
9.89e-01
|
GO:0001658 BP branching involved in ureteric bud morphogenesis
|
33
|
9.74e-01
|
-3.29e-03
|
9.90e-01
|
GO:0043154 BP negative regulation of cysteine-type endopeptidase activity involved in apoptotic process
|
32
|
9.75e-01
|
3.18e-03
|
9.90e-01
|
GO:0072593 BP reactive oxygen species metabolic process
|
27
|
9.80e-01
|
-2.76e-03
|
9.92e-01
|
GO:0042102 BP positive regulation of T cell proliferation
|
33
|
9.78e-01
|
2.72e-03
|
9.91e-01
|
GO:0001541 BP ovarian follicle development
|
31
|
9.79e-01
|
-2.68e-03
|
9.92e-01
|
GO:0051918 BP negative regulation of fibrinolysis
|
11
|
9.88e-01
|
2.67e-03
|
9.94e-01
|
GO:0035774 BP positive regulation of insulin secretion involved in cellular response to glucose stimulus
|
19
|
9.84e-01
|
2.67e-03
|
9.92e-01
|
GO:0032496 BP response to lipopolysaccharide
|
82
|
9.67e-01
|
-2.66e-03
|
9.89e-01
|
GO:0045600 BP positive regulation of fat cell differentiation
|
32
|
9.81e-01
|
2.43e-03
|
9.92e-01
|
GO:0032869 BP cellular response to insulin stimulus
|
74
|
9.72e-01
|
2.39e-03
|
9.90e-01
|
GO:0035116 BP embryonic hindlimb morphogenesis
|
19
|
9.87e-01
|
-2.21e-03
|
9.94e-01
|
GO:0010628 BP positive regulation of gene expression
|
306
|
9.50e-01
|
2.07e-03
|
9.86e-01
|
GO:0050768 BP negative regulation of neurogenesis
|
17
|
9.89e-01
|
2.01e-03
|
9.94e-01
|
GO:0042692 BP muscle cell differentiation
|
14
|
9.91e-01
|
1.83e-03
|
9.96e-01
|
GO:1901224 BP positive regulation of non-canonical NF-kappaB signal transduction
|
45
|
9.84e-01
|
-1.77e-03
|
9.92e-01
|
GO:0097352 BP autophagosome maturation
|
45
|
9.85e-01
|
-1.60e-03
|
9.93e-01
|
GO:0007399 BP nervous system development
|
252
|
9.66e-01
|
-1.55e-03
|
9.89e-01
|
GO:0051592 BP response to calcium ion
|
40
|
9.87e-01
|
-1.54e-03
|
9.94e-01
|
GO:0045725 BP positive regulation of glycogen biosynthetic process
|
11
|
9.93e-01
|
-1.43e-03
|
9.97e-01
|
GO:0008150 BP biological process
|
351
|
9.66e-01
|
-1.35e-03
|
9.89e-01
|
GO:0051603 BP proteolysis involved in protein catabolic process
|
26
|
9.91e-01
|
-1.30e-03
|
9.96e-01
|
GO:0002931 BP response to ischemia
|
48
|
9.88e-01
|
-1.24e-03
|
9.94e-01
|
GO:0060071 BP Wnt signaling pathway, planar cell polarity pathway
|
28
|
9.92e-01
|
-1.11e-03
|
9.96e-01
|
GO:1900407 BP regulation of cellular response to oxidative stress
|
10
|
9.95e-01
|
-1.08e-03
|
9.97e-01
|
GO:2000647 BP negative regulation of stem cell proliferation
|
15
|
9.94e-01
|
-1.05e-03
|
9.97e-01
|
GO:0018149 BP peptide cross-linking
|
10
|
9.96e-01
|
-9.84e-04
|
9.97e-01
|
GO:2000008 BP regulation of protein localization to cell surface
|
10
|
9.96e-01
|
-8.90e-04
|
9.97e-01
|
GO:0010596 BP negative regulation of endothelial cell migration
|
16
|
9.95e-01
|
8.42e-04
|
9.97e-01
|
GO:0034394 BP protein localization to cell surface
|
26
|
9.95e-01
|
6.85e-04
|
9.97e-01
|
GO:0032402 BP melanosome transport
|
17
|
9.97e-01
|
4.55e-04
|
9.98e-01
|
GO:0150104 BP transport across blood-brain barrier
|
59
|
9.96e-01
|
-3.46e-04
|
9.97e-01
|
GO:0006919 BP activation of cysteine-type endopeptidase activity involved in apoptotic process
|
56
|
1.00e+00
|
1.89e-05
|
1.00e+00
|